<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://hdl.handle.net/10023/176" />
  <subtitle />
  <id>http://hdl.handle.net/10023/176</id>
  <updated>2013-06-18T20:49:59Z</updated>
  <dc:date>2013-06-18T20:49:59Z</dc:date>
  <entry>
    <title>Structure of the archaeal Cascade subunit Csa5 : Relating the small subunits of CRISPR effector complexes</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3550" />
    <author>
      <name>Reeks, Judith Anne</name>
    </author>
    <author>
      <name>Graham, Shirley</name>
    </author>
    <author>
      <name>Liu, Huanting</name>
    </author>
    <author>
      <name>White, Malcolm F</name>
    </author>
    <author>
      <name>Naismith, Jim</name>
    </author>
    <id>http://hdl.handle.net/10023/3550</id>
    <updated>2013-05-24T11:01:02Z</updated>
    <published>2013-05-01T00:00:00Z</published>
    <summary type="text">Abstract: The Cascade complex for CRISPR-mediated antiviral immunity uses CRISPR RNA (crRNA) to target invading DNA species from mobile elements such as viruses, leading to their destruction. The core of the Cascade effector complex consists of the Cas5 and Cas7 subunits, which are widely conserved in prokaryotes. Cas7 binds crRNA and forms the helical backbone of Cascade. Many archaea encode a version of the Cascade complex (denoted Type I-A) that includes a Csa5 (or small) subunit, which interacts weakly with the core proteins. Here, we report the crystal structure of the Csa5 protein from Sulfolobus solfataricus. Csa5 comprises a conserved α-helical domain with a small insertion consisting of a weakly conserved β-strand domain. In the crystal, the Csa5 monomers have multimerized into infinite helical threads. At each interface is a strictly conserved intersubunit salt bridge, deletion of which disrupts multimerization. Structural analysis indicates a shared evolutionary history among the small subunits of the CRISPR effector complexes. The same α-helical domain is found in the C-terminal domain of Cse2 (from Type I-E Cascade), while the N-terminal domain of Cse2 is found in Cmr5 of the CMR (Type III-B) effector complex. As Cmr5 shares no match with Csa5, two possibilities present themselves: selective domain loss from an ancestral Cse2 to create two new subfamilies or domain fusion of two separate families to create a new Cse2 family. A definitive answer awaits structural studies of further small subunits from other CRISPR effector complexes.
Description: This work was funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) (REF: BB/G011400/1) to M.F.W. and J.H.N. and a BBSRC-funded studentship to J.R.</summary>
    <dc:date>2013-05-01T00:00:00Z</dc:date>
    <dc:creator>Reeks, Judith Anne</dc:creator>
    <dc:creator>Graham, Shirley</dc:creator>
    <dc:creator>Liu, Huanting</dc:creator>
    <dc:creator>White, Malcolm F</dc:creator>
    <dc:creator>Naismith, Jim</dc:creator>
    <dc:description>The Cascade complex for CRISPR-mediated antiviral immunity uses CRISPR RNA (crRNA) to target invading DNA species from mobile elements such as viruses, leading to their destruction. The core of the Cascade effector complex consists of the Cas5 and Cas7 subunits, which are widely conserved in prokaryotes. Cas7 binds crRNA and forms the helical backbone of Cascade. Many archaea encode a version of the Cascade complex (denoted Type I-A) that includes a Csa5 (or small) subunit, which interacts weakly with the core proteins. Here, we report the crystal structure of the Csa5 protein from Sulfolobus solfataricus. Csa5 comprises a conserved α-helical domain with a small insertion consisting of a weakly conserved β-strand domain. In the crystal, the Csa5 monomers have multimerized into infinite helical threads. At each interface is a strictly conserved intersubunit salt bridge, deletion of which disrupts multimerization. Structural analysis indicates a shared evolutionary history among the small subunits of the CRISPR effector complexes. The same α-helical domain is found in the C-terminal domain of Cse2 (from Type I-E Cascade), while the N-terminal domain of Cse2 is found in Cmr5 of the CMR (Type III-B) effector complex. As Cmr5 shares no match with Csa5, two possibilities present themselves: selective domain loss from an ancestral Cse2 to create two new subfamilies or domain fusion of two separate families to create a new Cse2 family. A definitive answer awaits structural studies of further small subunits from other CRISPR effector complexes.</dc:description>
  </entry>
  <entry>
    <title>Structural insights into the mechanism and inhibition of the beta-Hydroxydecanoyl-Acyl carrier protein dehydratase from pseudomonas aeruginosa</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3510" />
    <author>
      <name>Moynie, Lucile</name>
    </author>
    <author>
      <name>Leckie, Stuart M.</name>
    </author>
    <author>
      <name>McMahon, Stephen A.</name>
    </author>
    <author>
      <name>Duthie, Fraser G.</name>
    </author>
    <author>
      <name>Koehnke, Alessa</name>
    </author>
    <author>
      <name>Taylor, James W.</name>
    </author>
    <author>
      <name>Alphey, Magnus S.</name>
    </author>
    <author>
      <name>Brenk, Ruth</name>
    </author>
    <author>
      <name>Smith, Andrew D.</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <id>http://hdl.handle.net/10023/3510</id>
    <updated>2013-05-03T13:01:03Z</updated>
    <published>2013-01-23T00:00:00Z</published>
    <summary type="text">Abstract: Fatty acid biosynthesis is an essential component of metabolism in both eukaryotes and prokaryotes. The fatty acid biosynthetic pathway of Gram-negative bacteria is an established therapeutic target. Two homologous enzymes FabA and FabZ catalyze a key step in fatty acid biosynthesis; both dehydrate hydroxyacyl fatty acids that are coupled via a phosphopantetheine to an acyl carrier protein (ACP). The resulting trans-2-enoyl-ACP is further polymerized in a processive manner. FabA, however, carries out a second reaction involving isomerization of trans-2-enoyl fatty acid to cis-3-enoyl fatty acid. We have solved the structure of Pseudomonas aeruginosa FabA with a substrate allowing detailed molecular insight into the interactions of the active site. This has allowed a detailed examination of the factors governing the second catalytic step. We have also determined the structure of FabA in complex with small molecules (so-called fragments). These small molecules occupy distinct regions of the active site and form the basis for a rational inhibitor design program. (C) 2012 Elsevier Ltd. All rights reserved.</summary>
    <dc:date>2013-01-23T00:00:00Z</dc:date>
    <dc:creator>Moynie, Lucile</dc:creator>
    <dc:creator>Leckie, Stuart M.</dc:creator>
    <dc:creator>McMahon, Stephen A.</dc:creator>
    <dc:creator>Duthie, Fraser G.</dc:creator>
    <dc:creator>Koehnke, Alessa</dc:creator>
    <dc:creator>Taylor, James W.</dc:creator>
    <dc:creator>Alphey, Magnus S.</dc:creator>
    <dc:creator>Brenk, Ruth</dc:creator>
    <dc:creator>Smith, Andrew D.</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:description>Fatty acid biosynthesis is an essential component of metabolism in both eukaryotes and prokaryotes. The fatty acid biosynthetic pathway of Gram-negative bacteria is an established therapeutic target. Two homologous enzymes FabA and FabZ catalyze a key step in fatty acid biosynthesis; both dehydrate hydroxyacyl fatty acids that are coupled via a phosphopantetheine to an acyl carrier protein (ACP). The resulting trans-2-enoyl-ACP is further polymerized in a processive manner. FabA, however, carries out a second reaction involving isomerization of trans-2-enoyl fatty acid to cis-3-enoyl fatty acid. We have solved the structure of Pseudomonas aeruginosa FabA with a substrate allowing detailed molecular insight into the interactions of the active site. This has allowed a detailed examination of the factors governing the second catalytic step. We have also determined the structure of FabA in complex with small molecules (so-called fragments). These small molecules occupy distinct regions of the active site and form the basis for a rational inhibitor design program. (C) 2012 Elsevier Ltd. All rights reserved.</dc:description>
  </entry>
  <entry>
    <title>Mechanistic insights into the triazolylidene-catalysed Stetter and benzoin reactions : role of the N-aryl substituent</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3509" />
    <author>
      <name>Collett, Christopher J.</name>
    </author>
    <author>
      <name>Massey, Richard S.</name>
    </author>
    <author>
      <name>Maguire, Oliver R.</name>
    </author>
    <author>
      <name>Batsanov, Andrei S.</name>
    </author>
    <author>
      <name>O'Donoghue, AnnMarie C.</name>
    </author>
    <author>
      <name>Smith, Andrew D.</name>
    </author>
    <id>http://hdl.handle.net/10023/3509</id>
    <updated>2013-05-03T12:31:02Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Abstract: The in situ observation, isolation and reversible formation of intermediate 3-(hydroxybenzyl) azolium salts derived from NHC addition to a range of substituted benzaldehydes is probed. Equilibrium constants for the formation of these 3-(hydroxybenzyl) azolium salts, as well as rate constants of hydrogen-deuterium exchange (k(ex)) at C(alpha) of these intermediates for a range of N-aryl triazolinylidenes is reported. These combined studies give insight into the preference of N-pentafluorophenyl NHCs to participate in benzoin and Stetter reaction processes.</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
    <dc:creator>Collett, Christopher J.</dc:creator>
    <dc:creator>Massey, Richard S.</dc:creator>
    <dc:creator>Maguire, Oliver R.</dc:creator>
    <dc:creator>Batsanov, Andrei S.</dc:creator>
    <dc:creator>O'Donoghue, AnnMarie C.</dc:creator>
    <dc:creator>Smith, Andrew D.</dc:creator>
    <dc:description>The in situ observation, isolation and reversible formation of intermediate 3-(hydroxybenzyl) azolium salts derived from NHC addition to a range of substituted benzaldehydes is probed. Equilibrium constants for the formation of these 3-(hydroxybenzyl) azolium salts, as well as rate constants of hydrogen-deuterium exchange (k(ex)) at C(alpha) of these intermediates for a range of N-aryl triazolinylidenes is reported. These combined studies give insight into the preference of N-pentafluorophenyl NHCs to participate in benzoin and Stetter reaction processes.</dc:description>
  </entry>
  <entry>
    <title>Willin, an upstream component of the Hippo signaling pathway, orchestrates mammalian peripheral nerve fibroblasts</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3474" />
    <author>
      <name>Moleirinho, Susan</name>
    </author>
    <author>
      <name>Patrick, Calum</name>
    </author>
    <author>
      <name>Tilston-Lunel, Andrew Martin</name>
    </author>
    <author>
      <name>Higginson, JR</name>
    </author>
    <author>
      <name>Angus, Liselotte</name>
    </author>
    <author>
      <name>Antkowiak, Maciej</name>
    </author>
    <author>
      <name>Barnett, Susan</name>
    </author>
    <author>
      <name>Prystowsky, Michael</name>
    </author>
    <author>
      <name>Reynolds, Paul Andrew</name>
    </author>
    <author>
      <name>Gunn-Moore, Frank J</name>
    </author>
    <id>http://hdl.handle.net/10023/3474</id>
    <updated>2013-06-02T00:31:51Z</updated>
    <published>2013-04-08T00:00:00Z</published>
    <summary type="text">Abstract: Willin/FRMD6 was first identified in the rat sciatic nerve, which is composed of neurons, Schwann cells, and fibroblasts. Willin is an upstream component of the Hippo signaling pathway, which results in the inactivation of the transcriptional coactivator YAP through Ser127 phosphorylation. This in turn suppresses the expression of genes involved in cell growth, proliferation and cancer development ensuring the control of organ size, cell contact inhibition and apoptosis. Here we show that in the mammalian sciatic nerve, Willin is predominantly expressed in fibroblasts and that Willin expression activates the Hippo signaling cascade and induces YAP translocation from the nucleus to the cytoplasm. In addition within these cells, although it inhibits cellular proliferation, Willin expression induces a quicker directional migration towards scratch closure and an increased expression of factors linked to nerve regeneration. These results show that Willin modulates sciatic nerve fibroblast activity indicating that Willin may have a potential role in the regeneration of the peripheral nervous system.</summary>
    <dc:date>2013-04-08T00:00:00Z</dc:date>
    <dc:creator>Moleirinho, Susan</dc:creator>
    <dc:creator>Patrick, Calum</dc:creator>
    <dc:creator>Tilston-Lunel, Andrew Martin</dc:creator>
    <dc:creator>Higginson, JR</dc:creator>
    <dc:creator>Angus, Liselotte</dc:creator>
    <dc:creator>Antkowiak, Maciej</dc:creator>
    <dc:creator>Barnett, Susan</dc:creator>
    <dc:creator>Prystowsky, Michael</dc:creator>
    <dc:creator>Reynolds, Paul Andrew</dc:creator>
    <dc:creator>Gunn-Moore, Frank J</dc:creator>
    <dc:description>Willin/FRMD6 was first identified in the rat sciatic nerve, which is composed of neurons, Schwann cells, and fibroblasts. Willin is an upstream component of the Hippo signaling pathway, which results in the inactivation of the transcriptional coactivator YAP through Ser127 phosphorylation. This in turn suppresses the expression of genes involved in cell growth, proliferation and cancer development ensuring the control of organ size, cell contact inhibition and apoptosis. Here we show that in the mammalian sciatic nerve, Willin is predominantly expressed in fibroblasts and that Willin expression activates the Hippo signaling cascade and induces YAP translocation from the nucleus to the cytoplasm. In addition within these cells, although it inhibits cellular proliferation, Willin expression induces a quicker directional migration towards scratch closure and an increased expression of factors linked to nerve regeneration. These results show that Willin modulates sciatic nerve fibroblast activity indicating that Willin may have a potential role in the regeneration of the peripheral nervous system.</dc:description>
  </entry>
  <entry>
    <title>Synthesis of phosphonate and phostone analogues of ribose-1-phosphates</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3444" />
    <author>
      <name>Nasomjai, Pitak</name>
    </author>
    <author>
      <name>O'Hagan, David</name>
    </author>
    <author>
      <name>Slawin, Alexandra M. Z.</name>
    </author>
    <id>http://hdl.handle.net/10023/3444</id>
    <updated>2013-05-12T04:10:23Z</updated>
    <published>2009-07-27T00:00:00Z</published>
    <summary type="text">Abstract: The synthesis of phosphonate analogues of ribose-1-phosphate and 5-fluoro-5-deoxyribose-1-phosphate is described. Preparations of both the alpha- and beta-phosphonate anomers are reported for the ribose and 5-fluoro-5-deoxyribose series and a synthesis of the corresponding cyclic phostones of each alpha-ribose is also reported. These compounds have been prepared as tools to probe the details of fluorometabolism in S. cattleya.</summary>
    <dc:date>2009-07-27T00:00:00Z</dc:date>
    <dc:creator>Nasomjai, Pitak</dc:creator>
    <dc:creator>O'Hagan, David</dc:creator>
    <dc:creator>Slawin, Alexandra M. Z.</dc:creator>
    <dc:description>The synthesis of phosphonate analogues of ribose-1-phosphate and 5-fluoro-5-deoxyribose-1-phosphate is described. Preparations of both the alpha- and beta-phosphonate anomers are reported for the ribose and 5-fluoro-5-deoxyribose series and a synthesis of the corresponding cyclic phostones of each alpha-ribose is also reported. These compounds have been prepared as tools to probe the details of fluorometabolism in S. cattleya.</dc:description>
  </entry>
  <entry>
    <title>Three step synthesis of single diastereoisomers of the vicinal trifluoro motif</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3443" />
    <author>
      <name>Brunet, Vincent A.</name>
    </author>
    <author>
      <name>Slawin, Alexandra M. Z.</name>
    </author>
    <author>
      <name>O'Hagan, David</name>
    </author>
    <id>http://hdl.handle.net/10023/3443</id>
    <updated>2013-05-12T04:10:18Z</updated>
    <published>2009-11-05T00:00:00Z</published>
    <summary type="text">Abstract: A three step route to single diastereoisomers of the vicinal trifluoromethyl motif is described. The route starts from either syn- or anti-alpha,beta-epoxy alcohols and takes a direct approach in that each of the three steps introduces a fluorine atom in a regio- and stereospecific manner. Starting from either the syn- or the anti-alpha,beta-epoxy alcohol, stereospecific reactions generate two separate diastereoisomeric series of this motif. The route is a significant improvement on an earlier six step strategy.</summary>
    <dc:date>2009-11-05T00:00:00Z</dc:date>
    <dc:creator>Brunet, Vincent A.</dc:creator>
    <dc:creator>Slawin, Alexandra M. Z.</dc:creator>
    <dc:creator>O'Hagan, David</dc:creator>
    <dc:description>A three step route to single diastereoisomers of the vicinal trifluoromethyl motif is described. The route starts from either syn- or anti-alpha,beta-epoxy alcohols and takes a direct approach in that each of the three steps introduces a fluorine atom in a regio- and stereospecific manner. Starting from either the syn- or the anti-alpha,beta-epoxy alcohol, stereospecific reactions generate two separate diastereoisomeric series of this motif. The route is a significant improvement on an earlier six step strategy.</dc:description>
  </entry>
  <entry>
    <title>Crenarchaeal chromatin proteins Cren7 and Sul7 compact DNA by inducing rigid bends</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3440" />
    <author>
      <name>Driessen, Rosalie P. C.</name>
    </author>
    <author>
      <name>Meng, He</name>
    </author>
    <author>
      <name>Suresh, Gorle</name>
    </author>
    <author>
      <name>Shahapure, Rajesh</name>
    </author>
    <author>
      <name>Lanzani, Giovanni</name>
    </author>
    <author>
      <name>Priyakumar, U. Deva</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <author>
      <name>Schiessel, Helmut</name>
    </author>
    <author>
      <name>van Noort, John</name>
    </author>
    <author>
      <name>Dame, Remus Th</name>
    </author>
    <id>http://hdl.handle.net/10023/3440</id>
    <updated>2013-03-27T16:01:02Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Archaeal chromatin proteins share molecular and functional similarities with both bacterial and eukaryotic chromatin proteins. These proteins play an important role in functionally organizing the genomic DNA into a compact nucleoid. Cren7 and Sul7 are two crenarchaeal nucleoid-associated proteins, which are structurally homologous, but not conserved at the sequence level. Co-crystal structures have shown that these two proteins induce a sharp bend on binding to DNA. In this study, we have investigated the architectural properties of these proteins using atomic force microscopy, molecular dynamics simulations and magnetic tweezers. We demonstrate that Cren7 and Sul7 both compact DNA molecules to a similar extent. Using a theoretical model, we quantify the number of individual proteins bound to the DNA as a function of protein concentration and show that forces up to 3.5 pN do not affect this binding. Moreover, we investigate the flexibility of the bending angle induced by Cren7 and Sul7 and show that the protein-DNA complexes differ in flexibility from analogous bacterial and eukaryotic DNA-bending proteins.</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
    <dc:creator>Driessen, Rosalie P. C.</dc:creator>
    <dc:creator>Meng, He</dc:creator>
    <dc:creator>Suresh, Gorle</dc:creator>
    <dc:creator>Shahapure, Rajesh</dc:creator>
    <dc:creator>Lanzani, Giovanni</dc:creator>
    <dc:creator>Priyakumar, U. Deva</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:creator>Schiessel, Helmut</dc:creator>
    <dc:creator>van Noort, John</dc:creator>
    <dc:creator>Dame, Remus Th</dc:creator>
    <dc:description>Archaeal chromatin proteins share molecular and functional similarities with both bacterial and eukaryotic chromatin proteins. These proteins play an important role in functionally organizing the genomic DNA into a compact nucleoid. Cren7 and Sul7 are two crenarchaeal nucleoid-associated proteins, which are structurally homologous, but not conserved at the sequence level. Co-crystal structures have shown that these two proteins induce a sharp bend on binding to DNA. In this study, we have investigated the architectural properties of these proteins using atomic force microscopy, molecular dynamics simulations and magnetic tweezers. We demonstrate that Cren7 and Sul7 both compact DNA molecules to a similar extent. Using a theoretical model, we quantify the number of individual proteins bound to the DNA as a function of protein concentration and show that forces up to 3.5 pN do not affect this binding. Moreover, we investigate the flexibility of the bending angle induced by Cren7 and Sul7 and show that the protein-DNA complexes differ in flexibility from analogous bacterial and eukaryotic DNA-bending proteins.</dc:description>
  </entry>
  <entry>
    <title>hSSB1 interacts directly with the MRN complex stimulating its recruitment to DNA double-strand breaks and its endo-nuclease activity</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3439" />
    <author>
      <name>Richard, Derek J.</name>
    </author>
    <author>
      <name>Cubeddu, Liza</name>
    </author>
    <author>
      <name>Urquhart, Aaron J.</name>
    </author>
    <author>
      <name>Bain, Amanda</name>
    </author>
    <author>
      <name>Bolderson, Emma</name>
    </author>
    <author>
      <name>Menon, Dinoop</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <author>
      <name>Khanna, Kum Kum</name>
    </author>
    <id>http://hdl.handle.net/10023/3439</id>
    <updated>2013-06-16T00:33:52Z</updated>
    <published>2011-05-01T00:00:00Z</published>
    <summary type="text">Abstract: hSSB1 is a recently discovered single-stranded DNA binding protein that is essential for efficient repair of DNA double-strand breaks (DSBs) by the homologous recombination pathway. hSSB1 is required for the efficient recruitment of the MRN complex to sites of DSBs and for the efficient initiation of ATM dependent signalling. Here we explore the interplay between hSSB1 and MRN. We demonstrate that hSSB1 binds directly to NBS1, a component of the MRN complex, in a DNA damage independent manner. Consistent with the direct interaction, we observe that hSSB1 greatly stimulates the endo-nuclease activity of the MRN complex, a process that requires the C-terminal tail of hSSB1. Interestingly, analysis of two point mutations in NBS1, associated with Nijmegen breakage syndrome, revealed weaker binding to hSSB1, suggesting a possible disease mechanism.</summary>
    <dc:date>2011-05-01T00:00:00Z</dc:date>
    <dc:creator>Richard, Derek J.</dc:creator>
    <dc:creator>Cubeddu, Liza</dc:creator>
    <dc:creator>Urquhart, Aaron J.</dc:creator>
    <dc:creator>Bain, Amanda</dc:creator>
    <dc:creator>Bolderson, Emma</dc:creator>
    <dc:creator>Menon, Dinoop</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:creator>Khanna, Kum Kum</dc:creator>
    <dc:description>hSSB1 is a recently discovered single-stranded DNA binding protein that is essential for efficient repair of DNA double-strand breaks (DSBs) by the homologous recombination pathway. hSSB1 is required for the efficient recruitment of the MRN complex to sites of DSBs and for the efficient initiation of ATM dependent signalling. Here we explore the interplay between hSSB1 and MRN. We demonstrate that hSSB1 binds directly to NBS1, a component of the MRN complex, in a DNA damage independent manner. Consistent with the direct interaction, we observe that hSSB1 greatly stimulates the endo-nuclease activity of the MRN complex, a process that requires the C-terminal tail of hSSB1. Interestingly, analysis of two point mutations in NBS1, associated with Nijmegen breakage syndrome, revealed weaker binding to hSSB1, suggesting a possible disease mechanism.</dc:description>
  </entry>
  <entry>
    <title>hSSB1 rapidly binds at the sites of DNA double-strand breaks and is required for the efficient recruitment of the MRN complex</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3438" />
    <author>
      <name>Richard, Derek J.</name>
    </author>
    <author>
      <name>Savage, Kienan</name>
    </author>
    <author>
      <name>Bolderson, Emma</name>
    </author>
    <author>
      <name>Cubeddu, Liza</name>
    </author>
    <author>
      <name>So, Sairei</name>
    </author>
    <author>
      <name>Ghita, Mihaela</name>
    </author>
    <author>
      <name>Chen, David J.</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <author>
      <name>Richard, Kerry</name>
    </author>
    <author>
      <name>Prise, Kevin M.</name>
    </author>
    <author>
      <name>Schettino, Giuseppe</name>
    </author>
    <author>
      <name>Khanna, Kum Kum</name>
    </author>
    <id>http://hdl.handle.net/10023/3438</id>
    <updated>2013-06-16T00:33:48Z</updated>
    <published>2011-03-01T00:00:00Z</published>
    <summary type="text">Abstract: hSSB1 is a newly discovered single-stranded DNA (ssDNA)-binding protein that is essential for efficient DNA double-strand break signalling through ATM. However, the mechanism by which hSSB1 functions to allow efficient signalling is unknown. Here, we show that hSSB1 is recruited rapidly to sites of double-strand DNA breaks (DSBs) in all interphase cells (G1, S and G2) independently of, CtIP, MDC1 and the MRN complex (Rad50, Mre11, NBS1). However expansion of hSSB1 from the DSB site requires the function of MRN. Strikingly, silencing of hSSB1 prevents foci formation as well as recruitment of MRN to sites of DSBs and leads to a subsequent defect in resection of DSBs as evident by defective RPA and ssDNA generation. Our data suggests that hSSB1 functions upstream of MRN to promote its recruitment at DSBs and is required for efficient resection of DSBs. These findings, together with previous work establish essential roles of hSSB1 in controlling ATM activation and activity, and subsequent DSB resection and homologous recombination (HR).</summary>
    <dc:date>2011-03-01T00:00:00Z</dc:date>
    <dc:creator>Richard, Derek J.</dc:creator>
    <dc:creator>Savage, Kienan</dc:creator>
    <dc:creator>Bolderson, Emma</dc:creator>
    <dc:creator>Cubeddu, Liza</dc:creator>
    <dc:creator>So, Sairei</dc:creator>
    <dc:creator>Ghita, Mihaela</dc:creator>
    <dc:creator>Chen, David J.</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:creator>Richard, Kerry</dc:creator>
    <dc:creator>Prise, Kevin M.</dc:creator>
    <dc:creator>Schettino, Giuseppe</dc:creator>
    <dc:creator>Khanna, Kum Kum</dc:creator>
    <dc:description>hSSB1 is a newly discovered single-stranded DNA (ssDNA)-binding protein that is essential for efficient DNA double-strand break signalling through ATM. However, the mechanism by which hSSB1 functions to allow efficient signalling is unknown. Here, we show that hSSB1 is recruited rapidly to sites of double-strand DNA breaks (DSBs) in all interphase cells (G1, S and G2) independently of, CtIP, MDC1 and the MRN complex (Rad50, Mre11, NBS1). However expansion of hSSB1 from the DSB site requires the function of MRN. Strikingly, silencing of hSSB1 prevents foci formation as well as recruitment of MRN to sites of DSBs and leads to a subsequent defect in resection of DSBs as evident by defective RPA and ssDNA generation. Our data suggests that hSSB1 functions upstream of MRN to promote its recruitment at DSBs and is required for efficient resection of DSBs. These findings, together with previous work establish essential roles of hSSB1 in controlling ATM activation and activity, and subsequent DSB resection and homologous recombination (HR).</dc:description>
  </entry>
  <entry>
    <title>Crystallization of Ranasmurfin, a blue coloured protein from Polypedates leucomystax</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3437" />
    <author>
      <name>McMahon, Stephen</name>
    </author>
    <author>
      <name>Walsh, MA</name>
    </author>
    <author>
      <name>Ching, RTY</name>
    </author>
    <author>
      <name>Carter, Lester</name>
    </author>
    <author>
      <name>Dorward, M</name>
    </author>
    <author>
      <name>Johnson, Kenneth Alan</name>
    </author>
    <author>
      <name>Liu, Huanting</name>
    </author>
    <author>
      <name>Oke, Muse</name>
    </author>
    <author>
      <name>Block Jr, C</name>
    </author>
    <author>
      <name>Kennedy, MW</name>
    </author>
    <author>
      <name>Latiff, AA</name>
    </author>
    <author>
      <name>Cooper, A</name>
    </author>
    <author>
      <name>Taylor, Garry Lindsay</name>
    </author>
    <author>
      <name>White, Malcolm Frederick</name>
    </author>
    <author>
      <name>Naismith, James Henderson</name>
    </author>
    <id>http://hdl.handle.net/10023/3437</id>
    <updated>2013-05-12T02:01:33Z</updated>
    <published>2006-11-01T00:00:00Z</published>
    <summary type="text">Abstract: Ranasmurfin, a previously uncharacterized similar to 13 kDa blue protein found in the nests of the frog Polypedates leucomystax, has been purified and crystallized. The crystals are an intense blue colour and diffract to 1.51 angstrom with P2(1) symmetry and unit-cell parameters a = 40.9, b = 59.9, c = 45.0 angstrom, beta = 93.3 degrees. Self-rotation function analysis indicates the presence of a dimer in the asymmetric unit. Biochemical data suggest that the blue colour of the protein is related to dimer formation. Sequence data for the protein are incomplete, but thus far have identified no model for molecular replacement. A fluorescence scan shows a peak at 9.676 keV, indicating that the protein binds zinc and suggesting a route for structure solution.</summary>
    <dc:date>2006-11-01T00:00:00Z</dc:date>
    <dc:creator>McMahon, Stephen</dc:creator>
    <dc:creator>Walsh, MA</dc:creator>
    <dc:creator>Ching, RTY</dc:creator>
    <dc:creator>Carter, Lester</dc:creator>
    <dc:creator>Dorward, M</dc:creator>
    <dc:creator>Johnson, Kenneth Alan</dc:creator>
    <dc:creator>Liu, Huanting</dc:creator>
    <dc:creator>Oke, Muse</dc:creator>
    <dc:creator>Block Jr, C</dc:creator>
    <dc:creator>Kennedy, MW</dc:creator>
    <dc:creator>Latiff, AA</dc:creator>
    <dc:creator>Cooper, A</dc:creator>
    <dc:creator>Taylor, Garry Lindsay</dc:creator>
    <dc:creator>White, Malcolm Frederick</dc:creator>
    <dc:creator>Naismith, James Henderson</dc:creator>
    <dc:description>Ranasmurfin, a previously uncharacterized similar to 13 kDa blue protein found in the nests of the frog Polypedates leucomystax, has been purified and crystallized. The crystals are an intense blue colour and diffract to 1.51 angstrom with P2(1) symmetry and unit-cell parameters a = 40.9, b = 59.9, c = 45.0 angstrom, beta = 93.3 degrees. Self-rotation function analysis indicates the presence of a dimer in the asymmetric unit. Biochemical data suggest that the blue colour of the protein is related to dimer formation. Sequence data for the protein are incomplete, but thus far have identified no model for molecular replacement. A fluorescence scan shows a peak at 9.676 keV, indicating that the protein binds zinc and suggesting a route for structure solution.</dc:description>
  </entry>
  <entry>
    <title>Single-molecule chemical denaturation of riboswitches</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3427" />
    <author>
      <name>Dalgarno, Paul Allan</name>
    </author>
    <author>
      <name>Bordello, J</name>
    </author>
    <author>
      <name>Morris, Rhodri</name>
    </author>
    <author>
      <name>St-Pierre, P</name>
    </author>
    <author>
      <name>Dubé, A</name>
    </author>
    <author>
      <name>Samuel, Ifor David William</name>
    </author>
    <author>
      <name>Lafontaine, Daniel</name>
    </author>
    <author>
      <name>Penedo-Esteiro, Juan Carlos</name>
    </author>
    <id>http://hdl.handle.net/10023/3427</id>
    <updated>2013-04-18T11:31:04Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Abstract: To date, single-molecule RNA science has been developed almost exclusively around the effect of metal ions as folding promoters and stabilizers of the RNA structure. Here, we introduce a novel strategy that combines single-molecule Förster resonance energy transfer (FRET) and chemical denaturation to observe and manipulate RNA dynamics. We demonstrate that the competing interplay between metal ions and denaturant agents provides a platform to extract information that otherwise will remain hidden with current methods. Using the adenine-sensing riboswitch aptamer as a model, we provide strong evidence for a rate-limiting folding step of the aptamer domain being modulated through ligand binding, a feature that is important for regulation of the controlled gene. In the absence of ligand, the rate-determining step is dominated by the formation of long-range key tertiary contacts between peripheral stem-loop elements. In contrast, when the adenine ligand interacts with partially folded messenger RNAs, the aptamer requires specifically bound Mg2+ ions, as those observed in the crystal structure, to progress further towards the native form. Moreover, despite that the ligand-free and ligand-bound states are indistinguishable by FRET, their different stability against urea-induced denaturation allowed us to discriminate them, even when they coexist within a single FRET trajectory; a feature not accessible by existing methods.</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
    <dc:creator>Dalgarno, Paul Allan</dc:creator>
    <dc:creator>Bordello, J</dc:creator>
    <dc:creator>Morris, Rhodri</dc:creator>
    <dc:creator>St-Pierre, P</dc:creator>
    <dc:creator>Dubé, A</dc:creator>
    <dc:creator>Samuel, Ifor David William</dc:creator>
    <dc:creator>Lafontaine, Daniel</dc:creator>
    <dc:creator>Penedo-Esteiro, Juan Carlos</dc:creator>
    <dc:description>To date, single-molecule RNA science has been developed almost exclusively around the effect of metal ions as folding promoters and stabilizers of the RNA structure. Here, we introduce a novel strategy that combines single-molecule Förster resonance energy transfer (FRET) and chemical denaturation to observe and manipulate RNA dynamics. We demonstrate that the competing interplay between metal ions and denaturant agents provides a platform to extract information that otherwise will remain hidden with current methods. Using the adenine-sensing riboswitch aptamer as a model, we provide strong evidence for a rate-limiting folding step of the aptamer domain being modulated through ligand binding, a feature that is important for regulation of the controlled gene. In the absence of ligand, the rate-determining step is dominated by the formation of long-range key tertiary contacts between peripheral stem-loop elements. In contrast, when the adenine ligand interacts with partially folded messenger RNAs, the aptamer requires specifically bound Mg2+ ions, as those observed in the crystal structure, to progress further towards the native form. Moreover, despite that the ligand-free and ligand-bound states are indistinguishable by FRET, their different stability against urea-induced denaturation allowed us to discriminate them, even when they coexist within a single FRET trajectory; a feature not accessible by existing methods.</dc:description>
  </entry>
  <entry>
    <title>Iso-seco-tanapartholides : isolation, synthesis and biological evaluation</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3420" />
    <author>
      <name>Makiyi, Edward F.</name>
    </author>
    <author>
      <name>Frade, Raquel F. M.</name>
    </author>
    <author>
      <name>Lebl, Tomas</name>
    </author>
    <author>
      <name>Jaffray, Ellis G.</name>
    </author>
    <author>
      <name>Cobb, Susan E.</name>
    </author>
    <author>
      <name>Harvey, Alan L.</name>
    </author>
    <author>
      <name>Slawin, Alexandra M. Z.</name>
    </author>
    <author>
      <name>Hay, Ronald T.</name>
    </author>
    <author>
      <name>Westwood, Nicholas J.</name>
    </author>
    <id>http://hdl.handle.net/10023/3420</id>
    <updated>2013-06-16T04:31:24Z</updated>
    <published>2009-11-01T00:00:00Z</published>
    <summary type="text">Abstract: The isolation, identification and total synthesis of two plant-derived inhibitors of the NF-kappa B signaling pathway from the iso-seco-tanapartholide family of natural products is described. A key step in the efficient reaction sequence is a late-stage oxidative cleavage reaction that was carried out in the absence of protecting groups to give the natural products directly. A detailed comparison of the synthetic material with samples of the natural products proved informative. Biological studies on synthetic material confirmed that these compounds act late in the NF-kappa B signaling pathway. ((C) Wiley-VCH Verlag GmbH &amp; Co. KGaA, 69451 Weinheim, Germany, 2009)</summary>
    <dc:date>2009-11-01T00:00:00Z</dc:date>
    <dc:creator>Makiyi, Edward F.</dc:creator>
    <dc:creator>Frade, Raquel F. M.</dc:creator>
    <dc:creator>Lebl, Tomas</dc:creator>
    <dc:creator>Jaffray, Ellis G.</dc:creator>
    <dc:creator>Cobb, Susan E.</dc:creator>
    <dc:creator>Harvey, Alan L.</dc:creator>
    <dc:creator>Slawin, Alexandra M. Z.</dc:creator>
    <dc:creator>Hay, Ronald T.</dc:creator>
    <dc:creator>Westwood, Nicholas J.</dc:creator>
    <dc:description>The isolation, identification and total synthesis of two plant-derived inhibitors of the NF-kappa B signaling pathway from the iso-seco-tanapartholide family of natural products is described. A key step in the efficient reaction sequence is a late-stage oxidative cleavage reaction that was carried out in the absence of protecting groups to give the natural products directly. A detailed comparison of the synthetic material with samples of the natural products proved informative. Biological studies on synthetic material confirmed that these compounds act late in the NF-kappa B signaling pathway. ((C) Wiley-VCH Verlag GmbH &amp; Co. KGaA, 69451 Weinheim, Germany, 2009)</dc:description>
  </entry>
  <entry>
    <title>Dimer-dimer stacking interactions are important for nucleic acid binding by the archaeal chromatin protein Alba</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3374" />
    <author>
      <name>Jelinska, Clare</name>
    </author>
    <author>
      <name>Petrovic-Stojanovska, Biljana</name>
    </author>
    <author>
      <name>Ingledew, W John</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <id>http://hdl.handle.net/10023/3374</id>
    <updated>2013-06-16T04:31:11Z</updated>
    <published>2010-04-01T00:00:00Z</published>
    <summary type="text">Abstract: Archaea use a variety of small basic proteins to package their DNA. One of the most widespread and highly conserved is the Alba (Sso10b) protein. Alba interacts with both DNA and RNA in vitro, and we show in the present study that it binds more tightly to dsDNA (double-stranded DNA) than to either ssDNA (single-stranded DNA) or RNA. The Alba protein is dimeric in solution, and forms distinct ordered complexes with DNA that have been visualized by electron microscopy studies; these studies suggest that, on binding dsDNA, the protein forms extended helical protein fibres. An end-to-end association of consecutive Alba dimers is suggested by the presence of a dimer-dimer interface in crystal structures of Alba from several species, and by the strong conservation of the interface residues, centred on Are and Phe(60). In the present study we map perturbation of the polypeptide backbone of Alba upon binding to DNA and RNA by NMR, and demonstrate the central role of Phe(60) in forming the dimer dimer interface. Site-directed spin labelling and pulsed ESR are used to confirm that an end-to-end, dimer dimer interaction forms in the presence of dsDNA.</summary>
    <dc:date>2010-04-01T00:00:00Z</dc:date>
    <dc:creator>Jelinska, Clare</dc:creator>
    <dc:creator>Petrovic-Stojanovska, Biljana</dc:creator>
    <dc:creator>Ingledew, W John</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:description>Archaea use a variety of small basic proteins to package their DNA. One of the most widespread and highly conserved is the Alba (Sso10b) protein. Alba interacts with both DNA and RNA in vitro, and we show in the present study that it binds more tightly to dsDNA (double-stranded DNA) than to either ssDNA (single-stranded DNA) or RNA. The Alba protein is dimeric in solution, and forms distinct ordered complexes with DNA that have been visualized by electron microscopy studies; these studies suggest that, on binding dsDNA, the protein forms extended helical protein fibres. An end-to-end association of consecutive Alba dimers is suggested by the presence of a dimer-dimer interface in crystal structures of Alba from several species, and by the strong conservation of the interface residues, centred on Are and Phe(60). In the present study we map perturbation of the polypeptide backbone of Alba upon binding to DNA and RNA by NMR, and demonstrate the central role of Phe(60) in forming the dimer dimer interface. Site-directed spin labelling and pulsed ESR are used to confirm that an end-to-end, dimer dimer interaction forms in the presence of dsDNA.</dc:description>
  </entry>
  <entry>
    <title>A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3359" />
    <author>
      <name>Zhou, Linna</name>
    </author>
    <author>
      <name>Stewart, Gavin</name>
    </author>
    <author>
      <name>Rideau, Emeline</name>
    </author>
    <author>
      <name>Westwood, Nicholas James</name>
    </author>
    <author>
      <name>Smith, Terry K</name>
    </author>
    <id>http://hdl.handle.net/10023/3359</id>
    <updated>2013-05-12T04:36:57Z</updated>
    <published>2013-02-14T00:00:00Z</published>
    <summary type="text">Abstract: Recently, the World Health Organization approved the nifurtimox–eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases. In this study, we have synthesized a series of novel 5-nitro-2-furancarboxylamides that show potent trypanocidal activity, 1000-fold more potent than nifurtimox against in vitro Trypanosoma brucei with very low cytotoxicity against human HeLa cells. More importantly, the most potent analogue showed very limited cross-resistance to nifurtimox-resistant cells and vice versa. This implies that our novel, relatively easy to synthesize and therefore cheap, 5-nitro-2-furancarboxylamides are targeting a different, but still essential, biochemical process to those targeted by nifurtimox or its metabolites in the parasites. The significant increase in potency (smaller dose probably required) has the potential for greatly reducing unwanted side effects and also reducing the likelihood of drug resistance. Collectively, these findings have important implications for the future therapeutic treatment of African sleeping sickness.</summary>
    <dc:date>2013-02-14T00:00:00Z</dc:date>
    <dc:creator>Zhou, Linna</dc:creator>
    <dc:creator>Stewart, Gavin</dc:creator>
    <dc:creator>Rideau, Emeline</dc:creator>
    <dc:creator>Westwood, Nicholas James</dc:creator>
    <dc:creator>Smith, Terry K</dc:creator>
    <dc:description>Recently, the World Health Organization approved the nifurtimox–eflornithine combination therapy for the treatment of human African trypanosomiasis, renewing interest in nitroheterocycle therapies for this and associated diseases. In this study, we have synthesized a series of novel 5-nitro-2-furancarboxylamides that show potent trypanocidal activity, 1000-fold more potent than nifurtimox against in vitro Trypanosoma brucei with very low cytotoxicity against human HeLa cells. More importantly, the most potent analogue showed very limited cross-resistance to nifurtimox-resistant cells and vice versa. This implies that our novel, relatively easy to synthesize and therefore cheap, 5-nitro-2-furancarboxylamides are targeting a different, but still essential, biochemical process to those targeted by nifurtimox or its metabolites in the parasites. The significant increase in potency (smaller dose probably required) has the potential for greatly reducing unwanted side effects and also reducing the likelihood of drug resistance. Collectively, these findings have important implications for the future therapeutic treatment of African sleeping sickness.</dc:description>
  </entry>
  <entry>
    <title>Functional analysis of Leishmania cyclopropane fatty acid synthetase</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3354" />
    <author>
      <name>Oyola, Samuel O.</name>
    </author>
    <author>
      <name>Evans, Krystal J.</name>
    </author>
    <author>
      <name>Smith, Terry K.</name>
    </author>
    <author>
      <name>Smith, Barbara A.</name>
    </author>
    <author>
      <name>Hilley, James D.</name>
    </author>
    <author>
      <name>Mottram, Jeremy C.</name>
    </author>
    <author>
      <name>Kaye, Paul M.</name>
    </author>
    <author>
      <name>Smith, Deborah F.</name>
    </author>
    <id>http://hdl.handle.net/10023/3354</id>
    <updated>2013-02-11T16:31:06Z</updated>
    <published>2012-12-10T00:00:00Z</published>
    <summary type="text">Abstract: The single gene encoding cyclopropane fatty acid synthetase (CFAS) is present in Leishmania infantum, L. mexicana and L. braziliensis but absent from L. major, a causative agent of cutaneous leishmaniasis. In L. infantum, usually causative agent of visceral leishmaniasis, the CFAS gene is transcribed in both insect (extracellular) and host (intracellular) stages of the parasite life cycle. Tagged CFAS protein is stably detected in intracellular L. infantum but only during the early log phase of extracellular growth, when it shows partial localisation to the endoplasmic reticulum. Lipid analyses of L. infantum wild type, CFAS null and complemented parasites detect a low abundance CFAS-dependent C19 Delta fatty acid, characteristic of a cyclopropanated species, in wild type and add-back cells. Sub-cellular fractionation studies locate the C19 Delta fatty acid to both ER and plasma membrane-enriched fractions. This fatty acid is not detectable in wild type L. major, although expression of the L. infantum CFAS gene in L. major generates cyclopropanated fatty acids, indicating that the substrate for this modification is present in L. major, despite the absence of the modifying enzyme. Loss of the L. infantum CFAS gene does not affect extracellular parasite growth, phagocytosis or early survival in macrophages. However, while endocytosis is also unaffected in the extracellular CFAS nulls, membrane transporter activity is defective and the null parasites are more resistant to oxidative stress. Following infection in vivo, L. infantum CFAS nulls exhibit lower parasite burdens in both the liver and spleen of susceptible hosts but it has not been possible to complement this phenotype, suggesting that loss of C19 Delta fatty acid may lead to irreversible changes in cell physiology that cannot be rescued by re-expression. Aberrant cyclopropanation in L. major decreases parasite virulence but does not influence parasite tissue tropism.</summary>
    <dc:date>2012-12-10T00:00:00Z</dc:date>
    <dc:creator>Oyola, Samuel O.</dc:creator>
    <dc:creator>Evans, Krystal J.</dc:creator>
    <dc:creator>Smith, Terry K.</dc:creator>
    <dc:creator>Smith, Barbara A.</dc:creator>
    <dc:creator>Hilley, James D.</dc:creator>
    <dc:creator>Mottram, Jeremy C.</dc:creator>
    <dc:creator>Kaye, Paul M.</dc:creator>
    <dc:creator>Smith, Deborah F.</dc:creator>
    <dc:description>The single gene encoding cyclopropane fatty acid synthetase (CFAS) is present in Leishmania infantum, L. mexicana and L. braziliensis but absent from L. major, a causative agent of cutaneous leishmaniasis. In L. infantum, usually causative agent of visceral leishmaniasis, the CFAS gene is transcribed in both insect (extracellular) and host (intracellular) stages of the parasite life cycle. Tagged CFAS protein is stably detected in intracellular L. infantum but only during the early log phase of extracellular growth, when it shows partial localisation to the endoplasmic reticulum. Lipid analyses of L. infantum wild type, CFAS null and complemented parasites detect a low abundance CFAS-dependent C19 Delta fatty acid, characteristic of a cyclopropanated species, in wild type and add-back cells. Sub-cellular fractionation studies locate the C19 Delta fatty acid to both ER and plasma membrane-enriched fractions. This fatty acid is not detectable in wild type L. major, although expression of the L. infantum CFAS gene in L. major generates cyclopropanated fatty acids, indicating that the substrate for this modification is present in L. major, despite the absence of the modifying enzyme. Loss of the L. infantum CFAS gene does not affect extracellular parasite growth, phagocytosis or early survival in macrophages. However, while endocytosis is also unaffected in the extracellular CFAS nulls, membrane transporter activity is defective and the null parasites are more resistant to oxidative stress. Following infection in vivo, L. infantum CFAS nulls exhibit lower parasite burdens in both the liver and spleen of susceptible hosts but it has not been possible to complement this phenotype, suggesting that loss of C19 Delta fatty acid may lead to irreversible changes in cell physiology that cannot be rescued by re-expression. Aberrant cyclopropanation in L. major decreases parasite virulence but does not influence parasite tissue tropism.</dc:description>
  </entry>
  <entry>
    <title>The AEROPATH project targeting Pseudomonas aeruginosa : crystallographic studies for assessment of potential targets in early-stage drug discovery</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3352" />
    <author>
      <name>Moynie, Lucile</name>
    </author>
    <author>
      <name>Schnell, Robert</name>
    </author>
    <author>
      <name>McMahon, Stephen A.</name>
    </author>
    <author>
      <name>Sandalova, Tatyana</name>
    </author>
    <author>
      <name>Abdelli Boulkeroua, Wassila</name>
    </author>
    <author>
      <name>Schmidberger, Jason W.</name>
    </author>
    <author>
      <name>Alphey, Magnus</name>
    </author>
    <author>
      <name>Cukier, Cyprian</name>
    </author>
    <author>
      <name>Duthie, Fraser</name>
    </author>
    <author>
      <name>Kopec, Jolanta</name>
    </author>
    <author>
      <name>Liu, Huanting</name>
    </author>
    <author>
      <name>Jacewicz, Agata</name>
    </author>
    <author>
      <name>Hunter, William N.</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <author>
      <name>Schneider, Gunter</name>
    </author>
    <id>http://hdl.handle.net/10023/3352</id>
    <updated>2013-05-07T14:38:46Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Bacterial infections are increasingly difficult to treat owing to the spread of antibiotic resistance. A major concern is Gram-negative bacteria, for which the discovery of new antimicrobial drugs has been particularly scarce. In an effort to accelerate early steps in drug discovery, the EU-funded AEROPATH project aims to identify novel targets in the opportunistic pathogen Pseudomonas aeruginosa by applying a multidisciplinary approach encompassing target validation, structural characterization, assay development and hit identification from small-molecule libraries. Here, the strategies used for target selection are described and progress in protein production and structure analysis is reported. Of the 102 selected targets, 84 could be produced in soluble form and the de novo structures of 39 proteins have been determined. The crystal structures of eight of these targets, ranging from hypothetical unknown proteins to metabolic enzymes from different functional classes (PA1645, PA1648, PA2169, PA3770, PA4098, PA4485, PA4992 and PA5259), are reported here. The structural information is expected to provide a firm basis for the improvement of hit compounds identified from fragment-based and high-throughput screening campaigns.</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
    <dc:creator>Moynie, Lucile</dc:creator>
    <dc:creator>Schnell, Robert</dc:creator>
    <dc:creator>McMahon, Stephen A.</dc:creator>
    <dc:creator>Sandalova, Tatyana</dc:creator>
    <dc:creator>Abdelli Boulkeroua, Wassila</dc:creator>
    <dc:creator>Schmidberger, Jason W.</dc:creator>
    <dc:creator>Alphey, Magnus</dc:creator>
    <dc:creator>Cukier, Cyprian</dc:creator>
    <dc:creator>Duthie, Fraser</dc:creator>
    <dc:creator>Kopec, Jolanta</dc:creator>
    <dc:creator>Liu, Huanting</dc:creator>
    <dc:creator>Jacewicz, Agata</dc:creator>
    <dc:creator>Hunter, William N.</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:creator>Schneider, Gunter</dc:creator>
    <dc:description>Bacterial infections are increasingly difficult to treat owing to the spread of antibiotic resistance. A major concern is Gram-negative bacteria, for which the discovery of new antimicrobial drugs has been particularly scarce. In an effort to accelerate early steps in drug discovery, the EU-funded AEROPATH project aims to identify novel targets in the opportunistic pathogen Pseudomonas aeruginosa by applying a multidisciplinary approach encompassing target validation, structural characterization, assay development and hit identification from small-molecule libraries. Here, the strategies used for target selection are described and progress in protein production and structure analysis is reported. Of the 102 selected targets, 84 could be produced in soluble form and the de novo structures of 39 proteins have been determined. The crystal structures of eight of these targets, ranging from hypothetical unknown proteins to metabolic enzymes from different functional classes (PA1645, PA1648, PA2169, PA3770, PA4098, PA4485, PA4992 and PA5259), are reported here. The structural information is expected to provide a firm basis for the improvement of hit compounds identified from fragment-based and high-throughput screening campaigns.</dc:description>
  </entry>
  <entry>
    <title>A small-molecule inhibitor of T. gondii motility induces the posttranslational modification of myosin light chain-1 and inhibits myosin motor activity</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3351" />
    <author>
      <name>Heaslip, Aoife T.</name>
    </author>
    <author>
      <name>Leung, Jacqueline M.</name>
    </author>
    <author>
      <name>Carey, Kimberly L.</name>
    </author>
    <author>
      <name>Catti, Federica</name>
    </author>
    <author>
      <name>Warshaw, David M.</name>
    </author>
    <author>
      <name>Westwood, Nicholas J.</name>
    </author>
    <author>
      <name>Ballif, Bryan A.</name>
    </author>
    <author>
      <name>Ward, Gary E.</name>
    </author>
    <id>http://hdl.handle.net/10023/3351</id>
    <updated>2013-05-12T04:33:58Z</updated>
    <published>2010-01-15T00:00:00Z</published>
    <summary type="text">Abstract: Toxoplasma gondii is an obligate intracellular parasite that enters cells by a process of active penetration. Host cell penetration and parasite motility are driven by a myosin motor complex consisting of four known proteins: TgMyoA, an unconventional Class XIV myosin; TgMLC1, a myosin light chain; and two membrane-associated proteins, TgGAP45 and TgGAP50. Little is known about how the activity of the myosin motor complex is regulated. Here, we show that treatment of parasites with a recently identified small-molecule inhibitor of invasion and motility results in a rapid and irreversible change in the electrophoretic mobility of TgMLC1. While the precise nature of the TgMLC1 modification has not yet been established, it was mapped to the peptide Val46-Arg59. To determine if the TgMLC1 modification is responsible for the motility defect observed in parasites after compound treatment, the activity of myosin motor complexes from control and compound-treated parasites was compared in an in vitro motility assay. TgMyoA motor complexes containing the modified TgMLC1 showed significantly decreased motor activity compared to control complexes. This change in motor activity likely accounts for the motility defects seen in the parasites after compound treatment and provides the first evidence, in any species, that the mechanical activity of Class XIV myosins can be modulated by posttranslational modifications to their associated light chains.</summary>
    <dc:date>2010-01-15T00:00:00Z</dc:date>
    <dc:creator>Heaslip, Aoife T.</dc:creator>
    <dc:creator>Leung, Jacqueline M.</dc:creator>
    <dc:creator>Carey, Kimberly L.</dc:creator>
    <dc:creator>Catti, Federica</dc:creator>
    <dc:creator>Warshaw, David M.</dc:creator>
    <dc:creator>Westwood, Nicholas J.</dc:creator>
    <dc:creator>Ballif, Bryan A.</dc:creator>
    <dc:creator>Ward, Gary E.</dc:creator>
    <dc:description>Toxoplasma gondii is an obligate intracellular parasite that enters cells by a process of active penetration. Host cell penetration and parasite motility are driven by a myosin motor complex consisting of four known proteins: TgMyoA, an unconventional Class XIV myosin; TgMLC1, a myosin light chain; and two membrane-associated proteins, TgGAP45 and TgGAP50. Little is known about how the activity of the myosin motor complex is regulated. Here, we show that treatment of parasites with a recently identified small-molecule inhibitor of invasion and motility results in a rapid and irreversible change in the electrophoretic mobility of TgMLC1. While the precise nature of the TgMLC1 modification has not yet been established, it was mapped to the peptide Val46-Arg59. To determine if the TgMLC1 modification is responsible for the motility defect observed in parasites after compound treatment, the activity of myosin motor complexes from control and compound-treated parasites was compared in an in vitro motility assay. TgMyoA motor complexes containing the modified TgMLC1 showed significantly decreased motor activity compared to control complexes. This change in motor activity likely accounts for the motility defects seen in the parasites after compound treatment and provides the first evidence, in any species, that the mechanical activity of Class XIV myosins can be modulated by posttranslational modifications to their associated light chains.</dc:description>
  </entry>
  <entry>
    <title>Prins fluorination cyclisations : Preparation of 4-fluoro-pyran and -piperidine heterocycles</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3333" />
    <author>
      <name>Launay, Guillaume G.</name>
    </author>
    <author>
      <name>Slawin, Alexandra M. Z.</name>
    </author>
    <author>
      <name>O'Hagan, David</name>
    </author>
    <id>http://hdl.handle.net/10023/3333</id>
    <updated>2013-05-12T04:10:08Z</updated>
    <published>2010-04-26T00:00:00Z</published>
    <summary type="text">Abstract: The Prins reaction was investigated using BF3 center dot OEt2 as a Lewis acid. It has been recently demonstrated, that if BF3 center dot OEt2 is used in stoichiometric amounts then these reactions generate fluorinated products where the BF3 center dot OEt2 contributes fluoride ion to quench the intermediate carbocations. In this study oxa- and aza-Prins reactions for the synthesis of 4-fluoro-pyrans and -piperidines were investigated. The products were obtained in good yields, but only with moderate diastereoselectivity. These Prins fluorination reactions can be accelerated under microwave conditions. The study extends the Prins fluorination methodology for the generation of the C-F bond in heterocycles.</summary>
    <dc:date>2010-04-26T00:00:00Z</dc:date>
    <dc:creator>Launay, Guillaume G.</dc:creator>
    <dc:creator>Slawin, Alexandra M. Z.</dc:creator>
    <dc:creator>O'Hagan, David</dc:creator>
    <dc:description>The Prins reaction was investigated using BF3 center dot OEt2 as a Lewis acid. It has been recently demonstrated, that if BF3 center dot OEt2 is used in stoichiometric amounts then these reactions generate fluorinated products where the BF3 center dot OEt2 contributes fluoride ion to quench the intermediate carbocations. In this study oxa- and aza-Prins reactions for the synthesis of 4-fluoro-pyrans and -piperidines were investigated. The products were obtained in good yields, but only with moderate diastereoselectivity. These Prins fluorination reactions can be accelerated under microwave conditions. The study extends the Prins fluorination methodology for the generation of the C-F bond in heterocycles.</dc:description>
  </entry>
  <entry>
    <title>Aberrant NF-kappaB expression in autism spectrum condition : a mechanism for neuroinflammation</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3324" />
    <author>
      <name>Young, Adam</name>
    </author>
    <author>
      <name>Campbell, Elaine Catherine</name>
    </author>
    <author>
      <name>Lynch, Sarah Janice</name>
    </author>
    <author>
      <name>Suckling, John</name>
    </author>
    <author>
      <name>Powis, Simon John</name>
    </author>
    <id>http://hdl.handle.net/10023/3324</id>
    <updated>2013-06-16T00:33:55Z</updated>
    <published>2011-05-13T00:00:00Z</published>
    <summary type="text">Abstract: Autism spectrum condition (ASC) is recognized as having an inflammatory component. Post-mortem brain samples from patients with ASC display neuroglial activation and inflammatory markers in cerebrospinal fluid, although little is known about the underlying molecular mechanisms. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a protein found in almost all cell types and mediates regulation of immune response by inducing the expression of inflammatory cytokines and chemokines, establishing a feedback mechanism that can produce chronic or excessive inflammation. This article describes immunodetection and immunofluorescence measurements of NF-κB in human post-mortem samples of orbitofrontal cortex tissue donated to two independent centers: London Brain Bank, Kings College London, UK (ASC: n = 3, controls: n = 4) and Autism Tissue Program, Harvard Brain Bank, USA (ASC: n = 6, controls: n = 5). The hypothesis was that concentrations of NF-κB would be elevated, especially in activated microglia in ASC, and pH would be concomitantly reduced (i.e., acidification). Neurons, astrocytes, and microglia all demonstrated increased extranuclear and nuclear translocated NF-κB p65 expression in brain tissue from ASC donors relative to samples from matched controls. These between-groups differences were increased in astrocytes and microglia relative to neurons, but particularly pronounced for highly mature microglia. Measurement of pH in homogenized samples demonstrated a 0.98-unit difference in means and a strong (F = 98.3; p = 0.00018) linear relationship to the expression of nuclear translocated NF-κB in mature microglia. Acridine orange staining localized pH reductions to lysosomal compartments. In summary, NF-κB is aberrantly expressed in orbitofrontal cortex in patients with ASC, as part of a putative molecular cascade leading to inflammation, especially of resident immune cells in brain regions associated with the behavioral and clinical symptoms of ASC.</summary>
    <dc:date>2011-05-13T00:00:00Z</dc:date>
    <dc:creator>Young, Adam</dc:creator>
    <dc:creator>Campbell, Elaine Catherine</dc:creator>
    <dc:creator>Lynch, Sarah Janice</dc:creator>
    <dc:creator>Suckling, John</dc:creator>
    <dc:creator>Powis, Simon John</dc:creator>
    <dc:description>Autism spectrum condition (ASC) is recognized as having an inflammatory component. Post-mortem brain samples from patients with ASC display neuroglial activation and inflammatory markers in cerebrospinal fluid, although little is known about the underlying molecular mechanisms. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a protein found in almost all cell types and mediates regulation of immune response by inducing the expression of inflammatory cytokines and chemokines, establishing a feedback mechanism that can produce chronic or excessive inflammation. This article describes immunodetection and immunofluorescence measurements of NF-κB in human post-mortem samples of orbitofrontal cortex tissue donated to two independent centers: London Brain Bank, Kings College London, UK (ASC: n = 3, controls: n = 4) and Autism Tissue Program, Harvard Brain Bank, USA (ASC: n = 6, controls: n = 5). The hypothesis was that concentrations of NF-κB would be elevated, especially in activated microglia in ASC, and pH would be concomitantly reduced (i.e., acidification). Neurons, astrocytes, and microglia all demonstrated increased extranuclear and nuclear translocated NF-κB p65 expression in brain tissue from ASC donors relative to samples from matched controls. These between-groups differences were increased in astrocytes and microglia relative to neurons, but particularly pronounced for highly mature microglia. Measurement of pH in homogenized samples demonstrated a 0.98-unit difference in means and a strong (F = 98.3; p = 0.00018) linear relationship to the expression of nuclear translocated NF-κB in mature microglia. Acridine orange staining localized pH reductions to lysosomal compartments. In summary, NF-κB is aberrantly expressed in orbitofrontal cortex in patients with ASC, as part of a putative molecular cascade leading to inflammation, especially of resident immune cells in brain regions associated with the behavioral and clinical symptoms of ASC.</dc:description>
  </entry>
  <entry>
    <title>A model for 3-methyladenine recognition by 3-methyladenine DNA glycosylase I (TAG) from Staphylococcus aureus</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3302" />
    <author>
      <name>Zhu, Xiaofeng</name>
    </author>
    <author>
      <name>Yan, Xuan</name>
    </author>
    <author>
      <name>Carter, Lester G.</name>
    </author>
    <author>
      <name>Liu, Huanting</name>
    </author>
    <author>
      <name>Graham, Shirley</name>
    </author>
    <author>
      <name>Coote, Peter J.</name>
    </author>
    <author>
      <name>Naismith, James</name>
    </author>
    <id>http://hdl.handle.net/10023/3302</id>
    <updated>2013-05-12T04:36:35Z</updated>
    <published>2012-06-01T00:00:00Z</published>
    <summary type="text">Abstract: The removal of chemically damaged DNA bases such as 3-methyladenine (3-MeA) is an essential process in all living organisms and is catalyzed by the enzyme 3-MeA DNA glycosylase I. A key question is how the enzyme selectively recognizes the alkylated 3-MeA over the much more abundant adenine. The crystal structures of native and Y16F-mutant 3-MeA DNA glycosylase I from Staphylococcus aureus in complex with 3-MeA are reported to 1.8 and 2.2 angstrom resolution, respectively. Isothermal titration calorimetry shows that protonation of 3-MeA decreases its binding affinity, confirming previous fluorescence studies that show that chargecharge recognition is not critical for the selection of 3-MeA over adenine. It is hypothesized that the hydrogen-bonding pattern of Glu38 and Tyr16 of 3-MeA DNA glycosylase I with a particular tautomer unique to 3-MeA contributes to recognition and selection.</summary>
    <dc:date>2012-06-01T00:00:00Z</dc:date>
    <dc:creator>Zhu, Xiaofeng</dc:creator>
    <dc:creator>Yan, Xuan</dc:creator>
    <dc:creator>Carter, Lester G.</dc:creator>
    <dc:creator>Liu, Huanting</dc:creator>
    <dc:creator>Graham, Shirley</dc:creator>
    <dc:creator>Coote, Peter J.</dc:creator>
    <dc:creator>Naismith, James</dc:creator>
    <dc:description>The removal of chemically damaged DNA bases such as 3-methyladenine (3-MeA) is an essential process in all living organisms and is catalyzed by the enzyme 3-MeA DNA glycosylase I. A key question is how the enzyme selectively recognizes the alkylated 3-MeA over the much more abundant adenine. The crystal structures of native and Y16F-mutant 3-MeA DNA glycosylase I from Staphylococcus aureus in complex with 3-MeA are reported to 1.8 and 2.2 angstrom resolution, respectively. Isothermal titration calorimetry shows that protonation of 3-MeA decreases its binding affinity, confirming previous fluorescence studies that show that chargecharge recognition is not critical for the selection of 3-MeA over adenine. It is hypothesized that the hydrogen-bonding pattern of Glu38 and Tyr16 of 3-MeA DNA glycosylase I with a particular tautomer unique to 3-MeA contributes to recognition and selection.</dc:description>
  </entry>
  <entry>
    <title>Crystallization, dehydration and experimental phasing of WbdD, a bifunctional kinase and methyltransferase from Escherichia coli O9a</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3298" />
    <author>
      <name>Hagelueken, Gregor</name>
    </author>
    <author>
      <name>Huang, Hexian</name>
    </author>
    <author>
      <name>Harlos, Karl</name>
    </author>
    <author>
      <name>Clarke, Bradley R.</name>
    </author>
    <author>
      <name>Whitfield, Chris</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <id>http://hdl.handle.net/10023/3298</id>
    <updated>2013-05-12T04:36:54Z</updated>
    <published>2012-10-01T00:00:00Z</published>
    <summary type="text">Abstract: WbdD is a bifunctional kinase/methyltransferase that is responsible for regulation of lipopolysaccharide O antigen polysaccharide chain length in Escherichia coli serotype O9a. Solving the crystal structure of this protein proved to be a challenge because the available crystals belonging to space group I23 only diffracted to low resolution (&gt;95% of the crystals diffracted to resolution lower than 4 angstrom and most only to 8 angstrom) and were non-isomorphous, with changes in unit-cell dimensions of greater than 10%. Data from a serendipitously found single native crystal that diffracted to 3.0 angstrom resolution were non-isomorphous with a lower (3.5 angstrom) resolution selenomethionine data set. Here, a strategy for improving poor (3.5 angstrom resolution) initial phases by density modification and cross-crystal averaging with an additional 4.2 angstrom resolution data set to build a crude model of WbdD is desribed. Using this crude model as a mask to cut out the 3.5 angstrom resolution electron density yielded a successful molecular-replacement solution of the 3.0 angstrom resolution data set. The resulting map was used to build a complete model of WbdD. The hydration status of individual crystals appears to underpin the variable diffraction quality of WbdD crystals. After the initial structure had been solved, methods to control the hydration status of WbdD were developed and it was thus possible to routinely obtain high-resolution diffraction (to better than 2.5 angstrom resolution). This novel and facile crystal-dehydration protocol may be useful for similar challenging situations.</summary>
    <dc:date>2012-10-01T00:00:00Z</dc:date>
    <dc:creator>Hagelueken, Gregor</dc:creator>
    <dc:creator>Huang, Hexian</dc:creator>
    <dc:creator>Harlos, Karl</dc:creator>
    <dc:creator>Clarke, Bradley R.</dc:creator>
    <dc:creator>Whitfield, Chris</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:description>WbdD is a bifunctional kinase/methyltransferase that is responsible for regulation of lipopolysaccharide O antigen polysaccharide chain length in Escherichia coli serotype O9a. Solving the crystal structure of this protein proved to be a challenge because the available crystals belonging to space group I23 only diffracted to low resolution (&gt;95% of the crystals diffracted to resolution lower than 4 angstrom and most only to 8 angstrom) and were non-isomorphous, with changes in unit-cell dimensions of greater than 10%. Data from a serendipitously found single native crystal that diffracted to 3.0 angstrom resolution were non-isomorphous with a lower (3.5 angstrom) resolution selenomethionine data set. Here, a strategy for improving poor (3.5 angstrom resolution) initial phases by density modification and cross-crystal averaging with an additional 4.2 angstrom resolution data set to build a crude model of WbdD is desribed. Using this crude model as a mask to cut out the 3.5 angstrom resolution electron density yielded a successful molecular-replacement solution of the 3.0 angstrom resolution data set. The resulting map was used to build a complete model of WbdD. The hydration status of individual crystals appears to underpin the variable diffraction quality of WbdD crystals. After the initial structure had been solved, methods to control the hydration status of WbdD were developed and it was thus possible to routinely obtain high-resolution diffraction (to better than 2.5 angstrom resolution). This novel and facile crystal-dehydration protocol may be useful for similar challenging situations.</dc:description>
  </entry>
  <entry>
    <title>PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3297" />
    <author>
      <name>Illingworth, Robert S.</name>
    </author>
    <author>
      <name>Botting, Catherine H.</name>
    </author>
    <author>
      <name>Grimes, Graeme R.</name>
    </author>
    <author>
      <name>Bickmore, Wendy A.</name>
    </author>
    <author>
      <name>Eskeland, Ragnhild</name>
    </author>
    <id>http://hdl.handle.net/10023/3297</id>
    <updated>2013-06-09T01:02:47Z</updated>
    <published>2012-04-09T00:00:00Z</published>
    <summary type="text">Abstract: The essential histone variant H2A.Z localises to both active and silent chromatin sites. In embryonic stem cells (ESCs), H2A.Z is also reported to co-localise with polycomb repressive complex 2 (PRC2) at developmentally silenced genes. The mechanism of H2A.Z targeting is not clear, but a role for the PRC2 component Suz12 has been suggested. Given this association, we wished to determine if polycomb functionally directs H2A.Z incorporation in ESCs. We demonstrate that the PRC1 component Ring1B interacts with multiple complexes in ESCs. Moreover, we show that although the genomic distribution of H2A.Z co-localises with PRC2, Ring1B and with the presence of CpG islands, H2A.Z still blankets polycomb target loci in the absence of Suz12, Eed (PRC2) or Ring1B (PRC1). Therefore we conclude that H2A.Z accumulates at developmentally silenced genes in ESCs in a polycomb independent manner.</summary>
    <dc:date>2012-04-09T00:00:00Z</dc:date>
    <dc:creator>Illingworth, Robert S.</dc:creator>
    <dc:creator>Botting, Catherine H.</dc:creator>
    <dc:creator>Grimes, Graeme R.</dc:creator>
    <dc:creator>Bickmore, Wendy A.</dc:creator>
    <dc:creator>Eskeland, Ragnhild</dc:creator>
    <dc:description>The essential histone variant H2A.Z localises to both active and silent chromatin sites. In embryonic stem cells (ESCs), H2A.Z is also reported to co-localise with polycomb repressive complex 2 (PRC2) at developmentally silenced genes. The mechanism of H2A.Z targeting is not clear, but a role for the PRC2 component Suz12 has been suggested. Given this association, we wished to determine if polycomb functionally directs H2A.Z incorporation in ESCs. We demonstrate that the PRC1 component Ring1B interacts with multiple complexes in ESCs. Moreover, we show that although the genomic distribution of H2A.Z co-localises with PRC2, Ring1B and with the presence of CpG islands, H2A.Z still blankets polycomb target loci in the absence of Suz12, Eed (PRC2) or Ring1B (PRC1). Therefore we conclude that H2A.Z accumulates at developmentally silenced genes in ESCs in a polycomb independent manner.</dc:description>
  </entry>
  <entry>
    <title>Discovery and validation of SIRT2 inhibitors based on tenovin-6 : use of a H-1-NMR method to assess deacetylase activity</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3293" />
    <author>
      <name>Pirrie, Lisa</name>
    </author>
    <author>
      <name>McCarthy, Anna R.</name>
    </author>
    <author>
      <name>Major, Louise L.</name>
    </author>
    <author>
      <name>Morkunaite, Vaida</name>
    </author>
    <author>
      <name>Zubriene, Asta</name>
    </author>
    <author>
      <name>Matulis, Daumantas</name>
    </author>
    <author>
      <name>Lain, Sonia</name>
    </author>
    <author>
      <name>Lebl, Tomas</name>
    </author>
    <author>
      <name>Westwood, Nicholas J.</name>
    </author>
    <id>http://hdl.handle.net/10023/3293</id>
    <updated>2012-12-14T11:31:01Z</updated>
    <published>2012-10-01T00:00:00Z</published>
    <summary type="text">Abstract: The search for potent and selective sirtuin inhibitors continues as chemical tools of this type are of use in helping to assign the function of this interesting class of deacetylases. Here we describe SAR studies starting from the unselective sirtuin inhibitor tenovin-6. These studies identify a sub-micromolar inhibitor that has increased selectivity for SIRT2 over SIRT1 compared to tenovin-6. In addition, a H-1-NMR-based method is developed and used to validate further this class of sirtuin inhibitors. A thermal shift analysis of SIRT2 in the presence of tenovin-6, -43, a control tenovin and the known SIRT2 inhibitor AGK2 is also presented.</summary>
    <dc:date>2012-10-01T00:00:00Z</dc:date>
    <dc:creator>Pirrie, Lisa</dc:creator>
    <dc:creator>McCarthy, Anna R.</dc:creator>
    <dc:creator>Major, Louise L.</dc:creator>
    <dc:creator>Morkunaite, Vaida</dc:creator>
    <dc:creator>Zubriene, Asta</dc:creator>
    <dc:creator>Matulis, Daumantas</dc:creator>
    <dc:creator>Lain, Sonia</dc:creator>
    <dc:creator>Lebl, Tomas</dc:creator>
    <dc:creator>Westwood, Nicholas J.</dc:creator>
    <dc:description>The search for potent and selective sirtuin inhibitors continues as chemical tools of this type are of use in helping to assign the function of this interesting class of deacetylases. Here we describe SAR studies starting from the unselective sirtuin inhibitor tenovin-6. These studies identify a sub-micromolar inhibitor that has increased selectivity for SIRT2 over SIRT1 compared to tenovin-6. In addition, a H-1-NMR-based method is developed and used to validate further this class of sirtuin inhibitors. A thermal shift analysis of SIRT2 in the presence of tenovin-6, -43, a control tenovin and the known SIRT2 inhibitor AGK2 is also presented.</dc:description>
  </entry>
  <entry>
    <title>Structure of WbdD : a bifunctional kinase and methyltransferase that regulates the chain length of the O antigen in Escherichia coli O9a</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3292" />
    <author>
      <name>Hagelueken, Gregor</name>
    </author>
    <author>
      <name>Huang, Hexian</name>
    </author>
    <author>
      <name>Clarke, Bradley R.</name>
    </author>
    <author>
      <name>Lebl, Tomas</name>
    </author>
    <author>
      <name>Whitfield, Chris</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <id>http://hdl.handle.net/10023/3292</id>
    <updated>2012-12-14T11:01:01Z</updated>
    <published>2012-11-01T00:00:00Z</published>
    <summary type="text">Abstract: The Escherichia coli serotype O9a O-antigen polysaccharide (O-PS) is a model for glycan biosynthesis and export by the ATP-binding cassette transporter-dependent pathway. The polymannose O9a O-PS is synthesized as a polyprenol-linked glycan by mannosyltransferase enzymes located at the cytoplasmic membrane. The chain length of the O9a O-PS is tightly regulated by the WbdD enzyme. WbdD first phosphorylates the terminal non-reducing mannose of the O-PS and then methylates the phosphate, stopping polymerization. The 2.2?angstrom resolution structure of WbdD reveals a bacterial methyltransferase domain joined to a eukaryotic kinase domain. The kinase domain is again fused to an extended C-terminal coiled-coil domain reminiscent of eukaryotic DMPK (Myotonic Dystrophy Protein Kinase) family kinases such as Rho-associated protein kinase (ROCK). WbdD phosphorylates 2-a-d-mannosyl-d-mannose (2a-MB), a short mimic of the O9a polymer. Mutagenesis identifies those residues important in catalysis and substrate recognition and the in vivo phenotypes of these mutants are used to dissect the termination reaction. We have determined the structures of co-complexes of WbdD with two known eukaryotic protein kinase inhibitors. Although these are potent inhibitors in vitro, they do not show any in vivo activity. The structures reveal new insight into O-PS chain-length regulation in this important model system.</summary>
    <dc:date>2012-11-01T00:00:00Z</dc:date>
    <dc:creator>Hagelueken, Gregor</dc:creator>
    <dc:creator>Huang, Hexian</dc:creator>
    <dc:creator>Clarke, Bradley R.</dc:creator>
    <dc:creator>Lebl, Tomas</dc:creator>
    <dc:creator>Whitfield, Chris</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:description>The Escherichia coli serotype O9a O-antigen polysaccharide (O-PS) is a model for glycan biosynthesis and export by the ATP-binding cassette transporter-dependent pathway. The polymannose O9a O-PS is synthesized as a polyprenol-linked glycan by mannosyltransferase enzymes located at the cytoplasmic membrane. The chain length of the O9a O-PS is tightly regulated by the WbdD enzyme. WbdD first phosphorylates the terminal non-reducing mannose of the O-PS and then methylates the phosphate, stopping polymerization. The 2.2?angstrom resolution structure of WbdD reveals a bacterial methyltransferase domain joined to a eukaryotic kinase domain. The kinase domain is again fused to an extended C-terminal coiled-coil domain reminiscent of eukaryotic DMPK (Myotonic Dystrophy Protein Kinase) family kinases such as Rho-associated protein kinase (ROCK). WbdD phosphorylates 2-a-d-mannosyl-d-mannose (2a-MB), a short mimic of the O9a polymer. Mutagenesis identifies those residues important in catalysis and substrate recognition and the in vivo phenotypes of these mutants are used to dissect the termination reaction. We have determined the structures of co-complexes of WbdD with two known eukaryotic protein kinase inhibitors. Although these are potent inhibitors in vitro, they do not show any in vivo activity. The structures reveal new insight into O-PS chain-length regulation in this important model system.</dc:description>
  </entry>
  <entry>
    <title>Routine use of microbial whole genome sequencing in diagnostic and public health microbiology</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3290" />
    <author>
      <name>Koeser, Claudio U.</name>
    </author>
    <author>
      <name>Ellington, Matthew J.</name>
    </author>
    <author>
      <name>Cartwright, Edward J. P.</name>
    </author>
    <author>
      <name>Gillespie, Stephen H.</name>
    </author>
    <author>
      <name>Brown, Nicholas M.</name>
    </author>
    <author>
      <name>Farrington, Mark</name>
    </author>
    <author>
      <name>Holden, Matthew T. G.</name>
    </author>
    <author>
      <name>Dougan, Gordon</name>
    </author>
    <author>
      <name>Bentley, Stephen D.</name>
    </author>
    <author>
      <name>Parkhill, Julian</name>
    </author>
    <author>
      <name>Peacock, Sharon J.</name>
    </author>
    <id>http://hdl.handle.net/10023/3290</id>
    <updated>2013-05-20T15:01:01Z</updated>
    <published>2012-08-02T00:00:00Z</published>
    <summary type="text">Abstract: Whole genome sequencing (WGS) promises to be transformative for the practice of clinical microbiology, and the rapidly falling cost and turnaround time mean that this will become a viable technology in diagnostic and reference laboratories in the near future. The objective of this article is to consider at a very practical level where, in the context of a modern diagnostic microbiology laboratory, WGS might be cost-effective compared to current alternatives. We propose that molecular epidemiology performed for surveillance and outbreak investigation and genotypic antimicrobial susceptibility testing for microbes that are difficult to grow represent the most immediate areas for application of WGS, and discuss the technical and infrastructure requirements for this to be implemented.</summary>
    <dc:date>2012-08-02T00:00:00Z</dc:date>
    <dc:creator>Koeser, Claudio U.</dc:creator>
    <dc:creator>Ellington, Matthew J.</dc:creator>
    <dc:creator>Cartwright, Edward J. P.</dc:creator>
    <dc:creator>Gillespie, Stephen H.</dc:creator>
    <dc:creator>Brown, Nicholas M.</dc:creator>
    <dc:creator>Farrington, Mark</dc:creator>
    <dc:creator>Holden, Matthew T. G.</dc:creator>
    <dc:creator>Dougan, Gordon</dc:creator>
    <dc:creator>Bentley, Stephen D.</dc:creator>
    <dc:creator>Parkhill, Julian</dc:creator>
    <dc:creator>Peacock, Sharon J.</dc:creator>
    <dc:description>Whole genome sequencing (WGS) promises to be transformative for the practice of clinical microbiology, and the rapidly falling cost and turnaround time mean that this will become a viable technology in diagnostic and reference laboratories in the near future. The objective of this article is to consider at a very practical level where, in the context of a modern diagnostic microbiology laboratory, WGS might be cost-effective compared to current alternatives. We propose that molecular epidemiology performed for surveillance and outbreak investigation and genotypic antimicrobial susceptibility testing for microbes that are difficult to grow represent the most immediate areas for application of WGS, and discuss the technical and infrastructure requirements for this to be implemented.</dc:description>
  </entry>
  <entry>
    <title>Protein-induced changes in DNA structure and dynamics observed with noncovalent site-directed spin-labeling and PELDOR</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3286" />
    <author>
      <name>Reginsson, Gunnar Widtfeldt</name>
    </author>
    <author>
      <name>Shelke, Sandip</name>
    </author>
    <author>
      <name>Rouillon, Christophe</name>
    </author>
    <author>
      <name>White, Malcolm F</name>
    </author>
    <author>
      <name>Sigurdsson, Snorri T</name>
    </author>
    <author>
      <name>Schiemann, Olav</name>
    </author>
    <id>http://hdl.handle.net/10023/3286</id>
    <updated>2013-02-28T09:01:01Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Site-directed spin labeling and pulsed electron–electron double resonance (PELDOR or DEER) have previously been applied successfully to study the structure and dynamics of nucleic acids. Spin labeling nucleic acids at specific sites requires the covalent attachment of spin labels, which involves rather complicated and laborious chemical synthesis. Here, we use a noncovalent label strategy that bypasses the covalent labeling chemistry and show that the binding specificity and efficiency are large enough to enable PELDOR or DEER measurements in DNA duplexes and a DNA duplex bound to the Lac repressor protein. In addition, the rigidity of the label not only allows resolution of the structure and dynamics of oligonucleotides but also the determination of label orientation and protein-induced conformational changes. The results prove that this labeling strategy in combination with PELDOR has a great potential for studying both structure and dynamics of oligonucleotides and their complexes with various ligands.</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
    <dc:creator>Reginsson, Gunnar Widtfeldt</dc:creator>
    <dc:creator>Shelke, Sandip</dc:creator>
    <dc:creator>Rouillon, Christophe</dc:creator>
    <dc:creator>White, Malcolm F</dc:creator>
    <dc:creator>Sigurdsson, Snorri T</dc:creator>
    <dc:creator>Schiemann, Olav</dc:creator>
    <dc:description>Site-directed spin labeling and pulsed electron–electron double resonance (PELDOR or DEER) have previously been applied successfully to study the structure and dynamics of nucleic acids. Spin labeling nucleic acids at specific sites requires the covalent attachment of spin labels, which involves rather complicated and laborious chemical synthesis. Here, we use a noncovalent label strategy that bypasses the covalent labeling chemistry and show that the binding specificity and efficiency are large enough to enable PELDOR or DEER measurements in DNA duplexes and a DNA duplex bound to the Lac repressor protein. In addition, the rigidity of the label not only allows resolution of the structure and dynamics of oligonucleotides but also the determination of label orientation and protein-induced conformational changes. The results prove that this labeling strategy in combination with PELDOR has a great potential for studying both structure and dynamics of oligonucleotides and their complexes with various ligands.</dc:description>
  </entry>
  <entry>
    <title>Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3282" />
    <author>
      <name>Ballester, Pedro</name>
    </author>
    <author>
      <name>Mangold, Martina</name>
    </author>
    <author>
      <name>Howard, Nigel</name>
    </author>
    <author>
      <name>Marchese Robinson, Richard</name>
    </author>
    <author>
      <name>Abell, Chris</name>
    </author>
    <author>
      <name>Blumberger, Jochen</name>
    </author>
    <author>
      <name>Mitchell, John B. O.</name>
    </author>
    <id>http://hdl.handle.net/10023/3282</id>
    <updated>2012-12-12T13:31:34Z</updated>
    <published>2012-12-07T00:00:00Z</published>
    <summary type="text">Abstract: One of the initial steps of modern drug discovery is the identification of small organic molecules able to inhibit a target macromolecule of therapeutic interest. A small proportion of these hits are further developed into lead compounds, which in turn may ultimately lead to a marketed drug. A commonly used screening protocol used for this task is high-throughput screening (HTS). However, the performance of HTS against antibacterial targets has generally been unsatisfactory, with high costs and low rates of hit identification. Here, we present a novel computational methodology that is able to identify a high proportion of structurally diverse inhibitors by searching unusually large molecular databases in a time-, cost- and resource-efficient manner. This virtual screening methodology was tested prospectively on two versions of an antibacterial target (type II dehydroquinase from Mycobacterium tuberculosis and Streptomyces coelicolor), for which HTS has not provided satisfactory results and consequently practically all known inhibitors are derivatives of the same core scaffold. Overall, our protocols identified 100 new inhibitors, with calculated Ki ranging from 4 to 250 μM (confirmed hit rates are 60% and 62% against each version of the target). Most importantly, over 50 new active molecular scaffolds were discovered that underscore the benefits that a wide application of prospectively validated in silico screening tools is likely to bring to antibacterial hit identification.</summary>
    <dc:date>2012-12-07T00:00:00Z</dc:date>
    <dc:creator>Ballester, Pedro</dc:creator>
    <dc:creator>Mangold, Martina</dc:creator>
    <dc:creator>Howard, Nigel</dc:creator>
    <dc:creator>Marchese Robinson, Richard</dc:creator>
    <dc:creator>Abell, Chris</dc:creator>
    <dc:creator>Blumberger, Jochen</dc:creator>
    <dc:creator>Mitchell, John B. O.</dc:creator>
    <dc:description>One of the initial steps of modern drug discovery is the identification of small organic molecules able to inhibit a target macromolecule of therapeutic interest. A small proportion of these hits are further developed into lead compounds, which in turn may ultimately lead to a marketed drug. A commonly used screening protocol used for this task is high-throughput screening (HTS). However, the performance of HTS against antibacterial targets has generally been unsatisfactory, with high costs and low rates of hit identification. Here, we present a novel computational methodology that is able to identify a high proportion of structurally diverse inhibitors by searching unusually large molecular databases in a time-, cost- and resource-efficient manner. This virtual screening methodology was tested prospectively on two versions of an antibacterial target (type II dehydroquinase from Mycobacterium tuberculosis and Streptomyces coelicolor), for which HTS has not provided satisfactory results and consequently practically all known inhibitors are derivatives of the same core scaffold. Overall, our protocols identified 100 new inhibitors, with calculated Ki ranging from 4 to 250 μM (confirmed hit rates are 60% and 62% against each version of the target). Most importantly, over 50 new active molecular scaffolds were discovered that underscore the benefits that a wide application of prospectively validated in silico screening tools is likely to bring to antibacterial hit identification.</dc:description>
  </entry>
  <entry>
    <title>Role of Bunyamwera orthobunyavirus NSs protein in infection of mosquito cells</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3280" />
    <author>
      <name>Szemiel, Agnieszka M.</name>
    </author>
    <author>
      <name>Failloux, Anna-Bella</name>
    </author>
    <author>
      <name>Elliott, Richard M.</name>
    </author>
    <id>http://hdl.handle.net/10023/3280</id>
    <updated>2012-12-12T16:14:03Z</updated>
    <published>2012-09-01T00:00:00Z</published>
    <summary type="text">Abstract: Background: Bunyamwera orthobunyavirus is both the prototype and study model of the Bunyaviridae family. The viral NSs protein seems to contribute to the different outcomes of infection in mammalian and mosquito cell lines. However, only limited information is available on the growth of Bunyamwera virus in cultured mosquito cells other than the Aedes albopictus C6/36 line. Methodology and Principal Findings: To determine potential functions of the NSs protein in mosquito cells, replication of wild-type virus and a recombinant NSs deletion mutant was compared in Ae. albopictus C6/36, C7-10 and U4.4 cells, and in Ae. aegypti Ae cells by monitoring N protein production and virus yields at various times post infection. Both viruses established persistent infections, with the exception of NSs deletion mutant in U4.4 cells. The NSs protein was nonessential for growth in C6/36 and C7-10 cells, but was important for productive replication in U4.4 and Ae cells. Fluorescence microscopy studies using recombinant viruses expressing green fluorescent protein allowed observation of three stages of infection, early, acute and late, during which infected cells underwent morphological changes. In the absence of NSs, these changes were less pronounced. An RNAi response efficiently reduced virus replication in U4.4 cells transfected with virus specific dsRNA, but not in C6/36 or C7/10 cells. Lastly, Ae. aegypti mosquitoes were exposed to blood-meal containing either wild-type or NSs deletion virus, and at various times post-feeding, infection and disseminated infection rates were measured. Compared to wild-type virus, infection rates by the mutant virus were lower and more variable. If the NSs deletion virus was able to establish infection, it was detected in salivary glands at 6 days post-infection, 3 days later than wild-type virus. Conclusions/Significance: Bunyamwera virus NSs is required for efficient replication in certain mosquito cell lines and in Ae. aegypti mosquitoes.</summary>
    <dc:date>2012-09-01T00:00:00Z</dc:date>
    <dc:creator>Szemiel, Agnieszka M.</dc:creator>
    <dc:creator>Failloux, Anna-Bella</dc:creator>
    <dc:creator>Elliott, Richard M.</dc:creator>
    <dc:description>Background: Bunyamwera orthobunyavirus is both the prototype and study model of the Bunyaviridae family. The viral NSs protein seems to contribute to the different outcomes of infection in mammalian and mosquito cell lines. However, only limited information is available on the growth of Bunyamwera virus in cultured mosquito cells other than the Aedes albopictus C6/36 line. Methodology and Principal Findings: To determine potential functions of the NSs protein in mosquito cells, replication of wild-type virus and a recombinant NSs deletion mutant was compared in Ae. albopictus C6/36, C7-10 and U4.4 cells, and in Ae. aegypti Ae cells by monitoring N protein production and virus yields at various times post infection. Both viruses established persistent infections, with the exception of NSs deletion mutant in U4.4 cells. The NSs protein was nonessential for growth in C6/36 and C7-10 cells, but was important for productive replication in U4.4 and Ae cells. Fluorescence microscopy studies using recombinant viruses expressing green fluorescent protein allowed observation of three stages of infection, early, acute and late, during which infected cells underwent morphological changes. In the absence of NSs, these changes were less pronounced. An RNAi response efficiently reduced virus replication in U4.4 cells transfected with virus specific dsRNA, but not in C6/36 or C7/10 cells. Lastly, Ae. aegypti mosquitoes were exposed to blood-meal containing either wild-type or NSs deletion virus, and at various times post-feeding, infection and disseminated infection rates were measured. Compared to wild-type virus, infection rates by the mutant virus were lower and more variable. If the NSs deletion virus was able to establish infection, it was detected in salivary glands at 6 days post-infection, 3 days later than wild-type virus. Conclusions/Significance: Bunyamwera virus NSs is required for efficient replication in certain mosquito cell lines and in Ae. aegypti mosquitoes.</dc:description>
  </entry>
  <entry>
    <title>The CRISPR associated protein Cas4 Is a 5' to 3' DNA exonuclease with an iron-sulfur cluster</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3270" />
    <author>
      <name>Zhang, Jing</name>
    </author>
    <author>
      <name>Kasciukovic, Taciana</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <id>http://hdl.handle.net/10023/3270</id>
    <updated>2012-12-12T16:13:48Z</updated>
    <published>2012-10-08T00:00:00Z</published>
    <summary type="text">Abstract: The Cas4 protein is one of the core CRISPR-associated (Cas) proteins implicated in the prokaryotic CRISPR system for antiviral defence. Cas4 is thought to play a role in the capture of new viral DNA sequences for incorporation into the host genome. No biochemical activity has been reported for Cas4, but it is predicted to include a RecB nuclease domain. We show here that Cas4 family proteins from the archaeon Sulfolobus solfataricus utilise four conserved cysteine residues to bind an iron-sulfur cluster in an arrangement reminiscent of the AddB nuclease of Bacillus subtilis. The Cas4 family protein Sso0001 is a 5' to 3' single stranded DNA exonuclease in vitro that is stalled by extrahelical DNA adducts. A role for Cas4 in DNA duplex strand resectioning to generate recombinogenic 3' single stranded DNA overhangs is proposed. Comparison of the AddB structure with that of a related bacterial nuclease from Eubacterium rectales reveals that the iron-sulfur cluster can be replaced by a zinc ion without disrupting the protein structure, with implications for the evolution of iron-sulfur binding proteins.</summary>
    <dc:date>2012-10-08T00:00:00Z</dc:date>
    <dc:creator>Zhang, Jing</dc:creator>
    <dc:creator>Kasciukovic, Taciana</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:description>The Cas4 protein is one of the core CRISPR-associated (Cas) proteins implicated in the prokaryotic CRISPR system for antiviral defence. Cas4 is thought to play a role in the capture of new viral DNA sequences for incorporation into the host genome. No biochemical activity has been reported for Cas4, but it is predicted to include a RecB nuclease domain. We show here that Cas4 family proteins from the archaeon Sulfolobus solfataricus utilise four conserved cysteine residues to bind an iron-sulfur cluster in an arrangement reminiscent of the AddB nuclease of Bacillus subtilis. The Cas4 family protein Sso0001 is a 5' to 3' single stranded DNA exonuclease in vitro that is stalled by extrahelical DNA adducts. A role for Cas4 in DNA duplex strand resectioning to generate recombinogenic 3' single stranded DNA overhangs is proposed. Comparison of the AddB structure with that of a related bacterial nuclease from Eubacterium rectales reveals that the iron-sulfur cluster can be replaced by a zinc ion without disrupting the protein structure, with implications for the evolution of iron-sulfur binding proteins.</dc:description>
  </entry>
  <entry>
    <title>The preferred conformation of erythro- and threo-1,2-difluorocyclododecanes</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3261" />
    <author>
      <name>Wang, Yi</name>
    </author>
    <author>
      <name>Kirsch, Peer</name>
    </author>
    <author>
      <name>Lebl, Tomas</name>
    </author>
    <author>
      <name>Slawin, Alexandra M. Z.</name>
    </author>
    <author>
      <name>O'Hagan, David</name>
    </author>
    <id>http://hdl.handle.net/10023/3261</id>
    <updated>2013-05-12T04:36:38Z</updated>
    <published>2012-08-10T00:00:00Z</published>
    <summary type="text">Abstract: Cyclododecane adopts a square-like structure with corner and edge CH2 groups. In this study erythro- and threo-1,2-difluorocyclododecanes were prepared to explore whether the two vicinal C-F bonds, with different relative configurations, preferably locate at corner/edge or edge/edge locations. Conformational analysis comparing the diastereoisomers was explored by using a combination of F-19{H-1} NMR spectroscopy, computational studies and, in the case of the threo isomer, X-ray structural analysis. In the lowest energy conformers for both diastereoisomers the vicinal C-F bonds are located corner/edge, rather than edge/edge. These structures avoid placing a C-F bond endo into the ring, and appear to benefit from C-CHF-C angle widening, which relaxes 1,4-H, H transannular interactions.</summary>
    <dc:date>2012-08-10T00:00:00Z</dc:date>
    <dc:creator>Wang, Yi</dc:creator>
    <dc:creator>Kirsch, Peer</dc:creator>
    <dc:creator>Lebl, Tomas</dc:creator>
    <dc:creator>Slawin, Alexandra M. Z.</dc:creator>
    <dc:creator>O'Hagan, David</dc:creator>
    <dc:description>Cyclododecane adopts a square-like structure with corner and edge CH2 groups. In this study erythro- and threo-1,2-difluorocyclododecanes were prepared to explore whether the two vicinal C-F bonds, with different relative configurations, preferably locate at corner/edge or edge/edge locations. Conformational analysis comparing the diastereoisomers was explored by using a combination of F-19{H-1} NMR spectroscopy, computational studies and, in the case of the threo isomer, X-ray structural analysis. In the lowest energy conformers for both diastereoisomers the vicinal C-F bonds are located corner/edge, rather than edge/edge. These structures avoid placing a C-F bond endo into the ring, and appear to benefit from C-CHF-C angle widening, which relaxes 1,4-H, H transannular interactions.</dc:description>
  </entry>
  <entry>
    <title>MtsslWizard : in silico spin-labelling and generation of distance distributions in PyMOL</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3160" />
    <author>
      <name>Hageluken, Gregor</name>
    </author>
    <author>
      <name>Ward, Richard James</name>
    </author>
    <author>
      <name>Naismith, Jim</name>
    </author>
    <author>
      <name>Schiemann, Olav</name>
    </author>
    <id>http://hdl.handle.net/10023/3160</id>
    <updated>2013-05-12T04:06:51Z</updated>
    <published>2012-04-01T00:00:00Z</published>
    <summary type="text">Abstract: MtsslWizard is a computer program, which operates as a plugin for the PyMOL molecular graphics system. MtsslWizard estimates distances between spin labels on proteins quickly with user configurable options through a simple graphical interface. The program searches for ensembles of possible MTSSL conformations that do not clash with a static model of the protein. Options include restricting the search procedure to published rotamer libraries of MTSSL or scoring for contacts with protein. Once conformations are assigned, distance distributions between two or more sites are calculated, displayed and can be exported to other software. The program's use is evaluated in a number of challenging test cases and its performance discussed. The strength of the program is its accuracy and simplicity.</summary>
    <dc:date>2012-04-01T00:00:00Z</dc:date>
    <dc:creator>Hageluken, Gregor</dc:creator>
    <dc:creator>Ward, Richard James</dc:creator>
    <dc:creator>Naismith, Jim</dc:creator>
    <dc:creator>Schiemann, Olav</dc:creator>
    <dc:description>MtsslWizard is a computer program, which operates as a plugin for the PyMOL molecular graphics system. MtsslWizard estimates distances between spin labels on proteins quickly with user configurable options through a simple graphical interface. The program searches for ensembles of possible MTSSL conformations that do not clash with a static model of the protein. Options include restricting the search procedure to published rotamer libraries of MTSSL or scoring for contacts with protein. Once conformations are assigned, distance distributions between two or more sites are calculated, displayed and can be exported to other software. The program's use is evaluated in a number of challenging test cases and its performance discussed. The strength of the program is its accuracy and simplicity.</dc:description>
  </entry>
  <entry>
    <title>ATG5 Is Essential for ATG8-Dependent Autophagy and Mitochondrial Homeostasis in Leishmania major</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3051" />
    <author>
      <name>Williams, Roderick A. M.</name>
    </author>
    <author>
      <name>Smith, Terry K.</name>
    </author>
    <author>
      <name>Cull, Benjamin</name>
    </author>
    <author>
      <name>Mottram, Jeremy C.</name>
    </author>
    <author>
      <name>Coombs, Graham H.</name>
    </author>
    <id>http://hdl.handle.net/10023/3051</id>
    <updated>2013-05-19T00:34:38Z</updated>
    <published>2012-05-17T00:00:00Z</published>
    <summary type="text">Abstract: Macroautophagy has been shown to be important for the cellular remodelling required for Leishmania differentiation. We now demonstrate that L. major contains a functional ATG12-ATG5 conjugation system, which is required for ATG8-dependent autophagosome formation. Nascent autophagosomes were found commonly associated with the mitochondrion. L. major mutants lacking ATG5 (Δatg5) were viable as promastigotes but were unable to form autophagosomes, had morphological abnormalities including a much reduced flagellum, were less able to differentiate and had greatly reduced virulence to macrophages and mice. Analyses of the lipid metabolome of Δatg5 revealed marked elevation of phosphatidylethanolamines (PE) in comparison to wild type parasites. The Δatg5 mutants also had increased mitochondrial mass but reduced mitochondrial membrane potential and higher levels of reactive oxygen species. These findings indicate that the lack of ATG5 and autophagy leads to perturbation of the phospholipid balance in the mitochondrion, possibly through ablation of membrane use and conjugation of mitochondrial PE to ATG8 for autophagosome biogenesis, resulting in a dysfunctional mitochondrion with impaired oxidative ability and energy generation. The overall result of this is reduced virulence.</summary>
    <dc:date>2012-05-17T00:00:00Z</dc:date>
    <dc:creator>Williams, Roderick A. M.</dc:creator>
    <dc:creator>Smith, Terry K.</dc:creator>
    <dc:creator>Cull, Benjamin</dc:creator>
    <dc:creator>Mottram, Jeremy C.</dc:creator>
    <dc:creator>Coombs, Graham H.</dc:creator>
    <dc:description>Macroautophagy has been shown to be important for the cellular remodelling required for Leishmania differentiation. We now demonstrate that L. major contains a functional ATG12-ATG5 conjugation system, which is required for ATG8-dependent autophagosome formation. Nascent autophagosomes were found commonly associated with the mitochondrion. L. major mutants lacking ATG5 (Δatg5) were viable as promastigotes but were unable to form autophagosomes, had morphological abnormalities including a much reduced flagellum, were less able to differentiate and had greatly reduced virulence to macrophages and mice. Analyses of the lipid metabolome of Δatg5 revealed marked elevation of phosphatidylethanolamines (PE) in comparison to wild type parasites. The Δatg5 mutants also had increased mitochondrial mass but reduced mitochondrial membrane potential and higher levels of reactive oxygen species. These findings indicate that the lack of ATG5 and autophagy leads to perturbation of the phospholipid balance in the mitochondrion, possibly through ablation of membrane use and conjugation of mitochondrial PE to ATG8 for autophagosome biogenesis, resulting in a dysfunctional mitochondrion with impaired oxidative ability and energy generation. The overall result of this is reduced virulence.</dc:description>
  </entry>
  <entry>
    <title>ALDH2 mediates 5-nitrofuran activity in multiple species</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3043" />
    <author>
      <name>Zhou, Linna</name>
    </author>
    <author>
      <name>Ishizaki, Hironori</name>
    </author>
    <author>
      <name>Spitzer, Michaela</name>
    </author>
    <author>
      <name>Taylor, Kerrie</name>
    </author>
    <author>
      <name>Temperley, Nicholas</name>
    </author>
    <author>
      <name>Johnson, Stephen</name>
    </author>
    <author>
      <name>Brear, Paul</name>
    </author>
    <author>
      <name>Gautier, Philippe</name>
    </author>
    <author>
      <name>Zeng, Zhiqiang</name>
    </author>
    <author>
      <name>Mitchell, Amy</name>
    </author>
    <author>
      <name>Narayan, Vikram</name>
    </author>
    <author>
      <name>McNeil, Ewan</name>
    </author>
    <author>
      <name>Melton, David</name>
    </author>
    <author>
      <name>Smith, Terry K</name>
    </author>
    <author>
      <name>Tyers, Mike</name>
    </author>
    <author>
      <name>Westwood, Nicholas James</name>
    </author>
    <author>
      <name>Patton, Elizabeth</name>
    </author>
    <id>http://hdl.handle.net/10023/3043</id>
    <updated>2013-05-12T04:33:59Z</updated>
    <published>2012-07-27T00:00:00Z</published>
    <summary type="text">Abstract: Understanding how drugs work in vivo is critical for drug design and for maximizing the potential of currently available drugs. 5-nitrofurans are a class of pro-drugs widely used to treat bacterial and trypanosome infections, but despite relative specificity 5-nitrofurans often cause serious toxic side-effects in people. Here, we use yeast, zebrafish and human in vitro systems to assess the biological activity of 5-nitrofurans, and identify a conserved interaction between aldehyde dehydrogenase (ALDH) 2 and 5-nitrofurans across these species. In addition, we show that the activity of nifurtimox, a 5-nitrofuran anti-trypanosome pro-drug, is dependent on zebrafish Aldh2 and that nifurtimox is a substrate for human ALDH2. This study reveals a conserved and biologically relevant ALDH2-5-nitrofuran interaction that may have important implications for managing the toxicity of 5nitrofuran treatment.</summary>
    <dc:date>2012-07-27T00:00:00Z</dc:date>
    <dc:creator>Zhou, Linna</dc:creator>
    <dc:creator>Ishizaki, Hironori</dc:creator>
    <dc:creator>Spitzer, Michaela</dc:creator>
    <dc:creator>Taylor, Kerrie</dc:creator>
    <dc:creator>Temperley, Nicholas</dc:creator>
    <dc:creator>Johnson, Stephen</dc:creator>
    <dc:creator>Brear, Paul</dc:creator>
    <dc:creator>Gautier, Philippe</dc:creator>
    <dc:creator>Zeng, Zhiqiang</dc:creator>
    <dc:creator>Mitchell, Amy</dc:creator>
    <dc:creator>Narayan, Vikram</dc:creator>
    <dc:creator>McNeil, Ewan</dc:creator>
    <dc:creator>Melton, David</dc:creator>
    <dc:creator>Smith, Terry K</dc:creator>
    <dc:creator>Tyers, Mike</dc:creator>
    <dc:creator>Westwood, Nicholas James</dc:creator>
    <dc:creator>Patton, Elizabeth</dc:creator>
    <dc:description>Understanding how drugs work in vivo is critical for drug design and for maximizing the potential of currently available drugs. 5-nitrofurans are a class of pro-drugs widely used to treat bacterial and trypanosome infections, but despite relative specificity 5-nitrofurans often cause serious toxic side-effects in people. Here, we use yeast, zebrafish and human in vitro systems to assess the biological activity of 5-nitrofurans, and identify a conserved interaction between aldehyde dehydrogenase (ALDH) 2 and 5-nitrofurans across these species. In addition, we show that the activity of nifurtimox, a 5-nitrofuran anti-trypanosome pro-drug, is dependent on zebrafish Aldh2 and that nifurtimox is a substrate for human ALDH2. This study reveals a conserved and biologically relevant ALDH2-5-nitrofuran interaction that may have important implications for managing the toxicity of 5nitrofuran treatment.</dc:description>
  </entry>
  <entry>
    <title>The multifunctional NS1 protein of influenza virus</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/3001" />
    <author>
      <name>Hale, Benjamin Geoffrey</name>
    </author>
    <author>
      <name>Randall, Richard Edward</name>
    </author>
    <author>
      <name>Ortin, J</name>
    </author>
    <author>
      <name>Jackson, David</name>
    </author>
    <id>http://hdl.handle.net/10023/3001</id>
    <updated>2013-06-09T00:32:21Z</updated>
    <published>2008-10-01T00:00:00Z</published>
    <summary type="text">Abstract: The non-structural (NS1) protein of influenza A viruses is a non-essential virulence factor that has multiple accessory functions during viral infection. In recent years, the major role ascribed to NS1 has been its inhibition of host immune responses, especially the limitation of both interferon (IFN) production and the antiviral effects of IFN-induced proteins, such as dsRNA-dependent protein kinase R (PKR) and 2'5'-oligoadenylate synthetase (OAS)/RNase L. However, it is clear that NS1 also acts directly to modulate other important aspects of the virus replication cycle, including viral RNA replication, viral protein synthesis, and general host-cell physiology. Here, we review the current literature on this remarkably multifunctional viral protein. In the first part of this article, we summarize the basic biochemistry of NS1, in particular its synthesis, structure, and intracellular localization. We then discuss the various roles NS1 has in regulating viral replication mechanisms, host innate/adaptive immune responses, and cellular signalling pathways. We focus on the NS1-RNA and NS1-protein interactions that are fundamental to these processes, and highlight apparent strain-specific ways in which different NS1 proteins may act. In this regard, the contributions of certain NS1 functions to the pathogenicity of human and animal influenza A viruses are also discussed. Finally, we outline practical applications that future studies on NS1 may lead to, including the rational design and manufacture of influenza vaccines, the development of novel antiviral drugs, and the use of oncolytic influenza A viruses as potential anti-cancer agents.</summary>
    <dc:date>2008-10-01T00:00:00Z</dc:date>
    <dc:creator>Hale, Benjamin Geoffrey</dc:creator>
    <dc:creator>Randall, Richard Edward</dc:creator>
    <dc:creator>Ortin, J</dc:creator>
    <dc:creator>Jackson, David</dc:creator>
    <dc:description>The non-structural (NS1) protein of influenza A viruses is a non-essential virulence factor that has multiple accessory functions during viral infection. In recent years, the major role ascribed to NS1 has been its inhibition of host immune responses, especially the limitation of both interferon (IFN) production and the antiviral effects of IFN-induced proteins, such as dsRNA-dependent protein kinase R (PKR) and 2'5'-oligoadenylate synthetase (OAS)/RNase L. However, it is clear that NS1 also acts directly to modulate other important aspects of the virus replication cycle, including viral RNA replication, viral protein synthesis, and general host-cell physiology. Here, we review the current literature on this remarkably multifunctional viral protein. In the first part of this article, we summarize the basic biochemistry of NS1, in particular its synthesis, structure, and intracellular localization. We then discuss the various roles NS1 has in regulating viral replication mechanisms, host innate/adaptive immune responses, and cellular signalling pathways. We focus on the NS1-RNA and NS1-protein interactions that are fundamental to these processes, and highlight apparent strain-specific ways in which different NS1 proteins may act. In this regard, the contributions of certain NS1 functions to the pathogenicity of human and animal influenza A viruses are also discussed. Finally, we outline practical applications that future studies on NS1 may lead to, including the rational design and manufacture of influenza vaccines, the development of novel antiviral drugs, and the use of oncolytic influenza A viruses as potential anti-cancer agents.</dc:description>
  </entry>
  <entry>
    <title>Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2997" />
    <author>
      <name>Rudrawar, S</name>
    </author>
    <author>
      <name>Dyason, JC</name>
    </author>
    <author>
      <name>Rameix-Welti, MA</name>
    </author>
    <author>
      <name>Rose, FJ</name>
    </author>
    <author>
      <name>Kerry, Philip Stephen</name>
    </author>
    <author>
      <name>Russell, Rupert James Martin</name>
    </author>
    <author>
      <name>van der Werf, S</name>
    </author>
    <author>
      <name>Thomson, RJ</name>
    </author>
    <author>
      <name>Naffakh, N</name>
    </author>
    <author>
      <name>von Itzstein, M</name>
    </author>
    <id>http://hdl.handle.net/10023/2997</id>
    <updated>2013-05-12T03:36:38Z</updated>
    <published>2010-11-16T00:00:00Z</published>
    <summary type="text">Abstract: Influenza virus sialidase has an essential role in the virus’ life cycle. Two distinct groups of influenza A virus sialidases have been established, that differ in the flexibility of the ‘150-loop’, providing a more open active site in the apo form of the group-1 compared to group-2 enzymes. In this study we show, through a multidisciplinary approach, that novel sialic acid-based derivatives can exploit this structural difference and selectively inhibit the activity of group-1 sialidases. We also demonstrate that group-1 sialidases from drug-resistant mutant influenza viruses are sensitive to these designed compounds. Moreover, we have determined, by protein X-ray crystallography, that these inhibitors lock open the group-1 sialidase flexible 150-loop, in agreement with our molecular modelling prediction. This is the first direct proof that compounds may be developed to selectively target the pandemic A/H1N1, avian A/H5N1 and other group-1 sialidase-containing viruses, based on an open 150-loop conformation of the enzyme.
Description: This work was supported by the Medical Research Council and the Scottish Funding Council.</summary>
    <dc:date>2010-11-16T00:00:00Z</dc:date>
    <dc:creator>Rudrawar, S</dc:creator>
    <dc:creator>Dyason, JC</dc:creator>
    <dc:creator>Rameix-Welti, MA</dc:creator>
    <dc:creator>Rose, FJ</dc:creator>
    <dc:creator>Kerry, Philip Stephen</dc:creator>
    <dc:creator>Russell, Rupert James Martin</dc:creator>
    <dc:creator>van der Werf, S</dc:creator>
    <dc:creator>Thomson, RJ</dc:creator>
    <dc:creator>Naffakh, N</dc:creator>
    <dc:creator>von Itzstein, M</dc:creator>
    <dc:description>Influenza virus sialidase has an essential role in the virus’ life cycle. Two distinct groups of influenza A virus sialidases have been established, that differ in the flexibility of the ‘150-loop’, providing a more open active site in the apo form of the group-1 compared to group-2 enzymes. In this study we show, through a multidisciplinary approach, that novel sialic acid-based derivatives can exploit this structural difference and selectively inhibit the activity of group-1 sialidases. We also demonstrate that group-1 sialidases from drug-resistant mutant influenza viruses are sensitive to these designed compounds. Moreover, we have determined, by protein X-ray crystallography, that these inhibitors lock open the group-1 sialidase flexible 150-loop, in agreement with our molecular modelling prediction. This is the first direct proof that compounds may be developed to selectively target the pandemic A/H1N1, avian A/H5N1 and other group-1 sialidase-containing viruses, based on an open 150-loop conformation of the enzyme.</dc:description>
  </entry>
  <entry>
    <title>Conservation of a crystallographic interface suggests a role for beta-sheet augmentation in influenza virus NS1 multifunctionality</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2996" />
    <author>
      <name>Kerry, Philip Stephen</name>
    </author>
    <author>
      <name>Long, E</name>
    </author>
    <author>
      <name>Taylor, Margaret Alexandra</name>
    </author>
    <author>
      <name>Russell, Rupert James Martin</name>
    </author>
    <id>http://hdl.handle.net/10023/2996</id>
    <updated>2013-05-12T04:05:16Z</updated>
    <published>2011-08-01T00:00:00Z</published>
    <summary type="text">Abstract: The effector domain (ED) of the influenza virus virulence factor NS1 is capable of interaction with a variety of cellular and viral targets, although regulation of these events is poorly understood. Introduction of a W187A mutation into the ED abolishes dimer formation; however, strand-strand interactions between mutant NS1 ED monomers have been observed in two previous crystal forms. A new condition for crystallization of this protein [0.1 M Bis-Tris pH 6.0, 0.2 M NaCl, 22%(w/v) PEG 3350, 20 mM xylitol] was discovered using the hanging-drop vapour-diffusion method. Diffraction data extending to 1.8 Å resolution were collected from a crystal grown in the presence of 40 mM thieno[2,3-b]pyridin-2-ylmethanol. It was observed that there is conservation of the strand-strand interface in crystals of this monomeric NS1 ED in three different space groups. This observation, coupled with conformational changes in the interface region, suggests a potential role for [beta]-sheet augmentation in NS1 function.
Description: This research was supported by grants from the Medical Research Council (MRC) and the Scottish Funding Council (SFC).</summary>
    <dc:date>2011-08-01T00:00:00Z</dc:date>
    <dc:creator>Kerry, Philip Stephen</dc:creator>
    <dc:creator>Long, E</dc:creator>
    <dc:creator>Taylor, Margaret Alexandra</dc:creator>
    <dc:creator>Russell, Rupert James Martin</dc:creator>
    <dc:description>The effector domain (ED) of the influenza virus virulence factor NS1 is capable of interaction with a variety of cellular and viral targets, although regulation of these events is poorly understood. Introduction of a W187A mutation into the ED abolishes dimer formation; however, strand-strand interactions between mutant NS1 ED monomers have been observed in two previous crystal forms. A new condition for crystallization of this protein [0.1 M Bis-Tris pH 6.0, 0.2 M NaCl, 22%(w/v) PEG 3350, 20 mM xylitol] was discovered using the hanging-drop vapour-diffusion method. Diffraction data extending to 1.8 Å resolution were collected from a crystal grown in the presence of 40 mM thieno[2,3-b]pyridin-2-ylmethanol. It was observed that there is conservation of the strand-strand interface in crystals of this monomeric NS1 ED in three different space groups. This observation, coupled with conformational changes in the interface region, suggests a potential role for [beta]-sheet augmentation in NS1 function.</dc:description>
  </entry>
  <entry>
    <title>Regional susceptibility to TNF-alpha induction of murine brain inflammation via classical IKK/NF-kappa B signalling</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2984" />
    <author>
      <name>Young, Adam M. H.</name>
    </author>
    <author>
      <name>Campbell, Elaine C.</name>
    </author>
    <author>
      <name>Lynch, Sarah</name>
    </author>
    <author>
      <name>Dunn, Malcolm H.</name>
    </author>
    <author>
      <name>Powis, Simon J.</name>
    </author>
    <author>
      <name>Suckling, John</name>
    </author>
    <id>http://hdl.handle.net/10023/2984</id>
    <updated>2013-05-12T04:34:45Z</updated>
    <published>2012-06-11T00:00:00Z</published>
    <summary type="text">Abstract: It is becoming clear that inflammation plays a significant role in a number of neurological and psychiatric conditions. Post mortem brain samples in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia and most recently autism spectrum condition, all exhibit neuroglial activation and inflammatory markers within the CSF. Many questions remain about the underlying molecular mechanisms. By adding the pro-inflammatory cytokine, TNF-alpha, to mouse brain tissue we demonstrated that the frontal lobes and temporal region, areas involved in higher functions such as memory and learning, are most susceptible to cytokine-induced inflammation via the NF-kappa B signalling pathway. We observed direct correlations between the volumetric increase and molecular expression indicating that therapeutic targets in these lobes may require different approaches when treating conditions with a central neuroinflammatory component.</summary>
    <dc:date>2012-06-11T00:00:00Z</dc:date>
    <dc:creator>Young, Adam M. H.</dc:creator>
    <dc:creator>Campbell, Elaine C.</dc:creator>
    <dc:creator>Lynch, Sarah</dc:creator>
    <dc:creator>Dunn, Malcolm H.</dc:creator>
    <dc:creator>Powis, Simon J.</dc:creator>
    <dc:creator>Suckling, John</dc:creator>
    <dc:description>It is becoming clear that inflammation plays a significant role in a number of neurological and psychiatric conditions. Post mortem brain samples in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia and most recently autism spectrum condition, all exhibit neuroglial activation and inflammatory markers within the CSF. Many questions remain about the underlying molecular mechanisms. By adding the pro-inflammatory cytokine, TNF-alpha, to mouse brain tissue we demonstrated that the frontal lobes and temporal region, areas involved in higher functions such as memory and learning, are most susceptible to cytokine-induced inflammation via the NF-kappa B signalling pathway. We observed direct correlations between the volumetric increase and molecular expression indicating that therapeutic targets in these lobes may require different approaches when treating conditions with a central neuroinflammatory component.</dc:description>
  </entry>
  <entry>
    <title>MACiE (Mechanism, Annotation and Classification in Enzymes) : novel tools for searching catalytic mechanisms</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2890" />
    <author>
      <name>Holliday, Gemma L.</name>
    </author>
    <author>
      <name>Almonacid, Daniel E.</name>
    </author>
    <author>
      <name>Bartlett, Gail J.</name>
    </author>
    <author>
      <name>O'Boyle, Noel M.</name>
    </author>
    <author>
      <name>Torrance, James W.</name>
    </author>
    <author>
      <name>Murray-Rust, Peter</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <author>
      <name>Thornton, Janet M.</name>
    </author>
    <id>http://hdl.handle.net/10023/2890</id>
    <updated>2013-05-26T00:33:29Z</updated>
    <published>2007-01-01T00:00:00Z</published>
    <summary type="text">Abstract: MACiE (Mechanism, Annotation and Classification in Enzymes) is a database of enzyme reaction mechanisms, and is publicly available as a web-based data resource. This paper presents the first release of a web-based search tool to explore enzyme reaction mechanisms in MACiE. We also present Version 2 of MACiE, which doubles the dataset available (from Version 1). MACiE can be accessed from http://www.ebi.ac.uk/thornton-srv/databases/MACIE/.</summary>
    <dc:date>2007-01-01T00:00:00Z</dc:date>
    <dc:creator>Holliday, Gemma L.</dc:creator>
    <dc:creator>Almonacid, Daniel E.</dc:creator>
    <dc:creator>Bartlett, Gail J.</dc:creator>
    <dc:creator>O'Boyle, Noel M.</dc:creator>
    <dc:creator>Torrance, James W.</dc:creator>
    <dc:creator>Murray-Rust, Peter</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:creator>Thornton, Janet M.</dc:creator>
    <dc:description>MACiE (Mechanism, Annotation and Classification in Enzymes) is a database of enzyme reaction mechanisms, and is publicly available as a web-based data resource. This paper presents the first release of a web-based search tool to explore enzyme reaction mechanisms in MACiE. We also present Version 2 of MACiE, which doubles the dataset available (from Version 1). MACiE can be accessed from http://www.ebi.ac.uk/thornton-srv/databases/MACIE/.</dc:description>
  </entry>
  <entry>
    <title>The small genome segment of Bunyamwera orthobunyavirus harbours a single transcription-termination signal</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2884" />
    <author>
      <name>Blakqori, Gjon</name>
    </author>
    <author>
      <name>Lowen, Anice C.</name>
    </author>
    <author>
      <name>Elliott, Richard Michael</name>
    </author>
    <id>http://hdl.handle.net/10023/2884</id>
    <updated>2013-05-12T04:34:39Z</updated>
    <published>2012-07-01T00:00:00Z</published>
    <summary type="text">Abstract: Transcription termination of the mRNA produced from the small (S) genome segment of Bunyamwera orthobunyavirus (BUNV) has previously been mapped to two cis-acting sequences located within the 5′ UTR using a virus-free replication assay. The ability of these sequences to terminate transcription was attributed to the shared pentanucleotide motif 3′-UGUCG-5′. Taking advantage of our plasmid-based rescue system to generate recombinant viruses, we re-evaluated the importance of both pentanucleotide motifs as well as that of two other conserved sequences in transcription termination in vivo. Analysis of the 3′ ends of positive-stranded viral RNAs derived from the S segment revealed that only the region around the upstream pentanucleotide motif mediated transcription termination in cells infected with wild-type BUNV, leading to mRNAs that were about 100 nt shorter than antigenome RNA. Furthermore, the downstream motif was not recognized in recombinant viruses in which the upstream signal has been disrupted. Our results suggest that in the context of virus infection transcription termination of the BUNV S genome segment mRNA is exclusively directed by the upstream-termination signal. Interestingly, within this region we identified a motif similar to a transcription-termination sequence used by Rift Valley fever phlebovirus.</summary>
    <dc:date>2012-07-01T00:00:00Z</dc:date>
    <dc:creator>Blakqori, Gjon</dc:creator>
    <dc:creator>Lowen, Anice C.</dc:creator>
    <dc:creator>Elliott, Richard Michael</dc:creator>
    <dc:description>Transcription termination of the mRNA produced from the small (S) genome segment of Bunyamwera orthobunyavirus (BUNV) has previously been mapped to two cis-acting sequences located within the 5′ UTR using a virus-free replication assay. The ability of these sequences to terminate transcription was attributed to the shared pentanucleotide motif 3′-UGUCG-5′. Taking advantage of our plasmid-based rescue system to generate recombinant viruses, we re-evaluated the importance of both pentanucleotide motifs as well as that of two other conserved sequences in transcription termination in vivo. Analysis of the 3′ ends of positive-stranded viral RNAs derived from the S segment revealed that only the region around the upstream pentanucleotide motif mediated transcription termination in cells infected with wild-type BUNV, leading to mRNAs that were about 100 nt shorter than antigenome RNA. Furthermore, the downstream motif was not recognized in recombinant viruses in which the upstream signal has been disrupted. Our results suggest that in the context of virus infection transcription termination of the BUNV S genome segment mRNA is exclusively directed by the upstream-termination signal. Interestingly, within this region we identified a motif similar to a transcription-termination sequence used by Rift Valley fever phlebovirus.</dc:description>
  </entry>
  <entry>
    <title>Is EC class predictable from reaction mechanism?</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2883" />
    <author>
      <name>Nath, Neetika</name>
    </author>
    <author>
      <name>Mitchell, John B. O.</name>
    </author>
    <id>http://hdl.handle.net/10023/2883</id>
    <updated>2013-05-12T04:34:38Z</updated>
    <published>2012-04-24T00:00:00Z</published>
    <summary type="text">Abstract: Background: We investigate the relationships between the EC (Enzyme Commission) class, the associated chemical reaction, and the reaction mechanism by building predictive models using Support Vector Machine (SVM), Random Forest (RF) and k-Nearest Neighbours (kNN). We consider two ways of encoding the reaction mechanism in descriptors, and also three approaches that encode only the overall chemical reaction. Both cross-validation and also an external test set are used. Results: The three descriptor sets encoding overall chemical transformation perform better than the two descriptions of mechanism. SVM and RF models perform comparably well; kNN is less successful. Oxidoreductases and hydrolases are relatively well predicted by all types of descriptor; isomerases are well predicted by overall reaction descriptors but not by mechanistic ones. Conclusions: Our results suggest that pairs of similar enzyme reactions tend to proceed by different mechanisms. Oxidoreductases, hydrolases, and to some extent isomerases and ligases, have clear chemical signatures, making them easier to predict than transferases and lyases. We find evidence that isomerases as a class are notably mechanistically diverse and that their one shared property, of substrate and product being isomers, can arise in various unrelated ways. The performance of the different machine learning algorithms is in line with many cheminformatics applications, with SVM and RF being roughly equally effective. kNN is less successful, given the role that non-local information plays in successful classification. We note also that, despite a lack of clarity in the literature, EC number prediction is not a single problem; the challenge of predicting protein function from available sequence data is quite different from assigning an EC classification from a cheminformatics representation of a reaction.</summary>
    <dc:date>2012-04-24T00:00:00Z</dc:date>
    <dc:creator>Nath, Neetika</dc:creator>
    <dc:creator>Mitchell, John B. O.</dc:creator>
    <dc:description>Background: We investigate the relationships between the EC (Enzyme Commission) class, the associated chemical reaction, and the reaction mechanism by building predictive models using Support Vector Machine (SVM), Random Forest (RF) and k-Nearest Neighbours (kNN). We consider two ways of encoding the reaction mechanism in descriptors, and also three approaches that encode only the overall chemical reaction. Both cross-validation and also an external test set are used. Results: The three descriptor sets encoding overall chemical transformation perform better than the two descriptions of mechanism. SVM and RF models perform comparably well; kNN is less successful. Oxidoreductases and hydrolases are relatively well predicted by all types of descriptor; isomerases are well predicted by overall reaction descriptors but not by mechanistic ones. Conclusions: Our results suggest that pairs of similar enzyme reactions tend to proceed by different mechanisms. Oxidoreductases, hydrolases, and to some extent isomerases and ligases, have clear chemical signatures, making them easier to predict than transferases and lyases. We find evidence that isomerases as a class are notably mechanistically diverse and that their one shared property, of substrate and product being isomers, can arise in various unrelated ways. The performance of the different machine learning algorithms is in line with many cheminformatics applications, with SVM and RF being roughly equally effective. kNN is less successful, given the role that non-local information plays in successful classification. We note also that, despite a lack of clarity in the literature, EC number prediction is not a single problem; the challenge of predicting protein function from available sequence data is quite different from assigning an EC classification from a cheminformatics representation of a reaction.</dc:description>
  </entry>
  <entry>
    <title>Bunyaviruses and the type I interferon system</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2882" />
    <author>
      <name>Elliott, Richard Michael</name>
    </author>
    <author>
      <name>Weber, F</name>
    </author>
    <id>http://hdl.handle.net/10023/2882</id>
    <updated>2012-12-12T12:54:43Z</updated>
    <published>2009-11-23T00:00:00Z</published>
    <summary type="text">Abstract: The family Bunyaviridae contains more than 350 viruses that are distributed throughout the world. Most members of the family are transmitted by arthopods, and several cause disease in man, domesticated animals and crop plants. Despite being recognized as an emerging threat, details of the virulence mechanisms employed by bunyaviruses are scant. In this article we summarise the information currently available on how these viruses are able to establish infection when confronted with a powerful antiviral interferon system.</summary>
    <dc:date>2009-11-23T00:00:00Z</dc:date>
    <dc:creator>Elliott, Richard Michael</dc:creator>
    <dc:creator>Weber, F</dc:creator>
    <dc:description>The family Bunyaviridae contains more than 350 viruses that are distributed throughout the world. Most members of the family are transmitted by arthopods, and several cause disease in man, domesticated animals and crop plants. Despite being recognized as an emerging threat, details of the virulence mechanisms employed by bunyaviruses are scant. In this article we summarise the information currently available on how these viruses are able to establish infection when confronted with a powerful antiviral interferon system.</dc:description>
  </entry>
  <entry>
    <title>Structure and functional analysis of LptC, a conserved membrane protein involved in the lipopolysaccharide export pathway in Escherichia coli</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2880" />
    <author>
      <name>Tran, An X.</name>
    </author>
    <author>
      <name>Dong, Changjiang</name>
    </author>
    <author>
      <name>Whitfield, Chris</name>
    </author>
    <id>http://hdl.handle.net/10023/2880</id>
    <updated>2012-12-12T13:28:15Z</updated>
    <published>2010-10-22T00:00:00Z</published>
    <summary type="text">Abstract: LptC is a conserved bitopic inner membrane protein from Escherichia coli involved in the export of lipopolysaccharide from its site of synthesis in the cytoplasmic membrane to the outer membrane. LptC forms a complex with the ATP-binding cassette transporter, LptBFG, which is thought to facilitate the extraction of lipopolysaccharide from the inner membrane and release it into a translocation pathway that includes the putative periplasmic chaperone LptA. Cysteine modification experiments established that the catalytic domain of LptC is oriented toward the periplasm. The structure of the periplasmic domain is described at a resolution of 2.2-angstrom from x-ray crystallographic data. The periplasmic domain of LptC consists of a twisted boat structure with two beta-sheets in apposition to each other. The beta-sheets contain seven and eight antiparallel beta-strands, respectively. This structure bears a high degree of resemblance to the crystal structure of LptA. Like LptA, LptC binds lipopolysaccharide in vitro. In vitro, LptA can displace lipopolysaccharide from LptC (but not vice versa), consistent with their locations and their proposed placement in a unidirectional export pathway.
Description: This work is supported by a Wellcome Trust Career Development Fellowship to C.D.</summary>
    <dc:date>2010-10-22T00:00:00Z</dc:date>
    <dc:creator>Tran, An X.</dc:creator>
    <dc:creator>Dong, Changjiang</dc:creator>
    <dc:creator>Whitfield, Chris</dc:creator>
    <dc:description>LptC is a conserved bitopic inner membrane protein from Escherichia coli involved in the export of lipopolysaccharide from its site of synthesis in the cytoplasmic membrane to the outer membrane. LptC forms a complex with the ATP-binding cassette transporter, LptBFG, which is thought to facilitate the extraction of lipopolysaccharide from the inner membrane and release it into a translocation pathway that includes the putative periplasmic chaperone LptA. Cysteine modification experiments established that the catalytic domain of LptC is oriented toward the periplasm. The structure of the periplasmic domain is described at a resolution of 2.2-angstrom from x-ray crystallographic data. The periplasmic domain of LptC consists of a twisted boat structure with two beta-sheets in apposition to each other. The beta-sheets contain seven and eight antiparallel beta-strands, respectively. This structure bears a high degree of resemblance to the crystal structure of LptA. Like LptA, LptC binds lipopolysaccharide in vitro. In vitro, LptA can displace lipopolysaccharide from LptC (but not vice versa), consistent with their locations and their proposed placement in a unidirectional export pathway.</dc:description>
  </entry>
  <entry>
    <title>Scoring functions and enrichment : a case study on Hsp90</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2867" />
    <author>
      <name>Konstantinou-Kirtay, Chrysi</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <author>
      <name>Lumley, James A.</name>
    </author>
    <id>http://hdl.handle.net/10023/2867</id>
    <updated>2013-05-12T03:33:07Z</updated>
    <published>2007-01-26T00:00:00Z</published>
    <summary type="text">Abstract: Background: The need for fast and accurate scoring functions has been driven by the increased use of in silico virtual screening twinned with high-throughput screening as a method to rapidly identify potential candidates in the early stages of drug development. We examine the ability of some the most common scoring functions (GOLD, ChemScore, DOCK, PMF, BLEEP and Consensus) to discriminate correctly and efficiently between active and non-active compounds among a library of similar to 3,600 diverse decoy compounds in a virtual screening experiment against heat shock protein 90 (Hsp90). Results: Firstly, we investigated two ranking methodologies, GOLD(rank) and BestScore(rank). GOLD(rank) is based on ranks generated using GOLD. The various scoring functions, GOLD, ChemScore, DOCK, PMF, BLEEP and Consensus, are applied to the pose ranked number one by GOLD for that ligand. BestScore(rank) uses multiple poses for each ligand and independently chooses the best ranked pose of the ligand according to each different scoring function. Secondly, we considered the effect of introducing the Thr184 hydrogen bond tether to guide the docking process towards a particular solution, and its effect on enrichment. Thirdly, we considered normalisation to account for the known bias of scoring functions to select larger molecules. All the scoring functions gave fairly similar enrichments, with the exception of PMF which was consistently the poorest performer. In most cases, GOLD was marginally the best performing individual function; the Consensus score usually performed similarly to the best single scoring function. Our best results were obtained using the Thr184 tether in combination with the BestScore(rank) protocol and normalisation for molecular weight. For that particular combination, DOCK was the best individual function; DOCK recovered 90% of the actives in the top 10% of the ranked list; Consensus similarly recovered 89% of the actives in its top 10%. Conclusion: Overall, we demonstrate the validity of virtual screening as a method for identifying new leads from a pool of ligands with similar physicochemical properties and we believe that the outcome of this study provides useful insight into the setting up of a suitable docking and scoring protocol, resulting in enrichment of 'target active' compounds.
Description: This work was funded by the EPSRC, InsightFaraday (now part of the Chemistry Innovation Knowledge Transfer Network), Arrow Therapeutics Ltd and Unilever plc.</summary>
    <dc:date>2007-01-26T00:00:00Z</dc:date>
    <dc:creator>Konstantinou-Kirtay, Chrysi</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:creator>Lumley, James A.</dc:creator>
    <dc:description>Background: The need for fast and accurate scoring functions has been driven by the increased use of in silico virtual screening twinned with high-throughput screening as a method to rapidly identify potential candidates in the early stages of drug development. We examine the ability of some the most common scoring functions (GOLD, ChemScore, DOCK, PMF, BLEEP and Consensus) to discriminate correctly and efficiently between active and non-active compounds among a library of similar to 3,600 diverse decoy compounds in a virtual screening experiment against heat shock protein 90 (Hsp90). Results: Firstly, we investigated two ranking methodologies, GOLD(rank) and BestScore(rank). GOLD(rank) is based on ranks generated using GOLD. The various scoring functions, GOLD, ChemScore, DOCK, PMF, BLEEP and Consensus, are applied to the pose ranked number one by GOLD for that ligand. BestScore(rank) uses multiple poses for each ligand and independently chooses the best ranked pose of the ligand according to each different scoring function. Secondly, we considered the effect of introducing the Thr184 hydrogen bond tether to guide the docking process towards a particular solution, and its effect on enrichment. Thirdly, we considered normalisation to account for the known bias of scoring functions to select larger molecules. All the scoring functions gave fairly similar enrichments, with the exception of PMF which was consistently the poorest performer. In most cases, GOLD was marginally the best performing individual function; the Consensus score usually performed similarly to the best single scoring function. Our best results were obtained using the Thr184 tether in combination with the BestScore(rank) protocol and normalisation for molecular weight. For that particular combination, DOCK was the best individual function; DOCK recovered 90% of the actives in the top 10% of the ranked list; Consensus similarly recovered 89% of the actives in its top 10%. Conclusion: Overall, we demonstrate the validity of virtual screening as a method for identifying new leads from a pool of ligands with similar physicochemical properties and we believe that the outcome of this study provides useful insight into the setting up of a suitable docking and scoring protocol, resulting in enrichment of 'target active' compounds.</dc:description>
  </entry>
  <entry>
    <title>Quantitative comparison of catalytic mechanisms and overall reactions in convergently evolved enzymes : implications for classification of enzyme function</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2866" />
    <author>
      <name>Almonacid, Daniel E.</name>
    </author>
    <author>
      <name>Yera, Emmanuel R.</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <author>
      <name>Babbitt, Patricia C.</name>
    </author>
    <id>http://hdl.handle.net/10023/2866</id>
    <updated>2013-05-19T00:33:10Z</updated>
    <published>2010-03-12T00:00:00Z</published>
    <summary type="text">Abstract: Functionally analogous enzymes are those that catalyze similar reactions on similar substrates but do not share common ancestry, providing a window on the different structural strategies nature has used to evolve required catalysts. Identification and use of this information to improve reaction classification and computational annotation of enzymes newly discovered in the genome projects would benefit from systematic determination of reaction similarities. Here, we quantified similarity in bond changes for overall reactions and catalytic mechanisms for 95 pairs of functionally analogous enzymes (non-homologous enzymes with identical first three numbers of their EC codes) from the MACiE database. Similarity of overall reactions was computed by comparing the sets of bond changes in the transformations from substrates to products. For similarity of mechanisms, sets of bond changes occurring in each mechanistic step were compared; these similarities were then used to guide global and local alignments of mechanistic steps. Using this metric, only 44% of pairs of functionally analogous enzymes in the dataset had significantly similar overall reactions. For these enzymes, convergence to the same mechanism occurred in 33% of cases, with most pairs having at least one identical mechanistic step. Using our metric, overall reaction similarity serves as an upper bound for mechanistic similarity in functional analogs. For example, the four carbon-oxygen lyases acting on phosphates (EC 4.2.3) show neither significant overall reaction similarity nor significant mechanistic similarity. By contrast, the three carboxylic-ester hydrolases (EC 3.1.1) catalyze overall reactions with identical bond changes and have converged to almost identical mechanisms. The large proportion of enzyme pairs that do not show significant overall reaction similarity (56%) suggests that at least for the functionally analogous enzymes studied here, more stringent criteria could be used to refine definitions of EC sub-subclasses for improved discrimination in their classification of enzyme reactions. The results also indicate that mechanistic convergence of reaction steps is widespread, suggesting that quantitative measurement of mechanistic similarity can inform approaches for functional annotation.
Description: The authors thank the National Institutes of Health (NIH R01 GM60595 to PCB) and the Scottish Universities Life Sciences Alliance (SULSA to JBOM) for funding.</summary>
    <dc:date>2010-03-12T00:00:00Z</dc:date>
    <dc:creator>Almonacid, Daniel E.</dc:creator>
    <dc:creator>Yera, Emmanuel R.</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:creator>Babbitt, Patricia C.</dc:creator>
    <dc:description>Functionally analogous enzymes are those that catalyze similar reactions on similar substrates but do not share common ancestry, providing a window on the different structural strategies nature has used to evolve required catalysts. Identification and use of this information to improve reaction classification and computational annotation of enzymes newly discovered in the genome projects would benefit from systematic determination of reaction similarities. Here, we quantified similarity in bond changes for overall reactions and catalytic mechanisms for 95 pairs of functionally analogous enzymes (non-homologous enzymes with identical first three numbers of their EC codes) from the MACiE database. Similarity of overall reactions was computed by comparing the sets of bond changes in the transformations from substrates to products. For similarity of mechanisms, sets of bond changes occurring in each mechanistic step were compared; these similarities were then used to guide global and local alignments of mechanistic steps. Using this metric, only 44% of pairs of functionally analogous enzymes in the dataset had significantly similar overall reactions. For these enzymes, convergence to the same mechanism occurred in 33% of cases, with most pairs having at least one identical mechanistic step. Using our metric, overall reaction similarity serves as an upper bound for mechanistic similarity in functional analogs. For example, the four carbon-oxygen lyases acting on phosphates (EC 4.2.3) show neither significant overall reaction similarity nor significant mechanistic similarity. By contrast, the three carboxylic-ester hydrolases (EC 3.1.1) catalyze overall reactions with identical bond changes and have converged to almost identical mechanisms. The large proportion of enzyme pairs that do not show significant overall reaction similarity (56%) suggests that at least for the functionally analogous enzymes studied here, more stringent criteria could be used to refine definitions of EC sub-subclasses for improved discrimination in their classification of enzyme reactions. The results also indicate that mechanistic convergence of reaction steps is widespread, suggesting that quantitative measurement of mechanistic similarity can inform approaches for functional annotation.</dc:description>
  </entry>
  <entry>
    <title>A novel hybrid ultrafast shape descriptor method for use in virtual screening</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2865" />
    <author>
      <name>Cannon, EO</name>
    </author>
    <author>
      <name>Nigsch, F</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <id>http://hdl.handle.net/10023/2865</id>
    <updated>2013-05-12T02:31:51Z</updated>
    <published>2008-02-18T00:00:00Z</published>
    <summary type="text">Abstract: Background We have introduced a new Hybrid descriptor composed of the MACCS key descriptor encoding topological information and Ballester and Richards' Ultrafast Shape Recognition (USR) descriptor. The latter one is calculated from the moments of the distribution of the interatomic distances, and in this work we also included higher moments than in the original implementation. Results The performance of this Hybrid descriptor is assessed using Random Forest and a dataset of 116,476 molecules. Our dataset includes 5,245 molecules in ten classes from the 2005 World Anti-Doping Agency (WADA) dataset and 111,231 molecules from the National Cancer Institute (NCI) database. In a 10-fold Monte Carlo cross-validation this dataset was partitioned into three distinct parts for training, optimisation of an internal threshold that we introduced, and validation of the resulting model. The standard errors obtained were used to assess statistical significance of observed improvements in performance of our new descriptor. Conclusion The Hybrid descriptor was compared to the MACCS key descriptor, USR with the first three (USR), four (UF4) and five (UF5) moments, and a combination of MACCS with USR (three moments). The MACCS key descriptor was not combined with UF5, due to similar performance of UF5 and UF4. Superior performance in terms of all figures of merit was found for the MACCS/UF4 Hybrid descriptor with respect to all other descriptors examined. These figures of merit include recall in the top 1% and top 5% of the ranked validation sets, precision, F-measure, area under the Receiver Operating Characteristic curve and Matthews Correlation Coefficient.
Description: The authors thank the EPSRC and Unilever plc for funding.</summary>
    <dc:date>2008-02-18T00:00:00Z</dc:date>
    <dc:creator>Cannon, EO</dc:creator>
    <dc:creator>Nigsch, F</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:description>Background We have introduced a new Hybrid descriptor composed of the MACCS key descriptor encoding topological information and Ballester and Richards' Ultrafast Shape Recognition (USR) descriptor. The latter one is calculated from the moments of the distribution of the interatomic distances, and in this work we also included higher moments than in the original implementation. Results The performance of this Hybrid descriptor is assessed using Random Forest and a dataset of 116,476 molecules. Our dataset includes 5,245 molecules in ten classes from the 2005 World Anti-Doping Agency (WADA) dataset and 111,231 molecules from the National Cancer Institute (NCI) database. In a 10-fold Monte Carlo cross-validation this dataset was partitioned into three distinct parts for training, optimisation of an internal threshold that we introduced, and validation of the resulting model. The standard errors obtained were used to assess statistical significance of observed improvements in performance of our new descriptor. Conclusion The Hybrid descriptor was compared to the MACCS key descriptor, USR with the first three (USR), four (UF4) and five (UF5) moments, and a combination of MACCS with USR (three moments). The MACCS key descriptor was not combined with UF5, due to similar performance of UF5 and UF4. Superior performance in terms of all figures of merit was found for the MACCS/UF4 Hybrid descriptor with respect to all other descriptors examined. These figures of merit include recall in the top 1% and top 5% of the ranked validation sets, precision, F-measure, area under the Receiver Operating Characteristic curve and Matthews Correlation Coefficient.</dc:description>
  </entry>
  <entry>
    <title>Simultaneous feature selection and parameter optimisation using an artificial ant colony : case study of melting point prediction</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2864" />
    <author>
      <name>O'Boyle, NM</name>
    </author>
    <author>
      <name>Palmer, DS</name>
    </author>
    <author>
      <name>Nigsch, F</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <id>http://hdl.handle.net/10023/2864</id>
    <updated>2013-05-12T02:31:49Z</updated>
    <published>2008-10-29T00:00:00Z</published>
    <summary type="text">Abstract: Background We present a novel feature selection algorithm, Winnowing Artificial Ant Colony (WAAC), that performs simultaneous feature selection and model parameter optimisation for the development of predictive quantitative structure-property relationship (QSPR) models. The WAAC algorithm is an extension of the modified ant colony algorithm of Shen et al. (J Chem Inf Model 2005, 45: 1024–1029). We test the ability of the algorithm to develop a predictive partial least squares model for the Karthikeyan dataset (J Chem Inf Model 2005, 45: 581–590) of melting point values. We also test its ability to perform feature selection on a support vector machine model for the same dataset. Results Starting from an initial set of 203 descriptors, the WAAC algorithm selected a PLS model with 68 descriptors which has an RMSE on an external test set of 46.6°C and R2 of 0.51. The number of components chosen for the model was 49, which was close to optimal for this feature selection. The selected SVM model has 28 descriptors (cost of 5, ε of 0.21) and an RMSE of 45.1°C and R2 of 0.54. This model outperforms a kNN model (RMSE of 48.3°C, R2 of 0.47) for the same data and has similar performance to a Random Forest model (RMSE of 44.5°C, R2 of 0.55). However it is much less prone to bias at the extremes of the range of melting points as shown by the slope of the line through the residuals: -0.43 for WAAC/SVM, -0.53 for Random Forest. Conclusion With a careful choice of objective function, the WAAC algorithm can be used to optimise machine learning and regression models that suffer from overfitting. Where model parameters also need to be tuned, as is the case with support vector machine and partial least squares models, it can optimise these simultaneously. The moving probabilities used by the algorithm are easily interpreted in terms of the best and current models of the ants, and the winnowing procedure promotes the removal of irrelevant descriptors.
Description: The authors thank the BBSRC (NMOB and JBOM – grant BB/C51320X/1), Pfizer (DSP and JBOM – through the Pfizer Institute for Pharmaceutical Materials Science), and Unilever for funding FN and JBOM and for supporting the Centre for Molecular Science Informatics.</summary>
    <dc:date>2008-10-29T00:00:00Z</dc:date>
    <dc:creator>O'Boyle, NM</dc:creator>
    <dc:creator>Palmer, DS</dc:creator>
    <dc:creator>Nigsch, F</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:description>Background We present a novel feature selection algorithm, Winnowing Artificial Ant Colony (WAAC), that performs simultaneous feature selection and model parameter optimisation for the development of predictive quantitative structure-property relationship (QSPR) models. The WAAC algorithm is an extension of the modified ant colony algorithm of Shen et al. (J Chem Inf Model 2005, 45: 1024–1029). We test the ability of the algorithm to develop a predictive partial least squares model for the Karthikeyan dataset (J Chem Inf Model 2005, 45: 581–590) of melting point values. We also test its ability to perform feature selection on a support vector machine model for the same dataset. Results Starting from an initial set of 203 descriptors, the WAAC algorithm selected a PLS model with 68 descriptors which has an RMSE on an external test set of 46.6°C and R2 of 0.51. The number of components chosen for the model was 49, which was close to optimal for this feature selection. The selected SVM model has 28 descriptors (cost of 5, ε of 0.21) and an RMSE of 45.1°C and R2 of 0.54. This model outperforms a kNN model (RMSE of 48.3°C, R2 of 0.47) for the same data and has similar performance to a Random Forest model (RMSE of 44.5°C, R2 of 0.55). However it is much less prone to bias at the extremes of the range of melting points as shown by the slope of the line through the residuals: -0.43 for WAAC/SVM, -0.53 for Random Forest. Conclusion With a careful choice of objective function, the WAAC algorithm can be used to optimise machine learning and regression models that suffer from overfitting. Where model parameters also need to be tuned, as is the case with support vector machine and partial least squares models, it can optimise these simultaneously. The moving probabilities used by the algorithm are easily interpreted in terms of the best and current models of the ants, and the winnowing procedure promotes the removal of irrelevant descriptors.</dc:description>
  </entry>
  <entry>
    <title>CMLSnap : Animated reaction mechanisms</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2863" />
    <author>
      <name>Holliday, G L</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <author>
      <name>Murray-Rust, P</name>
    </author>
    <id>http://hdl.handle.net/10023/2863</id>
    <updated>2012-12-12T12:53:53Z</updated>
    <published>2004-10-26T00:00:00Z</published>
    <summary type="text">Abstract: Reactions with many steps can be represented by a single XML-based table of the atoms, bonds and electrons. For each step the complete Chemical Markup Language 1 representation of all components is obtained and a snapshot representing the end point of the step is generated. These snapshots can then be combined to give an animated description of the complete reaction, both in "2D" chemical structure diagrams and in three dimensions. Here we demonstrate the method's power with enzymatic reactions. It should be noted that readers of this paper will benefit from having an SVG (Scalable Vector Graphics) viewer plugin.
Description: The authors thank the EPSRC for financial support of this project and Unilever for their support of the Centre for Molecular Science Informatics.</summary>
    <dc:date>2004-10-26T00:00:00Z</dc:date>
    <dc:creator>Holliday, G L</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:creator>Murray-Rust, P</dc:creator>
    <dc:description>Reactions with many steps can be represented by a single XML-based table of the atoms, bonds and electrons. For each step the complete Chemical Markup Language 1 representation of all components is obtained and a snapshot representing the end point of the step is generated. These snapshots can then be combined to give an animated description of the complete reaction, both in "2D" chemical structure diagrams and in three dimensions. Here we demonstrate the method's power with enzymatic reactions. It should be noted that readers of this paper will benefit from having an SVG (Scalable Vector Graphics) viewer plugin.</dc:description>
  </entry>
  <entry>
    <title>Chemistry in Bioinformatics</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2862" />
    <author>
      <name>Murray-Rust, P</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <author>
      <name>Rzepa, H S</name>
    </author>
    <id>http://hdl.handle.net/10023/2862</id>
    <updated>2013-05-12T03:33:13Z</updated>
    <published>2005-06-07T00:00:00Z</published>
    <summary type="text">Abstract: Chemical information is now seen as critical for most areas of life sciences. But unlike Bioinformatics, where data is openly available and freely re-usable, most chemical information is closed and cannot be re-distributed without permission. This has led to a failure to adopt modern informatics and software techniques and therefore paucity of chemistry in bioinformatics. New technology, however, offers the hope of making chemical data (compounds and properties) free during the authoring process. We argue that the technology is already available; we require a collective agreement to enhance publication protocols.</summary>
    <dc:date>2005-06-07T00:00:00Z</dc:date>
    <dc:creator>Murray-Rust, P</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:creator>Rzepa, H S</dc:creator>
    <dc:description>Chemical information is now seen as critical for most areas of life sciences. But unlike Bioinformatics, where data is openly available and freely re-usable, most chemical information is closed and cannot be re-distributed without permission. This has led to a failure to adopt modern informatics and software techniques and therefore paucity of chemistry in bioinformatics. New technology, however, offers the hope of making chemical data (compounds and properties) free during the authoring process. We argue that the technology is already available; we require a collective agreement to enhance publication protocols.</dc:description>
  </entry>
  <entry>
    <title>Communication and re-use of chemical information in bioscience</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2861" />
    <author>
      <name>Murray-Rust, P</name>
    </author>
    <author>
      <name>Mitchell, John Blayney Owen</name>
    </author>
    <author>
      <name>Rzepa, H S</name>
    </author>
    <id>http://hdl.handle.net/10023/2861</id>
    <updated>2013-05-12T03:33:12Z</updated>
    <published>2005-07-18T00:00:00Z</published>
    <summary type="text">Abstract: The current methods of publishing chemical information in bioscience articles are analysed. Using 3 papers as use-cases, it is shown that conventional methods using human procedures, including cut-and-paste are time-consuming and introduce errors. The meaning of chemical terms and the identity of compounds is often ambiguous. valuable experimental data such as spectra and computational results are almost always omitted. We describe an Open XML architecture at proof-of-concept which addresses these concerns. Compounds are identified through explicit connection tables or links to persistent Open resources such as PubChem. It is argued that if publishers adopt these tools and protocols, then the quality and quantity of chemical information available to bioscientists will increase and the authors, publishers and readers will find the process cost-effective.</summary>
    <dc:date>2005-07-18T00:00:00Z</dc:date>
    <dc:creator>Murray-Rust, P</dc:creator>
    <dc:creator>Mitchell, John Blayney Owen</dc:creator>
    <dc:creator>Rzepa, H S</dc:creator>
    <dc:description>The current methods of publishing chemical information in bioscience articles are analysed. Using 3 papers as use-cases, it is shown that conventional methods using human procedures, including cut-and-paste are time-consuming and introduce errors. The meaning of chemical terms and the identity of compounds is often ambiguous. valuable experimental data such as spectra and computational results are almost always omitted. We describe an Open XML architecture at proof-of-concept which addresses these concerns. Compounds are identified through explicit connection tables or links to persistent Open resources such as PubChem. It is argued that if publishers adopt these tools and protocols, then the quality and quantity of chemical information available to bioscientists will increase and the authors, publishers and readers will find the process cost-effective.</dc:description>
  </entry>
  <entry>
    <title>Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2845" />
    <author>
      <name>Lain, Sonia</name>
    </author>
    <author>
      <name>Hollick, Jonathan J.</name>
    </author>
    <author>
      <name>Campbell, Johanna</name>
    </author>
    <author>
      <name>Staples, Oliver D.</name>
    </author>
    <author>
      <name>Higgins, Maureen</name>
    </author>
    <author>
      <name>Aoubala, Mustapha</name>
    </author>
    <author>
      <name>McCarthy, Anna</name>
    </author>
    <author>
      <name>Appleyard, Virginia</name>
    </author>
    <author>
      <name>Murray, Karen E.</name>
    </author>
    <author>
      <name>Baker, Lee</name>
    </author>
    <author>
      <name>Thompson, Alastair</name>
    </author>
    <author>
      <name>Mathers, Joanne</name>
    </author>
    <author>
      <name>Holland, Stephen J.</name>
    </author>
    <author>
      <name>Stark, Michael J. R.</name>
    </author>
    <author>
      <name>Pass, Georgia</name>
    </author>
    <author>
      <name>Woods, Julie</name>
    </author>
    <author>
      <name>Lane, David P.</name>
    </author>
    <author>
      <name>Westwood, Nicholas J.</name>
    </author>
    <id>http://hdl.handle.net/10023/2845</id>
    <updated>2013-05-26T04:31:02Z</updated>
    <published>2008-05-06T00:00:00Z</published>
    <summary type="text">Abstract: We have carried out a cell-based screen aimed at discovering small molecules that activate p53 and have the potential to decrease tumor growth. Here, we describe one of our hit compounds, tenovin-1, along with a more water-soluble analog, tenovin-6. Via a yeast genetic screen, biochemical assays, and target validation studies in mammalian cells, we show that tenovins act through inhibition of the protein-deacetylating activities of SirT1 and SirT2, two important members of the sirtuin family. Tenovins are active on mammalian cells at one-digit micromolar concentrations and decrease tumor growth in vivo as single agents. This underscores the utility of these compounds as biological tools for the study of sirtuin function as well as their potential therapeutic interest.</summary>
    <dc:date>2008-05-06T00:00:00Z</dc:date>
    <dc:creator>Lain, Sonia</dc:creator>
    <dc:creator>Hollick, Jonathan J.</dc:creator>
    <dc:creator>Campbell, Johanna</dc:creator>
    <dc:creator>Staples, Oliver D.</dc:creator>
    <dc:creator>Higgins, Maureen</dc:creator>
    <dc:creator>Aoubala, Mustapha</dc:creator>
    <dc:creator>McCarthy, Anna</dc:creator>
    <dc:creator>Appleyard, Virginia</dc:creator>
    <dc:creator>Murray, Karen E.</dc:creator>
    <dc:creator>Baker, Lee</dc:creator>
    <dc:creator>Thompson, Alastair</dc:creator>
    <dc:creator>Mathers, Joanne</dc:creator>
    <dc:creator>Holland, Stephen J.</dc:creator>
    <dc:creator>Stark, Michael J. R.</dc:creator>
    <dc:creator>Pass, Georgia</dc:creator>
    <dc:creator>Woods, Julie</dc:creator>
    <dc:creator>Lane, David P.</dc:creator>
    <dc:creator>Westwood, Nicholas J.</dc:creator>
    <dc:description>We have carried out a cell-based screen aimed at discovering small molecules that activate p53 and have the potential to decrease tumor growth. Here, we describe one of our hit compounds, tenovin-1, along with a more water-soluble analog, tenovin-6. Via a yeast genetic screen, biochemical assays, and target validation studies in mammalian cells, we show that tenovins act through inhibition of the protein-deacetylating activities of SirT1 and SirT2, two important members of the sirtuin family. Tenovins are active on mammalian cells at one-digit micromolar concentrations and decrease tumor growth in vivo as single agents. This underscores the utility of these compounds as biological tools for the study of sirtuin function as well as their potential therapeutic interest.</dc:description>
  </entry>
  <entry>
    <title>Changes in intra-nuclear mobility of mature snRNPs provide a mechanism for splicing defects in Spinal Muscular Atrophy</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2743" />
    <author>
      <name>Clelland, Allyson Kara</name>
    </author>
    <author>
      <name>Bales, Alexandra Beatrice Elizabeth</name>
    </author>
    <author>
      <name>Sleeman, Judith Elizabeth</name>
    </author>
    <id>http://hdl.handle.net/10023/2743</id>
    <updated>2013-05-12T04:14:24Z</updated>
    <published>2012-04-01T00:00:00Z</published>
    <summary type="text">Abstract: It is becoming increasingly clear that defects in RNA metabolism can lead to disease. Spinal Muscular Atrophy (SMA), a leading genetic cause of infant mortality, results from insufficient amounts of survival motor neuron (SMN) protein. SMN is required for the biogenesis of snRNPs: essential components of the spliceosome. Splicing abnormalities have been detected in models of SMA but it is unclear how lowered SMN affects the fidelity of pre-mRNA splicing. We have examined the dynamics of mature snRNPs in cells depleted of SMN and demonstrated that SMN depletion increases the mobility of mature snRNPs within the nucleus. To dissect the molecular mechanism by which SMN deficiency affects intra-nuclear snRNP mobility, we employed a panel of inhibitors of different stages of pre-mRNA processing. This in vivo modeling demonstrates that snRNP mobility is altered directly as a result of impaired snRNP maturation. Current models of nuclear dynamics predict that sub-nuclear structures, including the spliceosome, form by self-organization mediated by stochastic interactions between their molecular components. Thus, alteration of the intra-nuclear mobility of snRNPs provides a molecular mechanism for splicing defects in SMA.
Description: This work was funded by the Wellcome Trust (grant ID WT078810MA)</summary>
    <dc:date>2012-04-01T00:00:00Z</dc:date>
    <dc:creator>Clelland, Allyson Kara</dc:creator>
    <dc:creator>Bales, Alexandra Beatrice Elizabeth</dc:creator>
    <dc:creator>Sleeman, Judith Elizabeth</dc:creator>
    <dc:description>It is becoming increasingly clear that defects in RNA metabolism can lead to disease. Spinal Muscular Atrophy (SMA), a leading genetic cause of infant mortality, results from insufficient amounts of survival motor neuron (SMN) protein. SMN is required for the biogenesis of snRNPs: essential components of the spliceosome. Splicing abnormalities have been detected in models of SMA but it is unclear how lowered SMN affects the fidelity of pre-mRNA splicing. We have examined the dynamics of mature snRNPs in cells depleted of SMN and demonstrated that SMN depletion increases the mobility of mature snRNPs within the nucleus. To dissect the molecular mechanism by which SMN deficiency affects intra-nuclear snRNP mobility, we employed a panel of inhibitors of different stages of pre-mRNA processing. This in vivo modeling demonstrates that snRNP mobility is altered directly as a result of impaired snRNP maturation. Current models of nuclear dynamics predict that sub-nuclear structures, including the spliceosome, form by self-organization mediated by stochastic interactions between their molecular components. Thus, alteration of the intra-nuclear mobility of snRNPs provides a molecular mechanism for splicing defects in SMA.</dc:description>
  </entry>
  <entry>
    <title>Targeting mitotic chromosomes : a conserved mechanism to ensure viral genome persistence</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2472" />
    <author>
      <name>Feeney, Katherine Martha</name>
    </author>
    <author>
      <name>Parish, Joanna Louise</name>
    </author>
    <id>http://hdl.handle.net/10023/2472</id>
    <updated>2013-05-19T00:32:15Z</updated>
    <published>2009-05-07T00:00:00Z</published>
    <summary type="text">Abstract: Viruses that maintain their genomes as extrachromosomal circular DNA molecules and establish infection in actively dividing cells must ensure retention of their genomes within the nuclear envelope in order to prevent genome loss. The loss of nuclear membrane integrity during mitosis dictates that paired host cell chromosomes are captured and organized by the mitotic spindle apparatus before segregation to daughter cells. This prevents inaccurate chromosomal segregation and loss of genetic material. A similar mechanism may also exist for the nuclear retention of extrachromosomal viral genomes or episomes during mitosis, particularly for genomes maintained at a low copy number in latent infections. It has been heavily debated whether such a mechanism exists and to what extent this mechanism is conserved among diverse viruses. Research over the last two decades has provided a wealth of information regarding the mechanisms by which specific tumour viruses evade mitotic and DNA damage checkpoints. Here, we discuss the similarities and differences in how specific viruses tether episomal genomes to host cell chromosomes during mitosis to ensure long-term persistence.</summary>
    <dc:date>2009-05-07T00:00:00Z</dc:date>
    <dc:creator>Feeney, Katherine Martha</dc:creator>
    <dc:creator>Parish, Joanna Louise</dc:creator>
    <dc:description>Viruses that maintain their genomes as extrachromosomal circular DNA molecules and establish infection in actively dividing cells must ensure retention of their genomes within the nuclear envelope in order to prevent genome loss. The loss of nuclear membrane integrity during mitosis dictates that paired host cell chromosomes are captured and organized by the mitotic spindle apparatus before segregation to daughter cells. This prevents inaccurate chromosomal segregation and loss of genetic material. A similar mechanism may also exist for the nuclear retention of extrachromosomal viral genomes or episomes during mitosis, particularly for genomes maintained at a low copy number in latent infections. It has been heavily debated whether such a mechanism exists and to what extent this mechanism is conserved among diverse viruses. Research over the last two decades has provided a wealth of information regarding the mechanisms by which specific tumour viruses evade mitotic and DNA damage checkpoints. Here, we discuss the similarities and differences in how specific viruses tether episomal genomes to host cell chromosomes during mitosis to ensure long-term persistence.</dc:description>
  </entry>
  <entry>
    <title>Predicting the mechanism of phospholipidosis</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2463" />
    <author>
      <name>Lowe, Robert</name>
    </author>
    <author>
      <name>Mussa, Hamse Y.</name>
    </author>
    <author>
      <name>Nigsch, Florian</name>
    </author>
    <author>
      <name>Glen, Robert C.</name>
    </author>
    <author>
      <name>Mitchell, John B. O.</name>
    </author>
    <id>http://hdl.handle.net/10023/2463</id>
    <updated>2013-05-12T04:12:46Z</updated>
    <published>2012-01-26T00:00:00Z</published>
    <summary type="text">Abstract: The mechanism of phospholipidosis is still not well understood. Numerous different mechanisms have been proposed, varying from direct inhibition of the breakdown of phospholipids to the binding of a drug compound to the phospholipid, preventing breakdown. We have used a probabilistic method, the Parzen-Rosenblatt Window approach, to build a model from the ChEMBL dataset which can predict from a compound's structure both its primary pharmaceutical target and other targets with which it forms off-target, usually weaker, interactions. Using a small dataset of 182 phospholipidosis-inducing and non-inducing compounds, we predict their off-target activity against targets which could relate to phospholipidosis as a side-effect of a drug. We link these targets to specific mechanisms of inducing this lysosomal build-up of phospholipids in cells. Thus, we show that the induction of phospholipidosis is likely to occur by separate mechanisms when triggered by different cationic amphiphilic drugs. We find that both inhibition of phospholipase activity and enhanced cholesterol biosynthesis are likely to be important mechanisms. Furthermore, we provide evidence suggesting four specific protein targets. Sphingomyelin phosphodiesterase, phospholipase A2 and lysosomal phospholipase A1 are shown to be likely targets for the induction of phospholipidosis by inhibition of phospholipase activity, while lanosterol synthase is predicted to be associated with phospholipidosis being induced by enhanced cholesterol biosynthesis. This analysis provides the impetus for further experimental tests of these hypotheses.</summary>
    <dc:date>2012-01-26T00:00:00Z</dc:date>
    <dc:creator>Lowe, Robert</dc:creator>
    <dc:creator>Mussa, Hamse Y.</dc:creator>
    <dc:creator>Nigsch, Florian</dc:creator>
    <dc:creator>Glen, Robert C.</dc:creator>
    <dc:creator>Mitchell, John B. O.</dc:creator>
    <dc:description>The mechanism of phospholipidosis is still not well understood. Numerous different mechanisms have been proposed, varying from direct inhibition of the breakdown of phospholipids to the binding of a drug compound to the phospholipid, preventing breakdown. We have used a probabilistic method, the Parzen-Rosenblatt Window approach, to build a model from the ChEMBL dataset which can predict from a compound's structure both its primary pharmaceutical target and other targets with which it forms off-target, usually weaker, interactions. Using a small dataset of 182 phospholipidosis-inducing and non-inducing compounds, we predict their off-target activity against targets which could relate to phospholipidosis as a side-effect of a drug. We link these targets to specific mechanisms of inducing this lysosomal build-up of phospholipids in cells. Thus, we show that the induction of phospholipidosis is likely to occur by separate mechanisms when triggered by different cationic amphiphilic drugs. We find that both inhibition of phospholipase activity and enhanced cholesterol biosynthesis are likely to be important mechanisms. Furthermore, we provide evidence suggesting four specific protein targets. Sphingomyelin phosphodiesterase, phospholipase A2 and lysosomal phospholipase A1 are shown to be likely targets for the induction of phospholipidosis by inhibition of phospholipase activity, while lanosterol synthase is predicted to be associated with phospholipidosis being induced by enhanced cholesterol biosynthesis. This analysis provides the impetus for further experimental tests of these hypotheses.</dc:description>
  </entry>
  <entry>
    <title>An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2456" />
    <author>
      <name>Liu, Huanting</name>
    </author>
    <author>
      <name>Naismith, James Henderson</name>
    </author>
    <id>http://hdl.handle.net/10023/2456</id>
    <updated>2013-06-09T00:33:31Z</updated>
    <published>2008-12-04T00:00:00Z</published>
    <summary type="text">Abstract: Background: Mutagenesis plays an essential role in molecular biology and biochemistry. It has also been used in enzymology and protein science to generate proteins which are more tractable for biophysical techniques. The ability to quickly and specifically mutate a residue(s) in protein is important for mechanistic and functional studies. Although many site-directed mutagenesis methods have been developed, a simple, quick and multi-applicable method is still desirable. Results: We have developed a site-directed plasmid mutagenesis protocol that preserved the simple one step procedure of the QuikChange (TM) site-directed mutagenesis but enhanced its efficiency and extended its capability for multi-site mutagenesis. This modified protocol used a new primer design that promoted primer-template annealing by eliminating primer dimerization and also permitted the newly synthesized DNA to be used as the template in subsequent amplification cycles. These two factors we believe are the main reasons for the enhanced amplification efficiency and for its applications in multi-site mutagenesis. Conclusion: Our modified protocol significantly increased the efficiency of single mutation and also allowed facile large single insertions, deletions/truncations and multiple mutations in a single experiment, an option incompatible with the standard QuikChange (TM). Furthermore the new protocol required significantly less parental DNA which facilitated the DpnI digestion after the PCR amplification and enhanced the overall efficiency and reliability. Using our protocol, we generated single site, multiple single-site mutations and a combined insertion/deletion mutations. The results demonstrated that this new protocol imposed no additional reagent costs (beyond basic QuikChange T) but increased the overall success rates.</summary>
    <dc:date>2008-12-04T00:00:00Z</dc:date>
    <dc:creator>Liu, Huanting</dc:creator>
    <dc:creator>Naismith, James Henderson</dc:creator>
    <dc:description>Background: Mutagenesis plays an essential role in molecular biology and biochemistry. It has also been used in enzymology and protein science to generate proteins which are more tractable for biophysical techniques. The ability to quickly and specifically mutate a residue(s) in protein is important for mechanistic and functional studies. Although many site-directed mutagenesis methods have been developed, a simple, quick and multi-applicable method is still desirable. Results: We have developed a site-directed plasmid mutagenesis protocol that preserved the simple one step procedure of the QuikChange (TM) site-directed mutagenesis but enhanced its efficiency and extended its capability for multi-site mutagenesis. This modified protocol used a new primer design that promoted primer-template annealing by eliminating primer dimerization and also permitted the newly synthesized DNA to be used as the template in subsequent amplification cycles. These two factors we believe are the main reasons for the enhanced amplification efficiency and for its applications in multi-site mutagenesis. Conclusion: Our modified protocol significantly increased the efficiency of single mutation and also allowed facile large single insertions, deletions/truncations and multiple mutations in a single experiment, an option incompatible with the standard QuikChange (TM). Furthermore the new protocol required significantly less parental DNA which facilitated the DpnI digestion after the PCR amplification and enhanced the overall efficiency and reliability. Using our protocol, we generated single site, multiple single-site mutations and a combined insertion/deletion mutations. The results demonstrated that this new protocol imposed no additional reagent costs (beyond basic QuikChange T) but increased the overall success rates.</dc:description>
  </entry>
  <entry>
    <title>Activation of the beta interferon promoter by paramyxoviruses in the absence of virus protein synthesis</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2451" />
    <author>
      <name>Killip, M. J.</name>
    </author>
    <author>
      <name>Young, D. F.</name>
    </author>
    <author>
      <name>Precious, B. L.</name>
    </author>
    <author>
      <name>Goodbourn, S.</name>
    </author>
    <author>
      <name>Randall, R. E.</name>
    </author>
    <id>http://hdl.handle.net/10023/2451</id>
    <updated>2013-05-19T00:34:25Z</updated>
    <published>2012-02-01T00:00:00Z</published>
    <summary type="text">Abstract: Conflicting reports exist regarding the requirement for virus replication in interferon (IFN) induction by paramyxoviruses. Our previous work has demonstrated that pathogen-associated molecular patterns capable of activating the IFN-induction cascade are not normally generated during virus replication, but are associated instead with the presence of defective interfering (DI) viruses. We demonstrate here that DIs of paramyxoviruses, including parainfluenza virus 5, mumps virus and Sendai virus, can activate the IFN-induction cascade and the IFN-beta promoter in the absence of virus protein synthesis. As virus protein synthesis is an absolute requirement for paramyxovirus genome replication, our results indicate that these DI viruses do not require replication to activate the IFN-induction cascade.</summary>
    <dc:date>2012-02-01T00:00:00Z</dc:date>
    <dc:creator>Killip, M. J.</dc:creator>
    <dc:creator>Young, D. F.</dc:creator>
    <dc:creator>Precious, B. L.</dc:creator>
    <dc:creator>Goodbourn, S.</dc:creator>
    <dc:creator>Randall, R. E.</dc:creator>
    <dc:description>Conflicting reports exist regarding the requirement for virus replication in interferon (IFN) induction by paramyxoviruses. Our previous work has demonstrated that pathogen-associated molecular patterns capable of activating the IFN-induction cascade are not normally generated during virus replication, but are associated instead with the presence of defective interfering (DI) viruses. We demonstrate here that DIs of paramyxoviruses, including parainfluenza virus 5, mumps virus and Sendai virus, can activate the IFN-induction cascade and the IFN-beta promoter in the absence of virus protein synthesis. As virus protein synthesis is an absolute requirement for paramyxovirus genome replication, our results indicate that these DI viruses do not require replication to activate the IFN-induction cascade.</dc:description>
  </entry>
  <entry>
    <title>Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2448" />
    <author>
      <name>Lou, Hubing</name>
    </author>
    <author>
      <name>Chen, Min</name>
    </author>
    <author>
      <name>Black, Susan S.</name>
    </author>
    <author>
      <name>Bushell, Simon R.</name>
    </author>
    <author>
      <name>Ceccarelli, Matteo</name>
    </author>
    <author>
      <name>Mach, Tivadar</name>
    </author>
    <author>
      <name>Beis, Konstantinos</name>
    </author>
    <author>
      <name>Low, Alison S.</name>
    </author>
    <author>
      <name>Bamford, Victoria A.</name>
    </author>
    <author>
      <name>Booth, Ian R.</name>
    </author>
    <author>
      <name>Bayley, Hagan</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <id>http://hdl.handle.net/10023/2448</id>
    <updated>2013-05-12T04:11:59Z</updated>
    <published>2011-10-28T00:00:00Z</published>
    <summary type="text">Abstract: Antibiotic-resistant bacteria, particularly Gram negative species, present significant health care challenges. The permeation of antibiotics through the outer membrane is largely effected by the porin superfamily, changes in which contribute to antibiotic resistance. A series of antibiotic resistant E. coli isolates were obtained from a patient during serial treatment with various antibiotics. The sequence of OmpC changed at three positions during treatment giving rise to a total of four OmpC variants (denoted OmpC20, OmpC26, OmpC28 and OmpC33, in which OmpC20 was derived from the first clinical isolate). We demonstrate that expression of the OmpC K12 porin in the clinical isolates lowers the MIC, consistent with modified porin function contributing to drug resistance. By a range of assays we have established that the three mutations that occur between OmpC20 and OmpC33 modify transport of both small molecules and antibiotics across the outer membrane. This results in the modulation of resistance to antibiotics, particularly cefotaxime. Small ion unitary conductance measurements of the isolated porins do not show significant differences between isolates. Thus, resistance does not appear to arise from major changes in pore size. Crystal structures of all four OmpC clinical mutants and molecular dynamics simulations also show that the pore size is essentially unchanged. Molecular dynamics simulations suggest that perturbation of the transverse electrostatic field at the constriction zone reduces cefotaxime passage through the pore, consistent with laboratory and clinical data. This subtle modification of the transverse electric field is a very different source of resistance than occlusion of the pore or wholesale destruction of the transverse field and points to a new mechanism by which porins may modulate antibiotic passage through the outer membrane.</summary>
    <dc:date>2011-10-28T00:00:00Z</dc:date>
    <dc:creator>Lou, Hubing</dc:creator>
    <dc:creator>Chen, Min</dc:creator>
    <dc:creator>Black, Susan S.</dc:creator>
    <dc:creator>Bushell, Simon R.</dc:creator>
    <dc:creator>Ceccarelli, Matteo</dc:creator>
    <dc:creator>Mach, Tivadar</dc:creator>
    <dc:creator>Beis, Konstantinos</dc:creator>
    <dc:creator>Low, Alison S.</dc:creator>
    <dc:creator>Bamford, Victoria A.</dc:creator>
    <dc:creator>Booth, Ian R.</dc:creator>
    <dc:creator>Bayley, Hagan</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:description>Antibiotic-resistant bacteria, particularly Gram negative species, present significant health care challenges. The permeation of antibiotics through the outer membrane is largely effected by the porin superfamily, changes in which contribute to antibiotic resistance. A series of antibiotic resistant E. coli isolates were obtained from a patient during serial treatment with various antibiotics. The sequence of OmpC changed at three positions during treatment giving rise to a total of four OmpC variants (denoted OmpC20, OmpC26, OmpC28 and OmpC33, in which OmpC20 was derived from the first clinical isolate). We demonstrate that expression of the OmpC K12 porin in the clinical isolates lowers the MIC, consistent with modified porin function contributing to drug resistance. By a range of assays we have established that the three mutations that occur between OmpC20 and OmpC33 modify transport of both small molecules and antibiotics across the outer membrane. This results in the modulation of resistance to antibiotics, particularly cefotaxime. Small ion unitary conductance measurements of the isolated porins do not show significant differences between isolates. Thus, resistance does not appear to arise from major changes in pore size. Crystal structures of all four OmpC clinical mutants and molecular dynamics simulations also show that the pore size is essentially unchanged. Molecular dynamics simulations suggest that perturbation of the transverse electrostatic field at the constriction zone reduces cefotaxime passage through the pore, consistent with laboratory and clinical data. This subtle modification of the transverse electric field is a very different source of resistance than occlusion of the pore or wholesale destruction of the transverse field and points to a new mechanism by which porins may modulate antibiotic passage through the outer membrane.</dc:description>
  </entry>
  <entry>
    <title>Identification of essential and non-essential single-stranded DNA-binding proteins in a model archaeal organism</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2414" />
    <author>
      <name>Skowyra, Agnieszka</name>
    </author>
    <author>
      <name>MacNeill, Stuart</name>
    </author>
    <id>http://hdl.handle.net/10023/2414</id>
    <updated>2013-06-16T00:34:00Z</updated>
    <published>2012-02-01T00:00:00Z</published>
    <summary type="text">Abstract: Single-stranded DNA-binding proteins (SSBs) play vital roles in all aspects of DNA metabolism in all three domains of life and are characterized by the presence of one or more OB fold ssDNA-binding domains. Here, using the genetically tractable euryarchaeon Haloferax volcanii as a model, we present the first genetic analysis of SSB function in the archaea. We show that genes encoding the OB fold and zinc finger-containing RpaA1 and RpaB1 proteins are individually non-essential for cell viability but share an essential function, whereas the gene encoding the triple OB fold RpaC protein is essential. Loss of RpaC function can however be rescued by elevated expression of RpaB, indicative of functional overlap between the two classes of haloarchaeal SSB. Deletion analysis is used to demonstrate important roles for individual OB folds in RpaC and to show that conserved N- and C-terminal domains are required for efficient repair of DNA damage. Consistent with a role for RpaC in DNA repair, elevated expression of this protein leads to enhanced resistance to DNA damage. Taken together, our results offer important insights into archaeal SSB function and establish the haloarchaea as a valuable model for further studies.</summary>
    <dc:date>2012-02-01T00:00:00Z</dc:date>
    <dc:creator>Skowyra, Agnieszka</dc:creator>
    <dc:creator>MacNeill, Stuart</dc:creator>
    <dc:description>Single-stranded DNA-binding proteins (SSBs) play vital roles in all aspects of DNA metabolism in all three domains of life and are characterized by the presence of one or more OB fold ssDNA-binding domains. Here, using the genetically tractable euryarchaeon Haloferax volcanii as a model, we present the first genetic analysis of SSB function in the archaea. We show that genes encoding the OB fold and zinc finger-containing RpaA1 and RpaB1 proteins are individually non-essential for cell viability but share an essential function, whereas the gene encoding the triple OB fold RpaC protein is essential. Loss of RpaC function can however be rescued by elevated expression of RpaB, indicative of functional overlap between the two classes of haloarchaeal SSB. Deletion analysis is used to demonstrate important roles for individual OB folds in RpaC and to show that conserved N- and C-terminal domains are required for efficient repair of DNA damage. Consistent with a role for RpaC in DNA repair, elevated expression of this protein leads to enhanced resistance to DNA damage. Taken together, our results offer important insights into archaeal SSB function and establish the haloarchaea as a valuable model for further studies.</dc:description>
  </entry>
  <entry>
    <title>Sphingolipid and ceramide homeostasis : potential therapeutic targets</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2412" />
    <author>
      <name>Young, Simon</name>
    </author>
    <author>
      <name>Mina, John</name>
    </author>
    <author>
      <name>Denny, Paul</name>
    </author>
    <author>
      <name>Smith, Terry</name>
    </author>
    <id>http://hdl.handle.net/10023/2412</id>
    <updated>2013-05-12T04:06:43Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Sphingolipids are ubiquitous in eukaryotic cells where they have been attributed a plethora of functions from the formation of structural domains to polarized cellular trafficking and signal transduction. Recent research has identified and characterised many of the key enzymes involved in sphingolipid metabolism and this has lead to a heightened interest in the possibility of targeting these processes for therapies against cancers, Alzheimer’s disease and numerous important human pathogens. In this review we outline the major pathways in eukaryotic sphingolipid metabolism and discuss these in relation to disease and therapy for both chronic and infectious conditions.</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
    <dc:creator>Young, Simon</dc:creator>
    <dc:creator>Mina, John</dc:creator>
    <dc:creator>Denny, Paul</dc:creator>
    <dc:creator>Smith, Terry</dc:creator>
    <dc:description>Sphingolipids are ubiquitous in eukaryotic cells where they have been attributed a plethora of functions from the formation of structural domains to polarized cellular trafficking and signal transduction. Recent research has identified and characterised many of the key enzymes involved in sphingolipid metabolism and this has lead to a heightened interest in the possibility of targeting these processes for therapies against cancers, Alzheimer’s disease and numerous important human pathogens. In this review we outline the major pathways in eukaryotic sphingolipid metabolism and discuss these in relation to disease and therapy for both chronic and infectious conditions.</dc:description>
  </entry>
  <entry>
    <title>Mitochondrial β-amyloid in Alzheimer's disease</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2250" />
    <author>
      <name>Borger, Eva</name>
    </author>
    <author>
      <name>Aitken, Laura</name>
    </author>
    <author>
      <name>Muirhead, Kirsty Elizabeth Adair</name>
    </author>
    <author>
      <name>Allen, Zoe Eleanor</name>
    </author>
    <author>
      <name>Ainge, James Alexander</name>
    </author>
    <author>
      <name>Conway, Stuart</name>
    </author>
    <author>
      <name>Gunn-Moore, Frank J</name>
    </author>
    <id>http://hdl.handle.net/10023/2250</id>
    <updated>2013-05-12T04:04:45Z</updated>
    <published>2011-08-01T00:00:00Z</published>
    <summary type="text">Abstract: It is well established that the intracellular accumulation of beta-amyloid is associated with Alzheimer’s disease and that this accumulation is toxic to neurons. The precise mechanism by which this toxicity occurs is not well understood, however, identifying the causes of this toxicity is an essential step in developing treatments for Alzheimer’s disease. One intracellular location where the accumulation of beta-amyloid can have a major effect is within mitochondria has identified mitochondrial proteins that act as binding sites for beta-amyloid and when binding occurs a toxic response results. For one of these identified sites, an enzyme known as ‘ABAD’, we have identified the changes in gene expression in the brain cortex following beta-amyloid accumulation within mitochondria. Specifically, we have identified two proteins that are upregulated in the brains of transgenic animal models for Alzheimer’s disease but also human sufferers. The increased expression of these proteins demonstrates the complex and counter-acting pathways that are activated in Alzheimer’s disease. Previous studies have identified the approximate contact sites between ABAD and beta-amyloid, and based on these observations we have shown that using a modified peptide approach, it is possible to reverse the expression of these two proteins in living transgenic animals and also recover both mitochondrial and behavioural deficits. This indicates that the ABAD-beta-amyloid interaction is potentially an interesting target for therapeutic intervention. To explore this further we used a fluorescing substrate mimic to measure the activity of ABAD within living cells, and in addition we have identified chemical fragments that bind to ABAD, by using a thermal shift assay.
Description: This research is supported by Alzheimer's Research UK, the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.</summary>
    <dc:date>2011-08-01T00:00:00Z</dc:date>
    <dc:creator>Borger, Eva</dc:creator>
    <dc:creator>Aitken, Laura</dc:creator>
    <dc:creator>Muirhead, Kirsty Elizabeth Adair</dc:creator>
    <dc:creator>Allen, Zoe Eleanor</dc:creator>
    <dc:creator>Ainge, James Alexander</dc:creator>
    <dc:creator>Conway, Stuart</dc:creator>
    <dc:creator>Gunn-Moore, Frank J</dc:creator>
    <dc:description>It is well established that the intracellular accumulation of beta-amyloid is associated with Alzheimer’s disease and that this accumulation is toxic to neurons. The precise mechanism by which this toxicity occurs is not well understood, however, identifying the causes of this toxicity is an essential step in developing treatments for Alzheimer’s disease. One intracellular location where the accumulation of beta-amyloid can have a major effect is within mitochondria has identified mitochondrial proteins that act as binding sites for beta-amyloid and when binding occurs a toxic response results. For one of these identified sites, an enzyme known as ‘ABAD’, we have identified the changes in gene expression in the brain cortex following beta-amyloid accumulation within mitochondria. Specifically, we have identified two proteins that are upregulated in the brains of transgenic animal models for Alzheimer’s disease but also human sufferers. The increased expression of these proteins demonstrates the complex and counter-acting pathways that are activated in Alzheimer’s disease. Previous studies have identified the approximate contact sites between ABAD and beta-amyloid, and based on these observations we have shown that using a modified peptide approach, it is possible to reverse the expression of these two proteins in living transgenic animals and also recover both mitochondrial and behavioural deficits. This indicates that the ABAD-beta-amyloid interaction is potentially an interesting target for therapeutic intervention. To explore this further we used a fluorescing substrate mimic to measure the activity of ABAD within living cells, and in addition we have identified chemical fragments that bind to ABAD, by using a thermal shift assay.</dc:description>
  </entry>
  <entry>
    <title>2A peptides provide distinct solutions to driving stop-carry on translational recoding</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2227" />
    <author>
      <name>Sharma, P</name>
    </author>
    <author>
      <name>Yan, F</name>
    </author>
    <author>
      <name>Doronina, V</name>
    </author>
    <author>
      <name>Escuin-Ordinas, Helena</name>
    </author>
    <author>
      <name>Ryan, Martin Denis</name>
    </author>
    <author>
      <name>Brown, Jeremy</name>
    </author>
    <id>http://hdl.handle.net/10023/2227</id>
    <updated>2013-05-12T04:09:47Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Expression of viral proteins frequently includes non-canonical decoding events (‘recoding’) during translation. ‘2A’ oligopeptides drive one such event, termed ‘stop-carry on’ recoding. Nascent 2A peptides interact with the ribosomal exit tunnel to dictate an unusual stop codon-independent termination of translation at the final Pro codon of 2A. Subsequently, translation ‘reinitiates’ on the same codon, two individual proteins being generated from one open reading frame. Many 2A peptides have been identified, and they have a conserved C-terminal motif. Little similarity is present in the N-terminal portions of these peptides, which might suggest that these amino acids are not important in the 2A reaction. However, mutagenesis indicates that identity of the amino acid at nearly all positions of a single 2A peptide is important for activity. Each 2A may then represent a specific solution for positioning the conserved C-terminus within the peptidyl-transferase centre to promote recoding. Nascent 2A peptide:ribosome interactions are suggested to alter ribosomal fine structure to discriminate against prolyl-tRNAPro and promote termination in the absence of a stop codon. Such structural modifications may account for our observation that replacement of the final Pro codon of 2A with any stop codon both stalls ribosome processivity and inhibits nascent chain release.</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
    <dc:creator>Sharma, P</dc:creator>
    <dc:creator>Yan, F</dc:creator>
    <dc:creator>Doronina, V</dc:creator>
    <dc:creator>Escuin-Ordinas, Helena</dc:creator>
    <dc:creator>Ryan, Martin Denis</dc:creator>
    <dc:creator>Brown, Jeremy</dc:creator>
    <dc:description>Expression of viral proteins frequently includes non-canonical decoding events (‘recoding’) during translation. ‘2A’ oligopeptides drive one such event, termed ‘stop-carry on’ recoding. Nascent 2A peptides interact with the ribosomal exit tunnel to dictate an unusual stop codon-independent termination of translation at the final Pro codon of 2A. Subsequently, translation ‘reinitiates’ on the same codon, two individual proteins being generated from one open reading frame. Many 2A peptides have been identified, and they have a conserved C-terminal motif. Little similarity is present in the N-terminal portions of these peptides, which might suggest that these amino acids are not important in the 2A reaction. However, mutagenesis indicates that identity of the amino acid at nearly all positions of a single 2A peptide is important for activity. Each 2A may then represent a specific solution for positioning the conserved C-terminus within the peptidyl-transferase centre to promote recoding. Nascent 2A peptide:ribosome interactions are suggested to alter ribosomal fine structure to discriminate against prolyl-tRNAPro and promote termination in the absence of a stop codon. Such structural modifications may account for our observation that replacement of the final Pro codon of 2A with any stop codon both stalls ribosome processivity and inhibits nascent chain release.</dc:description>
  </entry>
  <entry>
    <title>Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2191" />
    <author>
      <name>Brennan, Benjamin</name>
    </author>
    <author>
      <name>Li, Ping</name>
    </author>
    <author>
      <name>Elliott, Richard M.</name>
    </author>
    <id>http://hdl.handle.net/10023/2191</id>
    <updated>2013-06-16T00:34:15Z</updated>
    <published>2011-12-01T00:00:00Z</published>
    <summary type="text">Abstract: The viral RNA-dependent RNA polymerase (RdRp; L protein) of Rift Valley fever virus (RVFV; family Bunyaviridae) is a 238 kDa protein that is crucial for the life cycle of the virus, as it catalyses both transcription of viral mRNAs and replication of the tripartite genome. Despite its importance, little is known about the intracellular distribution of the polymerase or its other roles during infection, primarily because of lack of specific antibodies that recognize L protein. To begin to address these questions we investigated whether the RVFV (MP12 strain) polymerase could tolerate insertion of the V5 epitope, as has been previously demonstrated for the Bunyamwera virus L protein. Insertion of the 14 aa epitope into the polymerase sequence at aa 1852 resulted in a polymerase that retained functionality in a minigenome assay, and we were able to rescue recombinant viruses that expressed the modified L protein by reverse genetics. The L protein could be detected in infected cells by Western blotting with anti-V5 antibodies. Examination of recombinant virus-infected cells by immunofluorescence revealed a punctate perinuclear or cytoplasmic distribution of the polymerase that co-localized with the nucleocapsid protein. The generation of RVFV expressing a tagged RdRp will allow detailed examination of the role of the viral polymerase in the virus life cycle.</summary>
    <dc:date>2011-12-01T00:00:00Z</dc:date>
    <dc:creator>Brennan, Benjamin</dc:creator>
    <dc:creator>Li, Ping</dc:creator>
    <dc:creator>Elliott, Richard M.</dc:creator>
    <dc:description>The viral RNA-dependent RNA polymerase (RdRp; L protein) of Rift Valley fever virus (RVFV; family Bunyaviridae) is a 238 kDa protein that is crucial for the life cycle of the virus, as it catalyses both transcription of viral mRNAs and replication of the tripartite genome. Despite its importance, little is known about the intracellular distribution of the polymerase or its other roles during infection, primarily because of lack of specific antibodies that recognize L protein. To begin to address these questions we investigated whether the RVFV (MP12 strain) polymerase could tolerate insertion of the V5 epitope, as has been previously demonstrated for the Bunyamwera virus L protein. Insertion of the 14 aa epitope into the polymerase sequence at aa 1852 resulted in a polymerase that retained functionality in a minigenome assay, and we were able to rescue recombinant viruses that expressed the modified L protein by reverse genetics. The L protein could be detected in infected cells by Western blotting with anti-V5 antibodies. Examination of recombinant virus-infected cells by immunofluorescence revealed a punctate perinuclear or cytoplasmic distribution of the polymerase that co-localized with the nucleocapsid protein. The generation of RVFV expressing a tagged RdRp will allow detailed examination of the role of the viral polymerase in the virus life cycle.</dc:description>
  </entry>
  <entry>
    <title>Innate sensing of HIV-infected cells</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2178" />
    <author>
      <name>Lepelley, Alice</name>
    </author>
    <author>
      <name>Louis, Stephanie</name>
    </author>
    <author>
      <name>Sourisseau, Marion</name>
    </author>
    <author>
      <name>Law, Helen K. W.</name>
    </author>
    <author>
      <name>Pothlichet, Julien</name>
    </author>
    <author>
      <name>Schilte, Clementine</name>
    </author>
    <author>
      <name>Chaperot, Laurence</name>
    </author>
    <author>
      <name>Plumas, Joel</name>
    </author>
    <author>
      <name>Randall, Richard E.</name>
    </author>
    <author>
      <name>Si-Tahar, Mustapha</name>
    </author>
    <author>
      <name>Mammano, Fabrizio</name>
    </author>
    <author>
      <name>Albert, Matthew L.</name>
    </author>
    <author>
      <name>Schwartz, Olivier</name>
    </author>
    <id>http://hdl.handle.net/10023/2178</id>
    <updated>2013-05-12T04:09:35Z</updated>
    <published>2011-02-01T00:00:00Z</published>
    <summary type="text">Abstract: Cell-free HIV-1 virions are poor stimulators of type I interferon (IFN) production. We examined here how HIV-infected cells are recognized by plasmacytoid dendritic cells (pDCs) and by other cells. We show that infected lymphocytes are more potent inducers of IFN than virions. There are target cell-type differences in the recognition of infected lymphocytes. In primary pDCs and pDC-like cells, recognition occurs in large part through TLR7, as demonstrated by the use of inhibitors and by TLR7 silencing. Donor cells expressing replication-defective viruses, carrying mutated reverse transcriptase, integrase or nucleocapsid proteins induced IFN production by target cells as potently as wild-type virus. In contrast, Env-deleted or fusion defective HIV-1 mutants were less efficient, suggesting that in addition to TLR7, cytoplasmic cellular sensors may also mediate sensing of infected cells. Furthermore, in a model of TLR7-negative cells, we demonstrate that the IRF3 pathway, through a process requiring access of incoming viral material to the cytoplasm, allows sensing of HIV-infected lymphocytes. Therefore, detection of HIV-infected lymphocytes occurs through both endosomal and cytoplasmic pathways. Characterization of the mechanisms of innate recognition of HIV-infected cells allows a better understanding of the pathogenic and exacerbated immunologic events associated with HIV infection.</summary>
    <dc:date>2011-02-01T00:00:00Z</dc:date>
    <dc:creator>Lepelley, Alice</dc:creator>
    <dc:creator>Louis, Stephanie</dc:creator>
    <dc:creator>Sourisseau, Marion</dc:creator>
    <dc:creator>Law, Helen K. W.</dc:creator>
    <dc:creator>Pothlichet, Julien</dc:creator>
    <dc:creator>Schilte, Clementine</dc:creator>
    <dc:creator>Chaperot, Laurence</dc:creator>
    <dc:creator>Plumas, Joel</dc:creator>
    <dc:creator>Randall, Richard E.</dc:creator>
    <dc:creator>Si-Tahar, Mustapha</dc:creator>
    <dc:creator>Mammano, Fabrizio</dc:creator>
    <dc:creator>Albert, Matthew L.</dc:creator>
    <dc:creator>Schwartz, Olivier</dc:creator>
    <dc:description>Cell-free HIV-1 virions are poor stimulators of type I interferon (IFN) production. We examined here how HIV-infected cells are recognized by plasmacytoid dendritic cells (pDCs) and by other cells. We show that infected lymphocytes are more potent inducers of IFN than virions. There are target cell-type differences in the recognition of infected lymphocytes. In primary pDCs and pDC-like cells, recognition occurs in large part through TLR7, as demonstrated by the use of inhibitors and by TLR7 silencing. Donor cells expressing replication-defective viruses, carrying mutated reverse transcriptase, integrase or nucleocapsid proteins induced IFN production by target cells as potently as wild-type virus. In contrast, Env-deleted or fusion defective HIV-1 mutants were less efficient, suggesting that in addition to TLR7, cytoplasmic cellular sensors may also mediate sensing of infected cells. Furthermore, in a model of TLR7-negative cells, we demonstrate that the IRF3 pathway, through a process requiring access of incoming viral material to the cytoplasm, allows sensing of HIV-infected lymphocytes. Therefore, detection of HIV-infected lymphocytes occurs through both endosomal and cytoplasmic pathways. Characterization of the mechanisms of innate recognition of HIV-infected cells allows a better understanding of the pathogenic and exacerbated immunologic events associated with HIV infection.</dc:description>
  </entry>
  <entry>
    <title>A transient homotypic interaction model for the influenza A virus NS1 protein effector domain</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2177" />
    <author>
      <name>Kerry, Philip S.</name>
    </author>
    <author>
      <name>Ayllon, Juan</name>
    </author>
    <author>
      <name>Taylor, Margaret A.</name>
    </author>
    <author>
      <name>Hass, Claudia</name>
    </author>
    <author>
      <name>Lewis, Andrew</name>
    </author>
    <author>
      <name>Garcia-Sastre, Adolfo</name>
    </author>
    <author>
      <name>Randall, Richard E.</name>
    </author>
    <author>
      <name>Hale, Benjamin G.</name>
    </author>
    <author>
      <name>Russell, Rupert J.</name>
    </author>
    <id>http://hdl.handle.net/10023/2177</id>
    <updated>2013-05-12T04:09:34Z</updated>
    <published>2011-03-28T00:00:00Z</published>
    <summary type="text">Abstract: Influenza A virus NS1 protein is a multifunctional virulence factor consisting of an RNA binding domain (RBD), a short linker, an effector domain (ED), and a C-terminal 'tail'. Although poorly understood, NS1 multimerization may autoregulate its actions. While RBD dimerization seems functionally conserved, two possible apo ED dimers have been proposed (helix-helix and strand-strand). Here, we analyze all available RBD, ED, and full-length NS1 structures, including four novel crystal structures obtained using EDs from divergent human and avian viruses, as well as two forms of a monomeric ED mutant. The data reveal the helix-helix interface as the only strictly conserved ED homodimeric contact. Furthermore, a mutant NS1 unable to form the helix-helix dimer is compromised in its ability to bind dsRNA efficiently, implying that ED multimerization influences RBD activity. Our bioinformatical work also suggests that the helix-helix interface is variable and transient, thereby allowing two ED monomers to twist relative to one another and possibly separate. In this regard, we found a mAb that recognizes NS1 via a residue completely buried within the ED helix-helix interface, and which may help highlight potential different conformational populations of NS1 (putatively termed 'helix-closed' and 'helix-open') in virus-infected cells. 'Helix-closed' conformations appear to enhance dsRNA binding, and 'helix-open' conformations allow otherwise inaccessible interactions with host factors. Our data support a new model of NS1 regulation in which the RBD remains dimeric throughout infection, while the ED switches between several quaternary states in order to expand its functional space. Such a concept may be applicable to other small multifunctional proteins.
Description: Work in St. Andrews was supported by the Medical Research Council, UK (RER and RJR), and the Scottish Funding Council (RJR).</summary>
    <dc:date>2011-03-28T00:00:00Z</dc:date>
    <dc:creator>Kerry, Philip S.</dc:creator>
    <dc:creator>Ayllon, Juan</dc:creator>
    <dc:creator>Taylor, Margaret A.</dc:creator>
    <dc:creator>Hass, Claudia</dc:creator>
    <dc:creator>Lewis, Andrew</dc:creator>
    <dc:creator>Garcia-Sastre, Adolfo</dc:creator>
    <dc:creator>Randall, Richard E.</dc:creator>
    <dc:creator>Hale, Benjamin G.</dc:creator>
    <dc:creator>Russell, Rupert J.</dc:creator>
    <dc:description>Influenza A virus NS1 protein is a multifunctional virulence factor consisting of an RNA binding domain (RBD), a short linker, an effector domain (ED), and a C-terminal 'tail'. Although poorly understood, NS1 multimerization may autoregulate its actions. While RBD dimerization seems functionally conserved, two possible apo ED dimers have been proposed (helix-helix and strand-strand). Here, we analyze all available RBD, ED, and full-length NS1 structures, including four novel crystal structures obtained using EDs from divergent human and avian viruses, as well as two forms of a monomeric ED mutant. The data reveal the helix-helix interface as the only strictly conserved ED homodimeric contact. Furthermore, a mutant NS1 unable to form the helix-helix dimer is compromised in its ability to bind dsRNA efficiently, implying that ED multimerization influences RBD activity. Our bioinformatical work also suggests that the helix-helix interface is variable and transient, thereby allowing two ED monomers to twist relative to one another and possibly separate. In this regard, we found a mAb that recognizes NS1 via a residue completely buried within the ED helix-helix interface, and which may help highlight potential different conformational populations of NS1 (putatively termed 'helix-closed' and 'helix-open') in virus-infected cells. 'Helix-closed' conformations appear to enhance dsRNA binding, and 'helix-open' conformations allow otherwise inaccessible interactions with host factors. Our data support a new model of NS1 regulation in which the RBD remains dimeric throughout infection, while the ED switches between several quaternary states in order to expand its functional space. Such a concept may be applicable to other small multifunctional proteins.</dc:description>
  </entry>
  <entry>
    <title>Lipidomic analysis of bloodstream and procyclic form Trypanosoma brucei</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2117" />
    <author>
      <name>Richmond, Gregory S.</name>
    </author>
    <author>
      <name>Gibellini, Federica</name>
    </author>
    <author>
      <name>Young, Simon A.</name>
    </author>
    <author>
      <name>Major, Louise</name>
    </author>
    <author>
      <name>Denton, Helen</name>
    </author>
    <author>
      <name>Lilley, Alison</name>
    </author>
    <author>
      <name>Smith, Terry K</name>
    </author>
    <id>http://hdl.handle.net/10023/2117</id>
    <updated>2013-06-09T00:34:02Z</updated>
    <published>2010-08-01T00:00:00Z</published>
    <summary type="text">Abstract: The biological membranes of Trypanosonza brucei contain a complex array of phospholipids that are synthesized de novo from precursors obtained either directly from the host, or as catabolised endocytosed lipids. This paper describes the use of nanoflow electrospray tandem mass spectrometry and high resolution mass spectrometry in both positive and negative ion modes, allowing the identification of similar to 500 individual molecular phospholipids species from total lipid extracts of cultured bloodstream and procyclic form T. brucei. Various molecular species of all of the major subclasses of glycerophospholipids were identified including phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol as well as phosphatidic acid, phosphatidylglycerol and cardolipin, and the sphingolipids sphingomyelin, inositol phosphoceramide and ethanolamine phosphoceramide. The lipidomic data obtained in this study will aid future biochemical phenotyping of either genetically or chemically manipulated commonly used bloodstream and procyclic strains of Trypanosoma brucei. Hopefully this will allow a greater understanding of the bizarre world of lipids in this important human pathogen.</summary>
    <dc:date>2010-08-01T00:00:00Z</dc:date>
    <dc:creator>Richmond, Gregory S.</dc:creator>
    <dc:creator>Gibellini, Federica</dc:creator>
    <dc:creator>Young, Simon A.</dc:creator>
    <dc:creator>Major, Louise</dc:creator>
    <dc:creator>Denton, Helen</dc:creator>
    <dc:creator>Lilley, Alison</dc:creator>
    <dc:creator>Smith, Terry K</dc:creator>
    <dc:description>The biological membranes of Trypanosonza brucei contain a complex array of phospholipids that are synthesized de novo from precursors obtained either directly from the host, or as catabolised endocytosed lipids. This paper describes the use of nanoflow electrospray tandem mass spectrometry and high resolution mass spectrometry in both positive and negative ion modes, allowing the identification of similar to 500 individual molecular phospholipids species from total lipid extracts of cultured bloodstream and procyclic form T. brucei. Various molecular species of all of the major subclasses of glycerophospholipids were identified including phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol as well as phosphatidic acid, phosphatidylglycerol and cardolipin, and the sphingolipids sphingomyelin, inositol phosphoceramide and ethanolamine phosphoceramide. The lipidomic data obtained in this study will aid future biochemical phenotyping of either genetically or chemically manipulated commonly used bloodstream and procyclic strains of Trypanosoma brucei. Hopefully this will allow a greater understanding of the bizarre world of lipids in this important human pathogen.</dc:description>
  </entry>
  <entry>
    <title>Displacement of the canonical single-stranded DNA-binding protein in the Thermoproteales</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2108" />
    <author>
      <name>Paytubi, Sonia</name>
    </author>
    <author>
      <name>McMahon, Stephen</name>
    </author>
    <author>
      <name>Graham, Shirley</name>
    </author>
    <author>
      <name>Liu, Huanting</name>
    </author>
    <author>
      <name>Botting, Catherine Helen</name>
    </author>
    <author>
      <name>Makarova, Kira S.</name>
    </author>
    <author>
      <name>Kroonin, Eugene V.</name>
    </author>
    <author>
      <name>Naismith, Jim</name>
    </author>
    <author>
      <name>White, Malcolm F</name>
    </author>
    <id>http://hdl.handle.net/10023/2108</id>
    <updated>2013-05-26T00:34:38Z</updated>
    <published>2012-02-14T00:00:00Z</published>
    <summary type="text">Abstract: Single-stranded DNA binding proteins (SSBs) based on the OB-fold are considered ubiquitous in nature and play a central role in many DNA transactions including replication, recombination and repair. We demonstrate that the thermoproteales, a clade of hyperthermophilic crenarchaea, lack a canonical SSB. Instead, they encode a distinct ssDNA-binding protein that we term "ThermoDBP", exemplified by protein Ttx1576 from Thermoproteus tenax. ThermoDBP binds specifically to ssDNA with low sequence specificity. The crystal structure of Ttx1576 reveals a unique fold and mechanism for ssDNA binding, consisting of an extended cleft lined with hydrophobic phenylalanine residues and flanked by basic amino acids. Two ssDNA-binding domains are linked by a coiled-coil leucine zipper. ThermoDBP appears to have displaced the canonical SSB during the diversification of the thermoproteales – a highly unusual example where a “ubiquitous” protein has been lost in evolution.</summary>
    <dc:date>2012-02-14T00:00:00Z</dc:date>
    <dc:creator>Paytubi, Sonia</dc:creator>
    <dc:creator>McMahon, Stephen</dc:creator>
    <dc:creator>Graham, Shirley</dc:creator>
    <dc:creator>Liu, Huanting</dc:creator>
    <dc:creator>Botting, Catherine Helen</dc:creator>
    <dc:creator>Makarova, Kira S.</dc:creator>
    <dc:creator>Kroonin, Eugene V.</dc:creator>
    <dc:creator>Naismith, Jim</dc:creator>
    <dc:creator>White, Malcolm F</dc:creator>
    <dc:description>Single-stranded DNA binding proteins (SSBs) based on the OB-fold are considered ubiquitous in nature and play a central role in many DNA transactions including replication, recombination and repair. We demonstrate that the thermoproteales, a clade of hyperthermophilic crenarchaea, lack a canonical SSB. Instead, they encode a distinct ssDNA-binding protein that we term "ThermoDBP", exemplified by protein Ttx1576 from Thermoproteus tenax. ThermoDBP binds specifically to ssDNA with low sequence specificity. The crystal structure of Ttx1576 reveals a unique fold and mechanism for ssDNA binding, consisting of an extended cleft lined with hydrophobic phenylalanine residues and flanked by basic amino acids. Two ssDNA-binding domains are linked by a coiled-coil leucine zipper. ThermoDBP appears to have displaced the canonical SSB during the diversification of the thermoproteales – a highly unusual example where a “ubiquitous” protein has been lost in evolution.</dc:description>
  </entry>
  <entry>
    <title>PCNA stimulates catalysis by structure-specific nuclease using two distinct mechanisms : substrate targeting and catalytic step</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2103" />
    <author>
      <name>Hutton, R D</name>
    </author>
    <author>
      <name>Roberts, J A</name>
    </author>
    <author>
      <name>Penedo, Carlos</name>
    </author>
    <author>
      <name>White, Malcolm Frederick</name>
    </author>
    <id>http://hdl.handle.net/10023/2103</id>
    <updated>2013-06-16T04:31:05Z</updated>
    <published>2008-12-01T00:00:00Z</published>
    <summary type="text">Abstract: The sliding clamp Proliferating Cell Nuclear Antigen (PCNA) functions as a recruiter and organizer of a wide variety of DNA modifying enzymes including nucleases, helicases, polymerases and glycosylases. The 5-flap endonuclease Fen-1 is essential for Okazaki fragment processing in eukaryotes and archaea, and is targeted to the replication fork by PCNA. Crenarchaeal XPF, a 3-flap endonuclease, is also stimulated by PCNA in vitro. Using a novel continuous fluorimetric assay, we demonstrate that PCNA activates these two nucleases by fundamentally different mechanisms. PCNA stimulates Fen-1 by increasing the enzymes binding affinity for substrates, as suggested previously. However, PCNA activates XPF by increasing the catalytic rate constant by four orders of magnitude without affecting the K-M. PCNA may function as a platform upon which XPF exerts force to distort DNA substrates, destabilizing the substrate and/or stabilizing the transition state structure. This suggests that PCNA can function directly in supporting catalysis as an essential cofactor in some circumstances, a new role for a protein that is generally assumed to perform a passive targeting and organizing function in molecular biology. This could provide a mechanism for the exquisite control of nuclease activity targeted to specific circumstances, such as replication forks or damaged DNA with pre-loaded PCNA.
Description: This work was supported by the Biotechnology and Biological Sciences Research Council [grants BBD0014391 and BBE0146741]</summary>
    <dc:date>2008-12-01T00:00:00Z</dc:date>
    <dc:creator>Hutton, R D</dc:creator>
    <dc:creator>Roberts, J A</dc:creator>
    <dc:creator>Penedo, Carlos</dc:creator>
    <dc:creator>White, Malcolm Frederick</dc:creator>
    <dc:description>The sliding clamp Proliferating Cell Nuclear Antigen (PCNA) functions as a recruiter and organizer of a wide variety of DNA modifying enzymes including nucleases, helicases, polymerases and glycosylases. The 5-flap endonuclease Fen-1 is essential for Okazaki fragment processing in eukaryotes and archaea, and is targeted to the replication fork by PCNA. Crenarchaeal XPF, a 3-flap endonuclease, is also stimulated by PCNA in vitro. Using a novel continuous fluorimetric assay, we demonstrate that PCNA activates these two nucleases by fundamentally different mechanisms. PCNA stimulates Fen-1 by increasing the enzymes binding affinity for substrates, as suggested previously. However, PCNA activates XPF by increasing the catalytic rate constant by four orders of magnitude without affecting the K-M. PCNA may function as a platform upon which XPF exerts force to distort DNA substrates, destabilizing the substrate and/or stabilizing the transition state structure. This suggests that PCNA can function directly in supporting catalysis as an essential cofactor in some circumstances, a new role for a protein that is generally assumed to perform a passive targeting and organizing function in molecular biology. This could provide a mechanism for the exquisite control of nuclease activity targeted to specific circumstances, such as replication forks or damaged DNA with pre-loaded PCNA.</dc:description>
  </entry>
  <entry>
    <title>PCNA and XPF cooperate to distort DNA substrates</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2089" />
    <author>
      <name>Hutton, Richard D.</name>
    </author>
    <author>
      <name>Craggs, Timothy D.</name>
    </author>
    <author>
      <name>White, Malcolm F</name>
    </author>
    <author>
      <name>Penedo, J. Carlos</name>
    </author>
    <id>http://hdl.handle.net/10023/2089</id>
    <updated>2013-05-12T03:03:51Z</updated>
    <published>2010-03-01T00:00:00Z</published>
    <summary type="text">Abstract: XPF is a structure-specific endonuclease that preferentially cleaves 3' DNA flaps during a variety of repair processes. The crystal structure of a crenarchaeal XPF protein bound to a DNA duplex yielded insights into how XPF might recognise branched DNA structures, and recent kinetic data have demonstrated that the sliding clamp PCNA acts as an essential cofactor, possibly by allowing XPF to distort the DNA structure into a proper conformation for efficient cleavage to occur. Here, we investigate the solution structure of the 3'-flap substrate bound to XPF in the presence and absence of PCNA using intramolecular Forster resonance energy transfer (FRET). We demonstrate that recognition of the flap substrate by XPF involves major conformational changes of the DNA, including a 90 degrees kink of the DNA duplex and organization of the single-stranded flap. In the presence of PCNA, there is a further substantial reorganization of the flap substrate bound to XPF, providing a structural basis for the observation that PCNA has an essential catalytic role in this system. The wider implications of these observations for the plethora of PCNA-dependent enzymes are discussed.</summary>
    <dc:date>2010-03-01T00:00:00Z</dc:date>
    <dc:creator>Hutton, Richard D.</dc:creator>
    <dc:creator>Craggs, Timothy D.</dc:creator>
    <dc:creator>White, Malcolm F</dc:creator>
    <dc:creator>Penedo, J. Carlos</dc:creator>
    <dc:description>XPF is a structure-specific endonuclease that preferentially cleaves 3' DNA flaps during a variety of repair processes. The crystal structure of a crenarchaeal XPF protein bound to a DNA duplex yielded insights into how XPF might recognise branched DNA structures, and recent kinetic data have demonstrated that the sliding clamp PCNA acts as an essential cofactor, possibly by allowing XPF to distort the DNA structure into a proper conformation for efficient cleavage to occur. Here, we investigate the solution structure of the 3'-flap substrate bound to XPF in the presence and absence of PCNA using intramolecular Forster resonance energy transfer (FRET). We demonstrate that recognition of the flap substrate by XPF involves major conformational changes of the DNA, including a 90 degrees kink of the DNA duplex and organization of the single-stranded flap. In the presence of PCNA, there is a further substantial reorganization of the flap substrate bound to XPF, providing a structural basis for the observation that PCNA has an essential catalytic role in this system. The wider implications of these observations for the plethora of PCNA-dependent enzymes are discussed.</dc:description>
  </entry>
  <entry>
    <title>Genome-wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic analysis of mRNA alterations during synchronous differentiation in Trypanosoma brucei</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2087" />
    <author>
      <name>Kabani, Sarah</name>
    </author>
    <author>
      <name>Fenn, Katelyn</name>
    </author>
    <author>
      <name>Ross, Alan</name>
    </author>
    <author>
      <name>Ivens, Al</name>
    </author>
    <author>
      <name>Smith, Terry K.</name>
    </author>
    <author>
      <name>Ghazal, Peter</name>
    </author>
    <author>
      <name>Matthews, Keith</name>
    </author>
    <id>http://hdl.handle.net/10023/2087</id>
    <updated>2013-06-09T00:33:46Z</updated>
    <published>2009-09-11T00:00:00Z</published>
    <summary type="text">Abstract: Background: Trypanosomes undergo extensive developmental changes during their complex life cycle. Crucial among these is the transition between slender and stumpy bloodstream forms and, thereafter, the differentiation from stumpy to tsetse-midgut procyclic forms. These developmental events are highly regulated, temporally reproducible and accompanied by expression changes mediated almost exclusively at the post-transcriptional level. Results: In this study we have examined, by whole-genome microarray analysis, the mRNA abundance of genes in slender and stumpy forms of T. brucei AnTat1.1 cells, and also during their synchronous differentiation to procyclic forms. In total, five biological replicates representing the differentiation of matched parasite populations derived from five individual mouse infections were assayed, with RNAs being derived at key biological time points during the time course of their synchronous differentiation to procyclic forms. Importantly, the biological context of these mRNA profiles was established by assaying the coincident cellular events in each population (surface antigen exchange, morphological restructuring, cell cycle re-entry), thereby linking the observed gene expression changes to the well-established framework of trypanosome differentiation. Conclusion: Using stringent statistical analysis and validation of the derived profiles against experimentally-predicted gene expression and phenotypic changes, we have established the profile of regulated gene expression during these important life-cycle transitions. The highly synchronous nature of differentiation between stumpy and procyclic forms also means that these studies of mRNA profiles are directly relevant to the changes in mRNA abundance within individual cells during this well-characterised developmental transition.</summary>
    <dc:date>2009-09-11T00:00:00Z</dc:date>
    <dc:creator>Kabani, Sarah</dc:creator>
    <dc:creator>Fenn, Katelyn</dc:creator>
    <dc:creator>Ross, Alan</dc:creator>
    <dc:creator>Ivens, Al</dc:creator>
    <dc:creator>Smith, Terry K.</dc:creator>
    <dc:creator>Ghazal, Peter</dc:creator>
    <dc:creator>Matthews, Keith</dc:creator>
    <dc:description>Background: Trypanosomes undergo extensive developmental changes during their complex life cycle. Crucial among these is the transition between slender and stumpy bloodstream forms and, thereafter, the differentiation from stumpy to tsetse-midgut procyclic forms. These developmental events are highly regulated, temporally reproducible and accompanied by expression changes mediated almost exclusively at the post-transcriptional level. Results: In this study we have examined, by whole-genome microarray analysis, the mRNA abundance of genes in slender and stumpy forms of T. brucei AnTat1.1 cells, and also during their synchronous differentiation to procyclic forms. In total, five biological replicates representing the differentiation of matched parasite populations derived from five individual mouse infections were assayed, with RNAs being derived at key biological time points during the time course of their synchronous differentiation to procyclic forms. Importantly, the biological context of these mRNA profiles was established by assaying the coincident cellular events in each population (surface antigen exchange, morphological restructuring, cell cycle re-entry), thereby linking the observed gene expression changes to the well-established framework of trypanosome differentiation. Conclusion: Using stringent statistical analysis and validation of the derived profiles against experimentally-predicted gene expression and phenotypic changes, we have established the profile of regulated gene expression during these important life-cycle transitions. The highly synchronous nature of differentiation between stumpy and procyclic forms also means that these studies of mRNA profiles are directly relevant to the changes in mRNA abundance within individual cells during this well-characterised developmental transition.</dc:description>
  </entry>
  <entry>
    <title>Biochemical characterization of the initial steps of the Kennedy pathway in Trypanosoma brucei : the ethanolamine and choline kinases</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2086" />
    <author>
      <name>Gibellini, Federica</name>
    </author>
    <author>
      <name>Hunter, William N.</name>
    </author>
    <author>
      <name>Smith, Terry K.</name>
    </author>
    <id>http://hdl.handle.net/10023/2086</id>
    <updated>2013-05-12T02:34:15Z</updated>
    <published>2008-10-01T00:00:00Z</published>
    <summary type="text">Abstract: Ethanolamine and choline are major components of the trypanosome membrane phospholipids, in the form of GPEtn (glycero-phosphoethanolamine) and GPCho (glycerophosphocholine). Ethanolamine is also found as an integral component of the GPI (glycosylpliosphatidylinositol) anchor that is required for membrane attachment of cell-surface proteins, most notably the variant-surface glycoproteins. The de novo synthesis of GPEtn and GPCho starts with the generation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases via the Kennedy pathway. Database mining revealed two putative C/EKs (choline/ethanolamine kinases) in the Trypanosoma brucei genome, which were cloned, overexpressed, purified and characterized. TbEK 1 (T brucei ethanolamine kinase 1) was shown to be catalytically active as an ethanolamine-specific kinase, i.e. it had no choline kinase activity. The K values for ethanolamine and ATP were found to be 18.4 +/- 0.9 and 219 29 mu M respectively. TbC/EK2 (T brucei choline/ethanolamine kinase 2), on the other hand, was found to be able to phosphorylate both ethanolamine and choline, even though choline was the preferred substrate, with a K-m 80 times lower than that of ethanolamine. The K. values for choline, ethanolamine and ATP were 31.4 +/- 2.6 mu M, 2.56 +/- 0.31 mu M and 20.6 +/- 1.96 mu M respectively. Further substrate specificity analysis revealed that both TbEK1 and TbC/EK2 were able to tolerate various modifications at the amino group, with the exception of a quaternary amine for TbEK1 (choline) and a primary amine for TbC/EK2 (ethanolamine). Both enzymes recognized analogues with substituents oil C-2, but substitutions oil C-1 and elongations of the carbon chain were not well tolerated.</summary>
    <dc:date>2008-10-01T00:00:00Z</dc:date>
    <dc:creator>Gibellini, Federica</dc:creator>
    <dc:creator>Hunter, William N.</dc:creator>
    <dc:creator>Smith, Terry K.</dc:creator>
    <dc:description>Ethanolamine and choline are major components of the trypanosome membrane phospholipids, in the form of GPEtn (glycero-phosphoethanolamine) and GPCho (glycerophosphocholine). Ethanolamine is also found as an integral component of the GPI (glycosylpliosphatidylinositol) anchor that is required for membrane attachment of cell-surface proteins, most notably the variant-surface glycoproteins. The de novo synthesis of GPEtn and GPCho starts with the generation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases via the Kennedy pathway. Database mining revealed two putative C/EKs (choline/ethanolamine kinases) in the Trypanosoma brucei genome, which were cloned, overexpressed, purified and characterized. TbEK 1 (T brucei ethanolamine kinase 1) was shown to be catalytically active as an ethanolamine-specific kinase, i.e. it had no choline kinase activity. The K values for ethanolamine and ATP were found to be 18.4 +/- 0.9 and 219 29 mu M respectively. TbC/EK2 (T brucei choline/ethanolamine kinase 2), on the other hand, was found to be able to phosphorylate both ethanolamine and choline, even though choline was the preferred substrate, with a K-m 80 times lower than that of ethanolamine. The K. values for choline, ethanolamine and ATP were 31.4 +/- 2.6 mu M, 2.56 +/- 0.31 mu M and 20.6 +/- 1.96 mu M respectively. Further substrate specificity analysis revealed that both TbEK1 and TbC/EK2 were able to tolerate various modifications at the amino group, with the exception of a quaternary amine for TbEK1 (choline) and a primary amine for TbC/EK2 (ethanolamine). Both enzymes recognized analogues with substituents oil C-2, but substitutions oil C-1 and elongations of the carbon chain were not well tolerated.</dc:description>
  </entry>
  <entry>
    <title>Integrated holographic system for all-optical manipulation of developing embryos</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/2007" />
    <author>
      <name>Torres, Maria Leilani</name>
    </author>
    <author>
      <name>Antkowiak, Maciej</name>
    </author>
    <author>
      <name>Cizmarova, Hana</name>
    </author>
    <author>
      <name>Ferrier, David Ellard Keith</name>
    </author>
    <author>
      <name>Dholakia, Kishan</name>
    </author>
    <author>
      <name>Gunn-Moore, Frank J</name>
    </author>
    <id>http://hdl.handle.net/10023/2007</id>
    <updated>2013-06-09T00:34:50Z</updated>
    <published>2011-06-01T00:00:00Z</published>
    <summary type="text">Abstract: We demonstrate a system for the combined optical injection and trapping of developing embryos. A Ti:sapphire femtosecond laser in tandem with a spatial light modulator, is used to perform fast and accurate beam-steering and multiplexing. We show successful intracellular delivery of a range of impermeable molecules into individual blastomeres of the annelid Pomatoceros lamarckii embryo by optoinjection, even when the embryo is still enclosed in a chorion. We also demonstrate the ability of the femtosecond laser optoinjection to deliver materials into inner layers of cells in a well-developed embryo. By switching to the continuous wave mode of the Ti:sapphire laser, the same system can be employed to optically trap and orient the 60 μm sized P. lamarckii embryo whilst maintaining its viability. Hence, a complete all-optical manipulation platform is demonstrated paving the way towards single-cell genetic modification and cell lineage mapping in emerging developmental biology model species.</summary>
    <dc:date>2011-06-01T00:00:00Z</dc:date>
    <dc:creator>Torres, Maria Leilani</dc:creator>
    <dc:creator>Antkowiak, Maciej</dc:creator>
    <dc:creator>Cizmarova, Hana</dc:creator>
    <dc:creator>Ferrier, David Ellard Keith</dc:creator>
    <dc:creator>Dholakia, Kishan</dc:creator>
    <dc:creator>Gunn-Moore, Frank J</dc:creator>
    <dc:description>We demonstrate a system for the combined optical injection and trapping of developing embryos. A Ti:sapphire femtosecond laser in tandem with a spatial light modulator, is used to perform fast and accurate beam-steering and multiplexing. We show successful intracellular delivery of a range of impermeable molecules into individual blastomeres of the annelid Pomatoceros lamarckii embryo by optoinjection, even when the embryo is still enclosed in a chorion. We also demonstrate the ability of the femtosecond laser optoinjection to deliver materials into inner layers of cells in a well-developed embryo. By switching to the continuous wave mode of the Ti:sapphire laser, the same system can be employed to optically trap and orient the 60 μm sized P. lamarckii embryo whilst maintaining its viability. Hence, a complete all-optical manipulation platform is demonstrated paving the way towards single-cell genetic modification and cell lineage mapping in emerging developmental biology model species.</dc:description>
  </entry>
  <entry>
    <title>Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1911" />
    <author>
      <name>Overton, Ian M.</name>
    </author>
    <author>
      <name>Graham, Shirley</name>
    </author>
    <author>
      <name>Gould, Katherine A.</name>
    </author>
    <author>
      <name>Hinds, Jason</name>
    </author>
    <author>
      <name>Botting, Catherine H.</name>
    </author>
    <author>
      <name>Shirran, Sally</name>
    </author>
    <author>
      <name>Barton, Geoffrey J.</name>
    </author>
    <author>
      <name>Coote, Peter J.</name>
    </author>
    <id>http://hdl.handle.net/10023/1911</id>
    <updated>2013-05-12T04:05:20Z</updated>
    <published>2011-05-12T00:00:00Z</published>
    <summary type="text">Abstract: Background: Staphylococcus aureus is a major human pathogen and strains resistant to existing treatments continue to emerge. Development of novel treatments is therefore important. Antimicrobial peptides represent a source of potential novel antibiotics to combat resistant bacteria such as Methicillin-Resistant Staphylococcus aureus (MRSA). A promising antimicrobial peptide is ranalexin, which has potent activity against Gram-positive bacteria, and particularly S. aureus. Understanding mode of action is a key component of drug discovery and network biology approaches enable a global, integrated view of microbial physiology, including mechanisms of antibiotic killing. We developed a systems-wide functional association network approach to integrate proteome and transcriptome profiles, enabling study of drug resistance and mode of action. Results: The functional association network was constructed by Bayesian logistic regression, providing a framework for identification of antimicrobial peptide (ranalexin) response modules from S. aureus MRSA-252 transcriptome and proteome profiling. These signatures of ranalexin treatment revealed multiple killing mechanisms, including cell wall activity. Cell wall effects were supported by gene disruption and osmotic fragility experiments. Furthermore, twenty-two novel virulence factors were inferred, while the VraRS two-component system and PhoU-mediated persister formation were implicated in MRSA tolerance to cationic antimicrobial peptides. Conclusions: This work demonstrates a powerful integrative approach to study drug resistance and mode of action. Our findings are informative to the development of novel therapeutic strategies against Staphylococcus aureus and particularly MRSA.</summary>
    <dc:date>2011-05-12T00:00:00Z</dc:date>
    <dc:creator>Overton, Ian M.</dc:creator>
    <dc:creator>Graham, Shirley</dc:creator>
    <dc:creator>Gould, Katherine A.</dc:creator>
    <dc:creator>Hinds, Jason</dc:creator>
    <dc:creator>Botting, Catherine H.</dc:creator>
    <dc:creator>Shirran, Sally</dc:creator>
    <dc:creator>Barton, Geoffrey J.</dc:creator>
    <dc:creator>Coote, Peter J.</dc:creator>
    <dc:description>Background: Staphylococcus aureus is a major human pathogen and strains resistant to existing treatments continue to emerge. Development of novel treatments is therefore important. Antimicrobial peptides represent a source of potential novel antibiotics to combat resistant bacteria such as Methicillin-Resistant Staphylococcus aureus (MRSA). A promising antimicrobial peptide is ranalexin, which has potent activity against Gram-positive bacteria, and particularly S. aureus. Understanding mode of action is a key component of drug discovery and network biology approaches enable a global, integrated view of microbial physiology, including mechanisms of antibiotic killing. We developed a systems-wide functional association network approach to integrate proteome and transcriptome profiles, enabling study of drug resistance and mode of action. Results: The functional association network was constructed by Bayesian logistic regression, providing a framework for identification of antimicrobial peptide (ranalexin) response modules from S. aureus MRSA-252 transcriptome and proteome profiling. These signatures of ranalexin treatment revealed multiple killing mechanisms, including cell wall activity. Cell wall effects were supported by gene disruption and osmotic fragility experiments. Furthermore, twenty-two novel virulence factors were inferred, while the VraRS two-component system and PhoU-mediated persister formation were implicated in MRSA tolerance to cationic antimicrobial peptides. Conclusions: This work demonstrates a powerful integrative approach to study drug resistance and mode of action. Our findings are informative to the development of novel therapeutic strategies against Staphylococcus aureus and particularly MRSA.</dc:description>
  </entry>
  <entry>
    <title>Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1908" />
    <author>
      <name>Al-Balas, Qosay</name>
    </author>
    <author>
      <name>Anthony, Nahoum G.</name>
    </author>
    <author>
      <name>Al-Jaidi, Bilal</name>
    </author>
    <author>
      <name>Alnimr, Amani</name>
    </author>
    <author>
      <name>Abbott, Grainne</name>
    </author>
    <author>
      <name>Brown, Alistair K.</name>
    </author>
    <author>
      <name>Taylor, Rebecca C.</name>
    </author>
    <author>
      <name>Besra, Gurdyal S.</name>
    </author>
    <author>
      <name>McHugh, Timothy D.</name>
    </author>
    <author>
      <name>Gillespie, Stephen H.</name>
    </author>
    <author>
      <name>Johnston, Blair F.</name>
    </author>
    <author>
      <name>Mackay, Simon P.</name>
    </author>
    <author>
      <name>Coxon, Geoffrey D.</name>
    </author>
    <id>http://hdl.handle.net/10023/1908</id>
    <updated>2013-05-12T04:05:37Z</updated>
    <published>2009-05-19T00:00:00Z</published>
    <summary type="text">Abstract: Background: Tuberculosis (TB) is a disease which kills two million people every year and infects approximately over one-third of the world's population. The difficulty in managing tuberculosis is the prolonged treatment duration, the emergence of drug resistance and co-infection with HIV/AIDS. Tuberculosis control requires new drugs that act at novel drug targets to help combat resistant forms of Mycobacterium tuberculosis and reduce treatment duration. Methodology/Principal Findings: Our approach was to modify the naturally occurring and synthetically challenging antibiotic thiolactomycin (TLM) to the more tractable 2-aminothiazole-4-carboxylate scaffold to generate compounds that mimic TLM's novel mode of action. We report here the identification of a series of compounds possessing excellent activity against M. tuberculosis H37Rv and, dissociatively, against the beta-ketoacyl synthase enzyme mtFabH which is targeted by TLM. Specifically, methyl 2-amino-5-benzylthiazole-4-carboxylate was found to inhibit M. tuberculosis H37Rv with an MIC of 0.06 mu g/ml (240 nM), but showed no activity against mtFabH, whereas methyl 2-(2-bromoacetamido)-5-(3-chlorophenyl)thiazole-4-carboxylate inhibited mtFabH with an IC50 of 0.95 +/- 0.05 mu g/ml (2.43 +/- 0.13 mu M) but was not active against the whole cell organism. Conclusions/Significance: These findings clearly identify the 2-aminothiazole-4-carboxylate scaffold as a promising new template towards the discovery of a new class of anti-tubercular agents.</summary>
    <dc:date>2009-05-19T00:00:00Z</dc:date>
    <dc:creator>Al-Balas, Qosay</dc:creator>
    <dc:creator>Anthony, Nahoum G.</dc:creator>
    <dc:creator>Al-Jaidi, Bilal</dc:creator>
    <dc:creator>Alnimr, Amani</dc:creator>
    <dc:creator>Abbott, Grainne</dc:creator>
    <dc:creator>Brown, Alistair K.</dc:creator>
    <dc:creator>Taylor, Rebecca C.</dc:creator>
    <dc:creator>Besra, Gurdyal S.</dc:creator>
    <dc:creator>McHugh, Timothy D.</dc:creator>
    <dc:creator>Gillespie, Stephen H.</dc:creator>
    <dc:creator>Johnston, Blair F.</dc:creator>
    <dc:creator>Mackay, Simon P.</dc:creator>
    <dc:creator>Coxon, Geoffrey D.</dc:creator>
    <dc:description>Background: Tuberculosis (TB) is a disease which kills two million people every year and infects approximately over one-third of the world's population. The difficulty in managing tuberculosis is the prolonged treatment duration, the emergence of drug resistance and co-infection with HIV/AIDS. Tuberculosis control requires new drugs that act at novel drug targets to help combat resistant forms of Mycobacterium tuberculosis and reduce treatment duration. Methodology/Principal Findings: Our approach was to modify the naturally occurring and synthetically challenging antibiotic thiolactomycin (TLM) to the more tractable 2-aminothiazole-4-carboxylate scaffold to generate compounds that mimic TLM's novel mode of action. We report here the identification of a series of compounds possessing excellent activity against M. tuberculosis H37Rv and, dissociatively, against the beta-ketoacyl synthase enzyme mtFabH which is targeted by TLM. Specifically, methyl 2-amino-5-benzylthiazole-4-carboxylate was found to inhibit M. tuberculosis H37Rv with an MIC of 0.06 mu g/ml (240 nM), but showed no activity against mtFabH, whereas methyl 2-(2-bromoacetamido)-5-(3-chlorophenyl)thiazole-4-carboxylate inhibited mtFabH with an IC50 of 0.95 +/- 0.05 mu g/ml (2.43 +/- 0.13 mu M) but was not active against the whole cell organism. Conclusions/Significance: These findings clearly identify the 2-aminothiazole-4-carboxylate scaffold as a promising new template towards the discovery of a new class of anti-tubercular agents.</dc:description>
  </entry>
  <entry>
    <title>Crystallization and preliminary diffraction analysis of Wzi, a member of the capsule export and assembly pathway in Escherichia coli</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1800" />
    <author>
      <name>Bushell, Simon R.</name>
    </author>
    <author>
      <name>Lou, Hubing</name>
    </author>
    <author>
      <name>Wallat, Gregor D.</name>
    </author>
    <author>
      <name>Beis, Konstantinos</name>
    </author>
    <author>
      <name>Whitfield, Chris</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <id>http://hdl.handle.net/10023/1800</id>
    <updated>2013-05-26T00:34:14Z</updated>
    <published>2010-12-01T00:00:00Z</published>
    <summary type="text">Abstract: External polysaccharide capsules provide a physical barrier that is employed by many species of bacteria for the purposes of host evasion and persistence. Wzi is a 53 kDa outer membrane beta-barrel protein that is thought to play a role in the attachment of group 1 capsular polysaccharides to the cell surface. The purification and crystallization of an Escherichia coli homologue of Wzi is reported and diffraction data from native and selenomethionine-incorporated protein crystals are presented. Crystals of C-terminally His(6)-tagged Wzi diffracted to 2.8 A resolution. Data processing showed that the crystals belonged to the orthorhombic space group C222, with unit-cell parameters a = 128.8, b = 152.8, c = 94.4 A, alpha = beta = gamma = 90 degrees. A His-tagged selenomethionine-containing variant of Wzi has also been crystallized in the same space group and diffraction data have been recorded to 3.8 A resolution. Data processing shows that the variant crystal has similar unit-cell parameters to the native crystal.
Description: Supported by a grant from The Wellcome Trust (081862/Z/06/Z)</summary>
    <dc:date>2010-12-01T00:00:00Z</dc:date>
    <dc:creator>Bushell, Simon R.</dc:creator>
    <dc:creator>Lou, Hubing</dc:creator>
    <dc:creator>Wallat, Gregor D.</dc:creator>
    <dc:creator>Beis, Konstantinos</dc:creator>
    <dc:creator>Whitfield, Chris</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:description>External polysaccharide capsules provide a physical barrier that is employed by many species of bacteria for the purposes of host evasion and persistence. Wzi is a 53 kDa outer membrane beta-barrel protein that is thought to play a role in the attachment of group 1 capsular polysaccharides to the cell surface. The purification and crystallization of an Escherichia coli homologue of Wzi is reported and diffraction data from native and selenomethionine-incorporated protein crystals are presented. Crystals of C-terminally His(6)-tagged Wzi diffracted to 2.8 A resolution. Data processing showed that the crystals belonged to the orthorhombic space group C222, with unit-cell parameters a = 128.8, b = 152.8, c = 94.4 A, alpha = beta = gamma = 90 degrees. A His-tagged selenomethionine-containing variant of Wzi has also been crystallized in the same space group and diffraction data have been recorded to 3.8 A resolution. Data processing shows that the variant crystal has similar unit-cell parameters to the native crystal.</dc:description>
  </entry>
  <entry>
    <title>Phospholipases A1</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1708" />
    <author>
      <name>Richmond, Gregory S.</name>
    </author>
    <author>
      <name>Smith, Terry K.</name>
    </author>
    <id>http://hdl.handle.net/10023/1708</id>
    <updated>2013-05-12T04:04:08Z</updated>
    <published>2011-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Phospholipase A1 (PLA1) is an enzyme that hydrolyzes phospholipids and produces 2-acyl-lysophospholipids and fatty acids. This lipolytic activity is conserved in a wide range of organisms but is carried out by a diverse set of PLA1 enzymes. Where their function is known, PLA1s have been shown to act as digestive enzymes, possess central roles in membrane maintenance and remodeling, or regulate important cellular mechanisms by the production of various lysophospholipid mediators, such as lysophosphatidylserine and lysophosphatidic acid, which in turn have multiple biological functions.
Description: Research in the author's laboratory is supported in part by a Wellcome Trust Senior Research Fellowship (067441), and Wellcome Trust project grants (086658 and 093228) and a Wellcome Trust Prize Studentship (G.S.R).</summary>
    <dc:date>2011-01-01T00:00:00Z</dc:date>
    <dc:creator>Richmond, Gregory S.</dc:creator>
    <dc:creator>Smith, Terry K.</dc:creator>
    <dc:description>Phospholipase A1 (PLA1) is an enzyme that hydrolyzes phospholipids and produces 2-acyl-lysophospholipids and fatty acids. This lipolytic activity is conserved in a wide range of organisms but is carried out by a diverse set of PLA1 enzymes. Where their function is known, PLA1s have been shown to act as digestive enzymes, possess central roles in membrane maintenance and remodeling, or regulate important cellular mechanisms by the production of various lysophospholipid mediators, such as lysophosphatidylserine and lysophosphatidic acid, which in turn have multiple biological functions.</dc:description>
  </entry>
  <entry>
    <title>Synthesis and stereochemical assignment of (+)-chamuvarinin</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1685" />
    <author>
      <name>Florence, Gordon John</name>
    </author>
    <author>
      <name>Morris, Joanne Charleen</name>
    </author>
    <author>
      <name>Murray, Ross George</name>
    </author>
    <author>
      <name>Osler, Jonathan</name>
    </author>
    <author>
      <name>Reddy, Vanga R.</name>
    </author>
    <author>
      <name>Smith, Terry K</name>
    </author>
    <id>http://hdl.handle.net/10023/1685</id>
    <updated>2013-05-12T03:36:21Z</updated>
    <published>2011-02-04T00:00:00Z</published>
    <summary type="text">Abstract: A stereocontrolled total synthesis of (+)-chamuvarinin, isolated from the root extract of Uvaria Chamae, utilizes a convergent modular strategy to construct the adjacently linked C15−C28 ether array, followed by a late-stage Julia−Kocienski olefination to append the butenolide motif. This constitutes the first total synthesis of (+)-chamuvarinin, defining the relative and absolute configuration of this unique annonaceous acetogenin.
Description: Supported by grants from EPSRC (EP/F011458/1) and The Wellcome Trust (086658).</summary>
    <dc:date>2011-02-04T00:00:00Z</dc:date>
    <dc:creator>Florence, Gordon John</dc:creator>
    <dc:creator>Morris, Joanne Charleen</dc:creator>
    <dc:creator>Murray, Ross George</dc:creator>
    <dc:creator>Osler, Jonathan</dc:creator>
    <dc:creator>Reddy, Vanga R.</dc:creator>
    <dc:creator>Smith, Terry K</dc:creator>
    <dc:description>A stereocontrolled total synthesis of (+)-chamuvarinin, isolated from the root extract of Uvaria Chamae, utilizes a convergent modular strategy to construct the adjacently linked C15−C28 ether array, followed by a late-stage Julia−Kocienski olefination to append the butenolide motif. This constitutes the first total synthesis of (+)-chamuvarinin, defining the relative and absolute configuration of this unique annonaceous acetogenin.</dc:description>
  </entry>
  <entry>
    <title>The crystal structure of the Y140F mutant of ADP-L-glycero-D-manno-heptose 6-epimerase bound to ADP-beta-D-mannose suggests a one base mechanism</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1642" />
    <author>
      <name>Kowatz, Thomas</name>
    </author>
    <author>
      <name>Morrison, James P.</name>
    </author>
    <author>
      <name>Tanner, Martin E.</name>
    </author>
    <author>
      <name>Naismith, James H.</name>
    </author>
    <id>http://hdl.handle.net/10023/1642</id>
    <updated>2013-05-12T03:04:22Z</updated>
    <published>2010-07-01T00:00:00Z</published>
    <summary type="text">Abstract: Bacteria synthesize a wide array of unusual carbohydrate molecules, which they use in a variety of ways. The carbohydrate L-glycero-D-manno-heptose is an important component of lipopolysaccharide and is synthesized in a complex series of enzymatic steps. One step involves the epimerization at the C6 '' position converting ADP-D-glycero-D-manno-heptose into ADP-L-glycero-D-manno-heptose. The enzyme responsible is a member of the short chain dehydrogenase superfamily, known as ADP-L-glycero-D-manno-heptose 6-epimerase (AGME). The structure of the enzyme was known but the arrangement of the catalytic site with respect to the substrate is unclear. We now report the structure of AGME bound to a substrate mimic, ADP-beta-D-mannose, which has the same stereochemical configuration as the substrate. The complex identifies the key residues and allows mechanistic insight into this novel enzyme.
Description: Supported by Wellcome Trust grant 081862/Z/06/Z</summary>
    <dc:date>2010-07-01T00:00:00Z</dc:date>
    <dc:creator>Kowatz, Thomas</dc:creator>
    <dc:creator>Morrison, James P.</dc:creator>
    <dc:creator>Tanner, Martin E.</dc:creator>
    <dc:creator>Naismith, James H.</dc:creator>
    <dc:description>Bacteria synthesize a wide array of unusual carbohydrate molecules, which they use in a variety of ways. The carbohydrate L-glycero-D-manno-heptose is an important component of lipopolysaccharide and is synthesized in a complex series of enzymatic steps. One step involves the epimerization at the C6 '' position converting ADP-D-glycero-D-manno-heptose into ADP-L-glycero-D-manno-heptose. The enzyme responsible is a member of the short chain dehydrogenase superfamily, known as ADP-L-glycero-D-manno-heptose 6-epimerase (AGME). The structure of the enzyme was known but the arrangement of the catalytic site with respect to the substrate is unclear. We now report the structure of AGME bound to a substrate mimic, ADP-beta-D-mannose, which has the same stereochemical configuration as the substrate. The complex identifies the key residues and allows mechanistic insight into this novel enzyme.</dc:description>
  </entry>
  <entry>
    <title>The essential neutral sphingomyelinase is involved in the trafficking of the variant surface glycoprotein in the bloodstream form of Trypanosoma brucei</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1641" />
    <author>
      <name>Young, Simon A.</name>
    </author>
    <author>
      <name>Smith, Terry K.</name>
    </author>
    <id>http://hdl.handle.net/10023/1641</id>
    <updated>2013-06-16T00:33:14Z</updated>
    <published>2010-06-01T00:00:00Z</published>
    <summary type="text">Abstract: Sphingomyelin is the main sphingolipid in Trypanosoma brucei, the causative agent of African sleeping sickness. In vitro and in vivo characterization of the T. brucei neutral sphingomyelinase demonstrates that it is directly involved in sphingomyelin catabolism. Gene knockout studies in the bloodstream form of the parasite indicate that the neutral sphingomyelinase is essential for growth and survival, thus highlighting that the de novo biosynthesis of ceramide is unable to compensate for the loss of sphingomyelin catabolism. The phenotype of the conditional knockout has given new insights into the highly active endocytic and exocytic pathways in the bloodstream form of T. brucei. Hence, the formation of ceramide in the endoplasmic reticulum affects post-Golgi sorting and rate of deposition of newly synthesized GPI-anchored variant surface glycoprotein on the cell surface. This directly influences the corresponding rate of endocytosis, via the recycling endosomes, of pre-existing cell surface variant surface glycoprotein. The trypanosomes use this coupled endocytic and exocytic mechanism to maintain the cell density of its crucial variant surface glycoprotein protective coat. TbnSMase is therefore genetically validated as a drug target against African trypanosomes, and suggests that interfering with the endocytic transport of variant surface glycoprotein is a highly desirable strategy for drug development against African trypanosomasis.</summary>
    <dc:date>2010-06-01T00:00:00Z</dc:date>
    <dc:creator>Young, Simon A.</dc:creator>
    <dc:creator>Smith, Terry K.</dc:creator>
    <dc:description>Sphingomyelin is the main sphingolipid in Trypanosoma brucei, the causative agent of African sleeping sickness. In vitro and in vivo characterization of the T. brucei neutral sphingomyelinase demonstrates that it is directly involved in sphingomyelin catabolism. Gene knockout studies in the bloodstream form of the parasite indicate that the neutral sphingomyelinase is essential for growth and survival, thus highlighting that the de novo biosynthesis of ceramide is unable to compensate for the loss of sphingomyelin catabolism. The phenotype of the conditional knockout has given new insights into the highly active endocytic and exocytic pathways in the bloodstream form of T. brucei. Hence, the formation of ceramide in the endoplasmic reticulum affects post-Golgi sorting and rate of deposition of newly synthesized GPI-anchored variant surface glycoprotein on the cell surface. This directly influences the corresponding rate of endocytosis, via the recycling endosomes, of pre-existing cell surface variant surface glycoprotein. The trypanosomes use this coupled endocytic and exocytic mechanism to maintain the cell density of its crucial variant surface glycoprotein protective coat. TbnSMase is therefore genetically validated as a drug target against African trypanosomes, and suggests that interfering with the endocytic transport of variant surface glycoprotein is a highly desirable strategy for drug development against African trypanosomasis.</dc:description>
  </entry>
  <entry>
    <title>Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1640" />
    <author>
      <name>Young, D F</name>
    </author>
    <author>
      <name>Galiano, M</name>
    </author>
    <author>
      <name>Lemon, K</name>
    </author>
    <author>
      <name>Chen, Y-H</name>
    </author>
    <author>
      <name>Andrejeva, Jelena</name>
    </author>
    <author>
      <name>Duprex, P</name>
    </author>
    <author>
      <name>Rima, B K</name>
    </author>
    <author>
      <name>Randall, Richard Edward</name>
    </author>
    <id>http://hdl.handle.net/10023/1640</id>
    <updated>2013-05-12T02:31:52Z</updated>
    <published>2009-11-01T00:00:00Z</published>
    <summary type="text">Abstract: Although the Enders strain of mumps virus (MuV) encodes a functional V protein that acts as an interferon (IFN) antagonist, in multi-cycle growth assays MuV Enders grew poorly in naive ('IFN-competent' Hep2) cells but grew to high titres in 'IFN-compromised' Hep2 cells. Even so, the growth rate of MuV Enders was significantly slower in 'IFN-compromised' Hep2 cells when compared with its replication rate in Vero cells and with the replication rate of parainfluenza virus type 5 (a closely related paramyxovirus) in both naive and 'IFN-compromised' Hep2 cells. This suggests that a consequence of slower growth is that the IFN system of naive Hep2 cells can respond quickly enough to control the growth of MuV Enders. This is supported by the finding that rapidly growing variants of MuV Enders that were selected on 'IFN-compromised' Hep2 cells (i.e. in the absence of any selection pressure exerted by the IFN response) also grew to high titres on naive Hep2 cells. Sequencing of the complete genome of one of these variants identified a single point mutation that resulted in a substitution of a conserved asparagine by histidine at position 498 of the haemagglutinin-neuraminidase protein, although this mutation was not present in all rapidly growing variants. These results support the concept that there is a race between the ability of a cell to detect and respond to virus infection and the ability of a virus to block the IFN response. Importantly, this emphasizes that factors other than viral IFN antagonists influence the sensitivity of viruses to IFN.</summary>
    <dc:date>2009-11-01T00:00:00Z</dc:date>
    <dc:creator>Young, D F</dc:creator>
    <dc:creator>Galiano, M</dc:creator>
    <dc:creator>Lemon, K</dc:creator>
    <dc:creator>Chen, Y-H</dc:creator>
    <dc:creator>Andrejeva, Jelena</dc:creator>
    <dc:creator>Duprex, P</dc:creator>
    <dc:creator>Rima, B K</dc:creator>
    <dc:creator>Randall, Richard Edward</dc:creator>
    <dc:description>Although the Enders strain of mumps virus (MuV) encodes a functional V protein that acts as an interferon (IFN) antagonist, in multi-cycle growth assays MuV Enders grew poorly in naive ('IFN-competent' Hep2) cells but grew to high titres in 'IFN-compromised' Hep2 cells. Even so, the growth rate of MuV Enders was significantly slower in 'IFN-compromised' Hep2 cells when compared with its replication rate in Vero cells and with the replication rate of parainfluenza virus type 5 (a closely related paramyxovirus) in both naive and 'IFN-compromised' Hep2 cells. This suggests that a consequence of slower growth is that the IFN system of naive Hep2 cells can respond quickly enough to control the growth of MuV Enders. This is supported by the finding that rapidly growing variants of MuV Enders that were selected on 'IFN-compromised' Hep2 cells (i.e. in the absence of any selection pressure exerted by the IFN response) also grew to high titres on naive Hep2 cells. Sequencing of the complete genome of one of these variants identified a single point mutation that resulted in a substitution of a conserved asparagine by histidine at position 498 of the haemagglutinin-neuraminidase protein, although this mutation was not present in all rapidly growing variants. These results support the concept that there is a race between the ability of a cell to detect and respond to virus infection and the ability of a virus to block the IFN response. Importantly, this emphasizes that factors other than viral IFN antagonists influence the sensitivity of viruses to IFN.</dc:description>
  </entry>
  <entry>
    <title>Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1439" />
    <author>
      <name>Adamson, Catherine S</name>
    </author>
    <author>
      <name>Sakalian, M</name>
    </author>
    <author>
      <name>Salzwedel, K</name>
    </author>
    <author>
      <name>Freed, E.O.</name>
    </author>
    <id>http://hdl.handle.net/10023/1439</id>
    <updated>2013-06-18T15:31:00Z</updated>
    <published>2010-04-01T00:00:00Z</published>
    <summary type="text">Abstract: Background: The maturation inhibitor bevirimat (BVM) potently inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking capsid-spacer peptide 1 (CA-SP1) cleavage. Recent clinical trials demonstrated that a significant proportion of HIV-1-infected patients do not respond to BVM. A patient’s failure to respond correlated with baseline polymorphisms at SP1 residues 6-8. Results: In this study, we demonstrate that varying levels of BVM resistance are associated with point mutations at these residues. BVM susceptibility was maintained by SP1-Q6A, -Q6H and -T8A mutations. However, an SP1-V7A mutation conferred high-level BVM resistance and SP1-V7M and T8Δ mutations conferred intermediate levels of BVM resistance. Conclusions: Future exploitation of the CA-SP1 cleavage site as an antiretroviral drug target will need to overcome the baseline variability in the SP1 region of Gag.</summary>
    <dc:date>2010-04-01T00:00:00Z</dc:date>
    <dc:creator>Adamson, Catherine S</dc:creator>
    <dc:creator>Sakalian, M</dc:creator>
    <dc:creator>Salzwedel, K</dc:creator>
    <dc:creator>Freed, E.O.</dc:creator>
    <dc:description>Background: The maturation inhibitor bevirimat (BVM) potently inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking capsid-spacer peptide 1 (CA-SP1) cleavage. Recent clinical trials demonstrated that a significant proportion of HIV-1-infected patients do not respond to BVM. A patient’s failure to respond correlated with baseline polymorphisms at SP1 residues 6-8. Results: In this study, we demonstrate that varying levels of BVM resistance are associated with point mutations at these residues. BVM susceptibility was maintained by SP1-Q6A, -Q6H and -T8A mutations. However, an SP1-V7A mutation conferred high-level BVM resistance and SP1-V7M and T8Δ mutations conferred intermediate levels of BVM resistance. Conclusions: Future exploitation of the CA-SP1 cleavage site as an antiretroviral drug target will need to overcome the baseline variability in the SP1 region of Gag.</dc:description>
  </entry>
  <entry>
    <title>The SMN protein is a key regulator of nuclear architecture in differentiating neuroblastoma cells</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1195" />
    <author>
      <name>Clelland, Allyson K.</name>
    </author>
    <author>
      <name>Kinnear, Nicholas P.</name>
    </author>
    <author>
      <name>Oram, Lisa</name>
    </author>
    <author>
      <name>Burza, Julie</name>
    </author>
    <author>
      <name>Sleeman, Judith Elizabeth</name>
    </author>
    <id>http://hdl.handle.net/10023/1195</id>
    <updated>2013-05-12T03:33:31Z</updated>
    <published>2009-11-01T00:00:00Z</published>
    <summary type="text">Abstract: The cell nucleus contains two closely related structures, Cajal bodies (CBs) and gems. CBs are the first site of accumulation of newly assembled splicing snRNPs (small nuclear ribonucleoproteins) following their import into the nucleus, before they form their steady-state localization in nuclear splicing speckles. Gems are the nuclear site of accumulation of survival motor neurons (SMNs), an insufficiency of which leads to the inherited neurodegenerative condition, spinal muscular atrophy (SMA). SMN is required in the cytoplasm for the addition of core, Sm, proteins to new snRNPs and is believed to accompany snRNPs to the CB. In most cell lines, gems are indistinguishable from CBs, although the structures are often separate in vivo. The relationship between CBs and gems is not fully understood, but there is evidence that symmetrical dimethylation of arginine residues in the CB protein coilin brings them together in HeLa cells. During neuronal differentiation of the human neuroblastoma cell line SH-SY5Y, CBs and gems increase their colocalization, mimicking changes seen during foetal development. This does not result from alterations in the methylation of coilin, but from increased levels of SMN. Expression of exogenous SMN results in an increased efficiency of snRNP transport to nuclear speckles. This suggests different mechanisms are present in different cell types and in vivo that may be significant for the tissue-specific pathology of SMA.</summary>
    <dc:date>2009-11-01T00:00:00Z</dc:date>
    <dc:creator>Clelland, Allyson K.</dc:creator>
    <dc:creator>Kinnear, Nicholas P.</dc:creator>
    <dc:creator>Oram, Lisa</dc:creator>
    <dc:creator>Burza, Julie</dc:creator>
    <dc:creator>Sleeman, Judith Elizabeth</dc:creator>
    <dc:description>The cell nucleus contains two closely related structures, Cajal bodies (CBs) and gems. CBs are the first site of accumulation of newly assembled splicing snRNPs (small nuclear ribonucleoproteins) following their import into the nucleus, before they form their steady-state localization in nuclear splicing speckles. Gems are the nuclear site of accumulation of survival motor neurons (SMNs), an insufficiency of which leads to the inherited neurodegenerative condition, spinal muscular atrophy (SMA). SMN is required in the cytoplasm for the addition of core, Sm, proteins to new snRNPs and is believed to accompany snRNPs to the CB. In most cell lines, gems are indistinguishable from CBs, although the structures are often separate in vivo. The relationship between CBs and gems is not fully understood, but there is evidence that symmetrical dimethylation of arginine residues in the CB protein coilin brings them together in HeLa cells. During neuronal differentiation of the human neuroblastoma cell line SH-SY5Y, CBs and gems increase their colocalization, mimicking changes seen during foetal development. This does not result from alterations in the methylation of coilin, but from increased levels of SMN. Expression of exogenous SMN results in an increased efficiency of snRNP transport to nuclear speckles. This suggests different mechanisms are present in different cell types and in vivo that may be significant for the tissue-specific pathology of SMA.</dc:description>
  </entry>
  <entry>
    <title>The regulation of type I interferon production by paramyxoviruses</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1194" />
    <author>
      <name>Goodbourn, S</name>
    </author>
    <author>
      <name>Randall, Richard Edward</name>
    </author>
    <id>http://hdl.handle.net/10023/1194</id>
    <updated>2013-06-09T00:32:37Z</updated>
    <published>2009-09-01T00:00:00Z</published>
    <summary type="text">Abstract: Experimentally, paramyxoviruses are conventionally considered good inducers of type I interferons (IFN-alpha/beta), and have been used as agents in the commercial production of human IFN-alpha. However, in the last few years it has become clear that viruses in general mount a major challenge to the IFN system, and paramyxoviruses are no exception. Indeed, most paramyxoviruses encode mechanisms to inhibit both the production of, and response to, type I IFN. Here we review our knowledge of the type I IFN-inducing signals (by so-called pathogen-associated molecular patterns, or PAMPs) produced during paramyxovirus infections, and discuss how paramyxoviruses limit the production of PAMPs and inhibit the cellular responses to PAMPs by interfering with the activities of the pattern recognition receptors (PRRs), mda-5, and RIG-I, as well as downstream components in the type I IFN induction cascades.
Description: Research supported by The Wellcome Trust (087751/A/08/Z)</summary>
    <dc:date>2009-09-01T00:00:00Z</dc:date>
    <dc:creator>Goodbourn, S</dc:creator>
    <dc:creator>Randall, Richard Edward</dc:creator>
    <dc:description>Experimentally, paramyxoviruses are conventionally considered good inducers of type I interferons (IFN-alpha/beta), and have been used as agents in the commercial production of human IFN-alpha. However, in the last few years it has become clear that viruses in general mount a major challenge to the IFN system, and paramyxoviruses are no exception. Indeed, most paramyxoviruses encode mechanisms to inhibit both the production of, and response to, type I IFN. Here we review our knowledge of the type I IFN-inducing signals (by so-called pathogen-associated molecular patterns, or PAMPs) produced during paramyxovirus infections, and discuss how paramyxoviruses limit the production of PAMPs and inhibit the cellular responses to PAMPs by interfering with the activities of the pattern recognition receptors (PRRs), mda-5, and RIG-I, as well as downstream components in the type I IFN induction cascades.</dc:description>
  </entry>
  <entry>
    <title>Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1192" />
    <author>
      <name>Potter, Jane A.</name>
    </author>
    <author>
      <name>Randall, Richard Edward</name>
    </author>
    <author>
      <name>Taylor, Garry L.</name>
    </author>
    <id>http://hdl.handle.net/10023/1192</id>
    <updated>2013-06-02T04:31:04Z</updated>
    <published>2008-02-28T00:00:00Z</published>
    <summary type="text">Abstract: Background: IPS-1/MAVS/VISA/Cardif is an adaptor protein that plays a crucial role in the induction of interferons in response to viral infection. In the initial stage of the intracellular antiviral response two RNA helicases, retinoic acid inducible gene-I (RIG-I) and melanoma differentiation-association gene 5 (MDA5), are independently able to bind viral RNA in the cytoplasm. The 62 kDa protein IPS-1/MAVS/VISA/Cardif contains an N-terminal caspase activation and recruitment (CARD) domain that associates with the CARD regions of RIG-I and MDA5, ultimately leading to the induction of type I interferons. As a first step towards understanding the molecular basis of this important adaptor protein we have undertaken structural studies of the IPS-1 MAVS/VISA/Cardif CARD region. Results: The crystal structure of human IPS-1/MAVS/VISA/Cardif CARD has been determined to 2.1 angstrom resolution. The protein was expressed and crystallized as a maltose-binding protein (MBP) fusion protein. The MBP and IPS-1 components each form a distinct domain within the structure. IPS-1/MAVS/VISA/Cardif CARD adopts a characteristic six-helix bundle with a Greek-key topology and, in common with a number of other known CARD structures, contains two major polar surfaces on opposite sides of the molecule. One face has a surface-exposed, disordered tryptophan residue that may explain the poor solubility of untagged expression constructs. Conclusion: The IPS-1/MAVS/VISA/Cardif CARD domain adopts the classic CARD fold with an asymmetric surface charge distribution that is typical of CARD domains involved in homotypic protein-protein interactions. The location of the two polar areas on IPS-1/MAVS/VISA/Cardif CARD suggest possible types of associations that this domain makes with the two CARD domains of MDA5 or RIG-I. The N-terminal CARD domains of RIG-I and MDA5 share greatest sequence similarity with IPS-1/MAVS/VISA/Cardif CARD and this has allowed modelling of their structures. These models show a very different charge profile for the equivalent surfaces compared to IPS-1/MAVS/VISA/Cardif CARD.</summary>
    <dc:date>2008-02-28T00:00:00Z</dc:date>
    <dc:creator>Potter, Jane A.</dc:creator>
    <dc:creator>Randall, Richard Edward</dc:creator>
    <dc:creator>Taylor, Garry L.</dc:creator>
    <dc:description>Background: IPS-1/MAVS/VISA/Cardif is an adaptor protein that plays a crucial role in the induction of interferons in response to viral infection. In the initial stage of the intracellular antiviral response two RNA helicases, retinoic acid inducible gene-I (RIG-I) and melanoma differentiation-association gene 5 (MDA5), are independently able to bind viral RNA in the cytoplasm. The 62 kDa protein IPS-1/MAVS/VISA/Cardif contains an N-terminal caspase activation and recruitment (CARD) domain that associates with the CARD regions of RIG-I and MDA5, ultimately leading to the induction of type I interferons. As a first step towards understanding the molecular basis of this important adaptor protein we have undertaken structural studies of the IPS-1 MAVS/VISA/Cardif CARD region. Results: The crystal structure of human IPS-1/MAVS/VISA/Cardif CARD has been determined to 2.1 angstrom resolution. The protein was expressed and crystallized as a maltose-binding protein (MBP) fusion protein. The MBP and IPS-1 components each form a distinct domain within the structure. IPS-1/MAVS/VISA/Cardif CARD adopts a characteristic six-helix bundle with a Greek-key topology and, in common with a number of other known CARD structures, contains two major polar surfaces on opposite sides of the molecule. One face has a surface-exposed, disordered tryptophan residue that may explain the poor solubility of untagged expression constructs. Conclusion: The IPS-1/MAVS/VISA/Cardif CARD domain adopts the classic CARD fold with an asymmetric surface charge distribution that is typical of CARD domains involved in homotypic protein-protein interactions. The location of the two polar areas on IPS-1/MAVS/VISA/Cardif CARD suggest possible types of associations that this domain makes with the two CARD domains of MDA5 or RIG-I. The N-terminal CARD domains of RIG-I and MDA5 share greatest sequence similarity with IPS-1/MAVS/VISA/Cardif CARD and this has allowed modelling of their structures. These models show a very different charge profile for the equivalent surfaces compared to IPS-1/MAVS/VISA/Cardif CARD.</dc:description>
  </entry>
  <entry>
    <title>Optineurin negatively regulates the induction of IFNβ in response to RNA virus infection</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1191" />
    <author>
      <name>Mankouri, J</name>
    </author>
    <author>
      <name>Fragkoudis, R</name>
    </author>
    <author>
      <name>Richards, K</name>
    </author>
    <author>
      <name>Wetherill, L</name>
    </author>
    <author>
      <name>Harris, M</name>
    </author>
    <author>
      <name>Kohl, A</name>
    </author>
    <author>
      <name>Elliott, Richard Michael</name>
    </author>
    <author>
      <name>MacDonald, A</name>
    </author>
    <id>http://hdl.handle.net/10023/1191</id>
    <updated>2013-05-19T00:33:17Z</updated>
    <published>2010-02-01T00:00:00Z</published>
    <summary type="text">Abstract: The innate immune response provides a critical defense against microbial infections, including viruses. These are recognised by pattern recognition receptors including Toll-like receptors (TLRs) and RIG-I like helicases (RLHs). Detection of virus triggers signalling cascades that induce transcription of type I interferons including IFNb, which are pivotal for the initiation of an anti-viral state. Despite the essential role of IFNb in the anti-viral response, there is an incomplete understanding of the negative regulation of IFNb induction. Here we provide evidence that expression of the Nemo-related protein, optineurin (NRP/FIP2), has a role in the inhibition of virus-triggered IFNb induction. Over-expression of optineurin inhibited Sendaivirus (SeV) and dsRNA triggered induction of IFNb, whereas depletion of optineurin with siRNA promoted virus-induced IFNb production and decreased RNA virus replication. Immunoprecipitation and immunofluorescence studies identified optineurin in a protein complex containing the antiviral protein kinase TBK1 and the ubiquitin ligase TRAF3. Furthermore, mutagenesis studies determined that binding of ubiquitin was essential for both the correct sub-cellular localisation and the inhibitory function of optineurin. This work identifies optineurin as a critical regulator of antiviral signalling and potential target for future antiviral therapy.
Description: Work in RME laboratories is funded by the Wellcome Trust [079810/Z/06/Z].</summary>
    <dc:date>2010-02-01T00:00:00Z</dc:date>
    <dc:creator>Mankouri, J</dc:creator>
    <dc:creator>Fragkoudis, R</dc:creator>
    <dc:creator>Richards, K</dc:creator>
    <dc:creator>Wetherill, L</dc:creator>
    <dc:creator>Harris, M</dc:creator>
    <dc:creator>Kohl, A</dc:creator>
    <dc:creator>Elliott, Richard Michael</dc:creator>
    <dc:creator>MacDonald, A</dc:creator>
    <dc:description>The innate immune response provides a critical defense against microbial infections, including viruses. These are recognised by pattern recognition receptors including Toll-like receptors (TLRs) and RIG-I like helicases (RLHs). Detection of virus triggers signalling cascades that induce transcription of type I interferons including IFNb, which are pivotal for the initiation of an anti-viral state. Despite the essential role of IFNb in the anti-viral response, there is an incomplete understanding of the negative regulation of IFNb induction. Here we provide evidence that expression of the Nemo-related protein, optineurin (NRP/FIP2), has a role in the inhibition of virus-triggered IFNb induction. Over-expression of optineurin inhibited Sendaivirus (SeV) and dsRNA triggered induction of IFNb, whereas depletion of optineurin with siRNA promoted virus-induced IFNb production and decreased RNA virus replication. Immunoprecipitation and immunofluorescence studies identified optineurin in a protein complex containing the antiviral protein kinase TBK1 and the ubiquitin ligase TRAF3. Furthermore, mutagenesis studies determined that binding of ubiquitin was essential for both the correct sub-cellular localisation and the inhibitory function of optineurin. This work identifies optineurin as a critical regulator of antiviral signalling and potential target for future antiviral therapy.</dc:description>
  </entry>
  <entry>
    <title>The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1148" />
    <author>
      <name>Van Knippenberg, Ingeborg Christine</name>
    </author>
    <author>
      <name>Carlton-Smith, Charles</name>
    </author>
    <author>
      <name>Elliott, Richard Michael</name>
    </author>
    <id>http://hdl.handle.net/10023/1148</id>
    <updated>2013-06-16T00:33:26Z</updated>
    <published>2010-04-01T00:00:00Z</published>
    <summary type="text">Abstract: Bunyamwera virus NSs protein is involved in the inhibition of cellular transcription and the interferon (IFN) response, and it interacts with the Med8 component of Mediator. A spontaneous mutant of a recombinant NSs-deleted Bunyamwera virus (rBUNdelNSs2) was identified and characterized. This mutant virus, termed mBUNNSs22, expresses a 21 aa N-terminally truncated form of NSs. Like rBUNdelNSs2, mBUNNSs22 is attenuated in IFN-deficient cells, and to a greater extent in IFN-competent cells. Both rBUNdelNSs2 and mBUNNSs22 are potent IFN inducers and their growth can be rescued by depleting cellular IRF3. Strikingly, despite encoding an NSs protein that contains the Med8 interaction domain, mBUNNSs22 fails to block RNA polymerase II activity during infection. Overall, our data suggest that both the interaction of NSs with Med8 and a novel unidentified function of the NSs N-terminus, seem necessary for Bunyamwera virus to counteract host antiviral responses.</summary>
    <dc:date>2010-04-01T00:00:00Z</dc:date>
    <dc:creator>Van Knippenberg, Ingeborg Christine</dc:creator>
    <dc:creator>Carlton-Smith, Charles</dc:creator>
    <dc:creator>Elliott, Richard Michael</dc:creator>
    <dc:description>Bunyamwera virus NSs protein is involved in the inhibition of cellular transcription and the interferon (IFN) response, and it interacts with the Med8 component of Mediator. A spontaneous mutant of a recombinant NSs-deleted Bunyamwera virus (rBUNdelNSs2) was identified and characterized. This mutant virus, termed mBUNNSs22, expresses a 21 aa N-terminally truncated form of NSs. Like rBUNdelNSs2, mBUNNSs22 is attenuated in IFN-deficient cells, and to a greater extent in IFN-competent cells. Both rBUNdelNSs2 and mBUNNSs22 are potent IFN inducers and their growth can be rescued by depleting cellular IRF3. Strikingly, despite encoding an NSs protein that contains the Med8 interaction domain, mBUNNSs22 fails to block RNA polymerase II activity during infection. Overall, our data suggest that both the interaction of NSs with Med8 and a novel unidentified function of the NSs N-terminus, seem necessary for Bunyamwera virus to counteract host antiviral responses.</dc:description>
  </entry>
  <entry>
    <title>Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1147" />
    <author>
      <name>Shi, Xiaohong</name>
    </author>
    <author>
      <name>Goli, Josthna</name>
    </author>
    <author>
      <name>Clark, Gordon</name>
    </author>
    <author>
      <name>Brauburger, Kristina</name>
    </author>
    <author>
      <name>Elliott, Richard Michael</name>
    </author>
    <id>http://hdl.handle.net/10023/1147</id>
    <updated>2013-06-16T00:32:30Z</updated>
    <published>2009-10-01T00:00:00Z</published>
    <summary type="text">Abstract: The virion glycoproteins Gn and Gc of Bunyamwera orthobunyavirus (BUNV, family Bunyaviridae) are encoded by the M RNA genome segment and have roles in both viral attachment and membrane fusion. To investigate further the structure and function of the Gc protein in viral replication we generated twelve mutants that contain truncations from the N-terminus. The effects of these deletions were analysed with regard to Golgi targeting, low-pH dependent membrane fusion, infectious virus-like particle (VLP) formation and virus infectivity. Our results showed that the N-terminal half (453 residues) of the Gc ectodomain (909 residues in total) is dispensable for Golgi trafficking and cell fusion. However, deletions in this region resulted in significant reduction in VLP formation. Four mutant viruses that contain N-terminal deletions in their Gc proteins were rescued, and found to be attenuated to different degrees in BHK-21 cells. Taken together, our data indicate that the N-terminal half of the Gc ectodomain is dispensable for replication in cell culture, whereas the C-terminal half is required to mediate cell fusion. A model for the domain structure of the Gc ectodomain is proposed.</summary>
    <dc:date>2009-10-01T00:00:00Z</dc:date>
    <dc:creator>Shi, Xiaohong</dc:creator>
    <dc:creator>Goli, Josthna</dc:creator>
    <dc:creator>Clark, Gordon</dc:creator>
    <dc:creator>Brauburger, Kristina</dc:creator>
    <dc:creator>Elliott, Richard Michael</dc:creator>
    <dc:description>The virion glycoproteins Gn and Gc of Bunyamwera orthobunyavirus (BUNV, family Bunyaviridae) are encoded by the M RNA genome segment and have roles in both viral attachment and membrane fusion. To investigate further the structure and function of the Gc protein in viral replication we generated twelve mutants that contain truncations from the N-terminus. The effects of these deletions were analysed with regard to Golgi targeting, low-pH dependent membrane fusion, infectious virus-like particle (VLP) formation and virus infectivity. Our results showed that the N-terminal half (453 residues) of the Gc ectodomain (909 residues in total) is dispensable for Golgi trafficking and cell fusion. However, deletions in this region resulted in significant reduction in VLP formation. Four mutant viruses that contain N-terminal deletions in their Gc proteins were rescued, and found to be attenuated to different degrees in BHK-21 cells. Taken together, our data indicate that the N-terminal half of the Gc ectodomain is dispensable for replication in cell culture, whereas the C-terminal half is required to mediate cell fusion. A model for the domain structure of the Gc ectodomain is proposed.</dc:description>
  </entry>
  <entry>
    <title>Differential expression and functional characterization of luteinizing hormone receptor splice variants in human luteal cells : Implications for luteolysis</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1049" />
    <author>
      <name>Dickinson, Rachel E</name>
    </author>
    <author>
      <name>Stewart, Alan J.</name>
    </author>
    <author>
      <name>Myers, Michelle</name>
    </author>
    <author>
      <name>Millar, Robert P</name>
    </author>
    <author>
      <name>Duncan, W Colin</name>
    </author>
    <id>http://hdl.handle.net/10023/1049</id>
    <updated>2013-06-09T00:33:36Z</updated>
    <published>2009-06-01T00:00:00Z</published>
    <summary type="text">Abstract: The human LH receptor (LHR) plays a key role in luteal function and the establishment of pregnancy through its interaction with the gonadotropins LH and human chorionic gonadotropin. We previously identified four splice variants of the LHR in human luteinized granulosa cells (LGCs) and corpora lutea (CL). Real-time quantitative PCR revealed that expression of the full-length LHR (LHRa) and the most truncated form (LHRd) changed significantly in CL harvested at different stages of the ovarian cycle (P &lt; 0.01, ANOVA). LHRa expression was reduced in the late luteal CL (P&lt;0.05). Conversely, an increase in LHRd expression was observed in the late luteal CL (P&lt;0.01). Chronic manipulation of human chorionic gonadotropin in LGC primary cultures supported the in vivo findings. LHRd encodes a protein lacking the transmembrane and carboxyl terminal domains. COS-7 cells expressing LHRd were unable to produce cAMP in response to LH stimulation. COS-7 cells coexpressing LHRd and LHRa also failed to generate cAMP in response to LH, suggesting that this truncated form has a negative effect on the signaling of LHRa. Immunofluorescence staining ofLGC and COS-7 cells implied that there is a reduction in cell surface expression ofLHRa when LHRd is present. Overall, these results imply expression of LHR splice variants is regulated in the human CL. Furthermore, during functional luteolysis a truncated variant could modulate the cell surface expression and activity of full-length LHR.</summary>
    <dc:date>2009-06-01T00:00:00Z</dc:date>
    <dc:creator>Dickinson, Rachel E</dc:creator>
    <dc:creator>Stewart, Alan J.</dc:creator>
    <dc:creator>Myers, Michelle</dc:creator>
    <dc:creator>Millar, Robert P</dc:creator>
    <dc:creator>Duncan, W Colin</dc:creator>
    <dc:description>The human LH receptor (LHR) plays a key role in luteal function and the establishment of pregnancy through its interaction with the gonadotropins LH and human chorionic gonadotropin. We previously identified four splice variants of the LHR in human luteinized granulosa cells (LGCs) and corpora lutea (CL). Real-time quantitative PCR revealed that expression of the full-length LHR (LHRa) and the most truncated form (LHRd) changed significantly in CL harvested at different stages of the ovarian cycle (P &lt; 0.01, ANOVA). LHRa expression was reduced in the late luteal CL (P&lt;0.05). Conversely, an increase in LHRd expression was observed in the late luteal CL (P&lt;0.01). Chronic manipulation of human chorionic gonadotropin in LGC primary cultures supported the in vivo findings. LHRd encodes a protein lacking the transmembrane and carboxyl terminal domains. COS-7 cells expressing LHRd were unable to produce cAMP in response to LH stimulation. COS-7 cells coexpressing LHRd and LHRa also failed to generate cAMP in response to LH, suggesting that this truncated form has a negative effect on the signaling of LHRa. Immunofluorescence staining ofLGC and COS-7 cells implied that there is a reduction in cell surface expression ofLHRa when LHRd is present. Overall, these results imply expression of LHR splice variants is regulated in the human CL. Furthermore, during functional luteolysis a truncated variant could modulate the cell surface expression and activity of full-length LHR.</dc:description>
  </entry>
  <entry>
    <title>The helicase XPD unwinds bubble structures and is not stalled by DNA lesions removed by the nucleotide excision repair pathway</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1048" />
    <author>
      <name>Rudolf, Jana</name>
    </author>
    <author>
      <name>Rouillon, Christophe</name>
    </author>
    <author>
      <name>Schwarz-Linek, Ulrich</name>
    </author>
    <author>
      <name>White, Malcolm F</name>
    </author>
    <id>http://hdl.handle.net/10023/1048</id>
    <updated>2013-06-16T04:31:09Z</updated>
    <published>2010-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Xeroderma pigmentosum factor D (XPD) is a 5'-3' superfamily 2 helicase and the founding member of a family of DNA helicases with iron-sulphur cluster domains. As a component of transcription factor II H (TFIIH), XPD is involved in DNA unwinding during nucleotide excision repair (NER). Archaeal XPD is closely related in sequence to the eukaryal enzyme and the crystal structure of the archaeal enzyme has provided a molecular understanding of mutations causing xeroderma pigmentosum and trichothiodystrophy in humans. Consistent with a role in NER, we show that archaeal XPD can initiate unwinding from a DNA bubble structure, differentiating it from the related helicases FancJ and DinG. XPD was not stalled by substrates containing extrahelical fluorescein adducts, abasic sites nor a cyclobutane pyrimidine dimer, regardless of whether these modifications were placed on either the displaced or translocated strands. This suggests that DNA lesions repaired by NER may not present a barrier to XPD translocation in vivo, in contrast to some predictions. Preferential binding of a fluorescein-adducted oligonucleotide was observed, and XPD helicase activity was readily inhibited by both single- and double-stranded DNA binding proteins. These observations have several implications for the current understanding of the NER pathway.</summary>
    <dc:date>2010-01-01T00:00:00Z</dc:date>
    <dc:creator>Rudolf, Jana</dc:creator>
    <dc:creator>Rouillon, Christophe</dc:creator>
    <dc:creator>Schwarz-Linek, Ulrich</dc:creator>
    <dc:creator>White, Malcolm F</dc:creator>
    <dc:description>Xeroderma pigmentosum factor D (XPD) is a 5'-3' superfamily 2 helicase and the founding member of a family of DNA helicases with iron-sulphur cluster domains. As a component of transcription factor II H (TFIIH), XPD is involved in DNA unwinding during nucleotide excision repair (NER). Archaeal XPD is closely related in sequence to the eukaryal enzyme and the crystal structure of the archaeal enzyme has provided a molecular understanding of mutations causing xeroderma pigmentosum and trichothiodystrophy in humans. Consistent with a role in NER, we show that archaeal XPD can initiate unwinding from a DNA bubble structure, differentiating it from the related helicases FancJ and DinG. XPD was not stalled by substrates containing extrahelical fluorescein adducts, abasic sites nor a cyclobutane pyrimidine dimer, regardless of whether these modifications were placed on either the displaced or translocated strands. This suggests that DNA lesions repaired by NER may not present a barrier to XPD translocation in vivo, in contrast to some predictions. Preferential binding of a fluorescein-adducted oligonucleotide was observed, and XPD helicase activity was readily inhibited by both single- and double-stranded DNA binding proteins. These observations have several implications for the current understanding of the NER pathway.</dc:description>
  </entry>
  <entry>
    <title>The archaeo-eukaryotic GINS proteins and the archaeal primase catalytic subunit PriS share a common domain</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1047" />
    <author>
      <name>Swiatek, Agnieszka</name>
    </author>
    <author>
      <name>MacNeill, Stuart Andrew</name>
    </author>
    <id>http://hdl.handle.net/10023/1047</id>
    <updated>2013-05-12T03:04:08Z</updated>
    <published>2010-04-12T00:00:00Z</published>
    <summary type="text">Abstract: Primase and GINS are essential factors for chromosomal DNA replication in eukaryotic and archaeal cells. Here we describe a previously undetected relationship between the C-terminal domain of the catalytic subunit (PriS) of archaeal primase and the B-domains of the archaeo-eukaryotic GINS proteins in the form of a conserved structural domain comprising a three-stranded antiparallel beta-sheet adjacent to an alpha-helix and a two-stranded beta-sheet or hairpin. The presence of a shared domain in archaeal PriS and GINS proteins, the genes for which are often found adjacent on the chromosome, suggests simple mechanisms for the evolution of these proteins.</summary>
    <dc:date>2010-04-12T00:00:00Z</dc:date>
    <dc:creator>Swiatek, Agnieszka</dc:creator>
    <dc:creator>MacNeill, Stuart Andrew</dc:creator>
    <dc:description>Primase and GINS are essential factors for chromosomal DNA replication in eukaryotic and archaeal cells. Here we describe a previously undetected relationship between the C-terminal domain of the catalytic subunit (PriS) of archaeal primase and the B-domains of the archaeo-eukaryotic GINS proteins in the form of a conserved structural domain comprising a three-stranded antiparallel beta-sheet adjacent to an alpha-helix and a two-stranded beta-sheet or hairpin. The presence of a shared domain in archaeal PriS and GINS proteins, the genes for which are often found adjacent on the chromosome, suggests simple mechanisms for the evolution of these proteins.</dc:description>
  </entry>
  <entry>
    <title>Responses of hyperthermophilic crenarchaea to UV irradiation</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1029" />
    <author>
      <name>Gotz, Dorothee</name>
    </author>
    <author>
      <name>Paytubi, Sonia</name>
    </author>
    <author>
      <name>Munro, Stacey</name>
    </author>
    <author>
      <name>Lundgren, Magnus</name>
    </author>
    <author>
      <name>Bernander, Rolf</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <id>http://hdl.handle.net/10023/1029</id>
    <updated>2013-05-12T03:03:59Z</updated>
    <published>2007-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Background: DNA damage leads to cellular responses that include the increased expression of DNA repair genes, repression of DNA replication and alterations in cellular metabolism. Archaeal information processing pathways resemble those in eukaryotes, but archaeal damage response pathways remain poorly understood. Results: We analyzed the transcriptional response to UV irradiation in two related crenarchaea, Sulfolobus solfataricus and Sulfolobus acidocaldarius. Sulfolobus species encounter high levels of DNA damage in nature, as they inhabit high temperature, aerobic environments and are exposed to sunlight. No increase in expression of DNA repair genes following UV irradiation was observed. There was, however, a clear transcriptional response, including repression of DNA replication and chromatin proteins. Differential effects on the expression of the three transcription factor B ( tfb) genes hint at a mechanism for the modulation of transcriptional patterns in response to DNA damage. TFB3, which is strongly induced following UV irradiation, competes with TFB1 for binding to RNA polymerase in vitro, and may act as a repressor of transcription or an alternative transcription factor for certain promoters. Conclusion: A clear response to DNA damage was observed, with down-regulation of the DNA replication machinery, changes in transcriptional regulatory proteins, and up-regulation of the biosynthetic enzymes for beta-carotene, which has UV protective properties, and proteins that detoxify reactive oxygen species. However, unlike eukaryotes and bacteria, there was no induction of DNA repair proteins in response to DNA damage, probably because these are expressed constitutively to deal with increased damage arising due to high growth temperatures.
Description: This work was supported by a dedicated functional genomics grant from the Swedish Research Council and the Swedish Graduate Research School in Genomics and Bioinformatics to RB, and by grants from the Wellcome Trust and BBSRC to MFW.</summary>
    <dc:date>2007-01-01T00:00:00Z</dc:date>
    <dc:creator>Gotz, Dorothee</dc:creator>
    <dc:creator>Paytubi, Sonia</dc:creator>
    <dc:creator>Munro, Stacey</dc:creator>
    <dc:creator>Lundgren, Magnus</dc:creator>
    <dc:creator>Bernander, Rolf</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:description>Background: DNA damage leads to cellular responses that include the increased expression of DNA repair genes, repression of DNA replication and alterations in cellular metabolism. Archaeal information processing pathways resemble those in eukaryotes, but archaeal damage response pathways remain poorly understood. Results: We analyzed the transcriptional response to UV irradiation in two related crenarchaea, Sulfolobus solfataricus and Sulfolobus acidocaldarius. Sulfolobus species encounter high levels of DNA damage in nature, as they inhabit high temperature, aerobic environments and are exposed to sunlight. No increase in expression of DNA repair genes following UV irradiation was observed. There was, however, a clear transcriptional response, including repression of DNA replication and chromatin proteins. Differential effects on the expression of the three transcription factor B ( tfb) genes hint at a mechanism for the modulation of transcriptional patterns in response to DNA damage. TFB3, which is strongly induced following UV irradiation, competes with TFB1 for binding to RNA polymerase in vitro, and may act as a repressor of transcription or an alternative transcription factor for certain promoters. Conclusion: A clear response to DNA damage was observed, with down-regulation of the DNA replication machinery, changes in transcriptional regulatory proteins, and up-regulation of the biosynthetic enzymes for beta-carotene, which has UV protective properties, and proteins that detoxify reactive oxygen species. However, unlike eukaryotes and bacteria, there was no induction of DNA repair proteins in response to DNA damage, probably because these are expressed constitutively to deal with increased damage arising due to high growth temperatures.</dc:description>
  </entry>
  <entry>
    <title>TarO : a target optimisation system for structural biology</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1028" />
    <author>
      <name>Overton, I M</name>
    </author>
    <author>
      <name>van Niekerk, C A</name>
    </author>
    <author>
      <name>Carter, L G</name>
    </author>
    <author>
      <name>Dawson, A</name>
    </author>
    <author>
      <name>Martin, D M</name>
    </author>
    <author>
      <name>Cameron, S</name>
    </author>
    <author>
      <name>McMahon, S A</name>
    </author>
    <author>
      <name>White, Malcolm Frederick</name>
    </author>
    <author>
      <name>Hunter, W N</name>
    </author>
    <author>
      <name>Naismith, James Henderson</name>
    </author>
    <author>
      <name>Barton, G J</name>
    </author>
    <id>http://hdl.handle.net/10023/1028</id>
    <updated>2013-05-12T02:05:16Z</updated>
    <published>2008-07-01T00:00:00Z</published>
    <summary type="text">Abstract: TarO (http://www.compbio.dundee.ac.uk/taro) offers a single point of reference for key bioinformatics analyses relevant to selecting proteins or domains for study by structural biology techniques. The protein sequence is analysed by 17 algorithms and compared to 8 databases. TarO gathers putative homologues, including orthologues, and then obtains predictions of properties for these sequences including crystallisation propensity, protein disorder and post-translational modifications. Analyses are run on a high-performance computing cluster, the results integrated, stored in a database and accessed through a web-based user interface. Output is in tabulated format and in the form of an annotated multiple sequence alignment (MSA) that may be edited interactively in the program Jalview. TarO also simplifies the gathering of additional annotations via the Distributed Annotation System, both from the MSA in Jalview and through links to Dasty2. Routes to other information gateways are included, for example to relevant pages from UniProt, COG and the Conserved Domains Database. Open access to TarO is available from a guest account with private accounts for academic use available on request. Future development of TarO will include further analysis steps and integration with the Protein Information Management System (PIMS), a sister project in the BBSRC Structural Proteomics of Rational Targets initiative.
Description: This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) Structural Proteomics of Rational Targets (SPoRT) initiative, (Grant BBS/B/14434). Funding to pay the Open Access publication charges for this article was provided by BBSRC.</summary>
    <dc:date>2008-07-01T00:00:00Z</dc:date>
    <dc:creator>Overton, I M</dc:creator>
    <dc:creator>van Niekerk, C A</dc:creator>
    <dc:creator>Carter, L G</dc:creator>
    <dc:creator>Dawson, A</dc:creator>
    <dc:creator>Martin, D M</dc:creator>
    <dc:creator>Cameron, S</dc:creator>
    <dc:creator>McMahon, S A</dc:creator>
    <dc:creator>White, Malcolm Frederick</dc:creator>
    <dc:creator>Hunter, W N</dc:creator>
    <dc:creator>Naismith, James Henderson</dc:creator>
    <dc:creator>Barton, G J</dc:creator>
    <dc:description>TarO (http://www.compbio.dundee.ac.uk/taro) offers a single point of reference for key bioinformatics analyses relevant to selecting proteins or domains for study by structural biology techniques. The protein sequence is analysed by 17 algorithms and compared to 8 databases. TarO gathers putative homologues, including orthologues, and then obtains predictions of properties for these sequences including crystallisation propensity, protein disorder and post-translational modifications. Analyses are run on a high-performance computing cluster, the results integrated, stored in a database and accessed through a web-based user interface. Output is in tabulated format and in the form of an annotated multiple sequence alignment (MSA) that may be edited interactively in the program Jalview. TarO also simplifies the gathering of additional annotations via the Distributed Annotation System, both from the MSA in Jalview and through links to Dasty2. Routes to other information gateways are included, for example to relevant pages from UniProt, COG and the Conserved Domains Database. Open access to TarO is available from a guest account with private accounts for academic use available on request. Future development of TarO will include further analysis steps and integration with the Protein Information Management System (PIMS), a sister project in the BBSRC Structural Proteomics of Rational Targets initiative.</dc:description>
  </entry>
  <entry>
    <title>The Mre11 protein interacts with both Rad50 and the HerA bipolar helicase and is recruited to DNA following gamma irradiation in the archaeon Sulfolobus acidocaldarius</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/1027" />
    <author>
      <name>Quaiser, Achim</name>
    </author>
    <author>
      <name>Constantinesco, Florence</name>
    </author>
    <author>
      <name>White, Malcolm F.</name>
    </author>
    <author>
      <name>Forterre, Patrick</name>
    </author>
    <author>
      <name>Elie, Christiane</name>
    </author>
    <id>http://hdl.handle.net/10023/1027</id>
    <updated>2013-05-12T02:35:56Z</updated>
    <published>2008-02-22T00:00:00Z</published>
    <summary type="text">Abstract: Background: The ubiquitous Rad50 and Mre11 proteins play a key role in many processes involved in the maintenance of genome integrity in Bacteria and Eucarya, but their function in the Archaea is presently unknown. We showed previously that in most hyperthermophilic archaea, rad50-mre11 genes are linked to nurA encoding both a single-strand endonuclease and a 5' to 3' exonuclease, and herA, encoding a bipolar DNA helicase which suggests the involvement of the four proteins in common molecular pathway(s). Since genetic tools for hyperthermophilic archaea are just emerging, we utilized immuno-detection approaches to get the first in vivo data on the role(s) of these proteins in the hyperthermophilic crenarchaeon Sulfolobus acidocaldarius. Results: We first showed that S. acidocaldarius can repair DNA damage induced by high doses of gamma rays, and we performed a time course analysis of the total levels and sub-cellular partitioning of Rad50, Mre11, HerA and NurA along with the RadA recombinase in both control and irradiated cells. We found that during the exponential phase, all proteins are synthesized and display constant levels, but that all of them exhibit a different sub-cellular partitioning. Following gamma irradiation, both Mre11 and RadA are immediately recruited to DNA and remain DNA-bound in the course of DNA repair. Furthermore, we show by immuno-precipitation assays that Rad50, Mre11 and the HerA helicase interact altogether. Conclusion: Our analyses strongly support that in Sulfolobus acidocaldarius, the Mre11 protein and the RadA recombinase might play an active role in the repair of DNA damage introduced by gamma rays and/or may act as DNA damage sensors. Moreover, our results demonstrate the functional interaction between Mre11, Rad50 and the HerA helicase and suggest that each protein play different roles when acting on its own or in association with its partners. This report provides the first in vivo evidence supporting the implication of the Mre11 protein in DNA repair processes in the Archaea and showing its interaction with both Rad50 and the HerA bipolar helicase. Further studies on the functional interactions between these proteins, the NurA nuclease and the RadA recombinase, will allow us to define their roles and mechanism of action.</summary>
    <dc:date>2008-02-22T00:00:00Z</dc:date>
    <dc:creator>Quaiser, Achim</dc:creator>
    <dc:creator>Constantinesco, Florence</dc:creator>
    <dc:creator>White, Malcolm F.</dc:creator>
    <dc:creator>Forterre, Patrick</dc:creator>
    <dc:creator>Elie, Christiane</dc:creator>
    <dc:description>Background: The ubiquitous Rad50 and Mre11 proteins play a key role in many processes involved in the maintenance of genome integrity in Bacteria and Eucarya, but their function in the Archaea is presently unknown. We showed previously that in most hyperthermophilic archaea, rad50-mre11 genes are linked to nurA encoding both a single-strand endonuclease and a 5' to 3' exonuclease, and herA, encoding a bipolar DNA helicase which suggests the involvement of the four proteins in common molecular pathway(s). Since genetic tools for hyperthermophilic archaea are just emerging, we utilized immuno-detection approaches to get the first in vivo data on the role(s) of these proteins in the hyperthermophilic crenarchaeon Sulfolobus acidocaldarius. Results: We first showed that S. acidocaldarius can repair DNA damage induced by high doses of gamma rays, and we performed a time course analysis of the total levels and sub-cellular partitioning of Rad50, Mre11, HerA and NurA along with the RadA recombinase in both control and irradiated cells. We found that during the exponential phase, all proteins are synthesized and display constant levels, but that all of them exhibit a different sub-cellular partitioning. Following gamma irradiation, both Mre11 and RadA are immediately recruited to DNA and remain DNA-bound in the course of DNA repair. Furthermore, we show by immuno-precipitation assays that Rad50, Mre11 and the HerA helicase interact altogether. Conclusion: Our analyses strongly support that in Sulfolobus acidocaldarius, the Mre11 protein and the RadA recombinase might play an active role in the repair of DNA damage introduced by gamma rays and/or may act as DNA damage sensors. Moreover, our results demonstrate the functional interaction between Mre11, Rad50 and the HerA helicase and suggest that each protein play different roles when acting on its own or in association with its partners. This report provides the first in vivo evidence supporting the implication of the Mre11 protein in DNA repair processes in the Archaea and showing its interaction with both Rad50 and the HerA bipolar helicase. Further studies on the functional interactions between these proteins, the NurA nuclease and the RadA recombinase, will allow us to define their roles and mechanism of action.</dc:description>
  </entry>
  <entry>
    <title>Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes.</title>
    <link rel="alternate" href="http://hdl.handle.net/10023/956" />
    <author>
      <name>Stewart, AJ</name>
    </author>
    <author>
      <name>Mukherjee, J</name>
    </author>
    <author>
      <name>Roberts, SJ</name>
    </author>
    <author>
      <name>Lester, D</name>
    </author>
    <author>
      <name>Farquharson, C</name>
    </author>
    <id>http://hdl.handle.net/10023/956</id>
    <updated>2010-12-07T15:29:17Z</updated>
    <published>2005-01-01T00:00:00Z</published>
    <summary type="text">Abstract: Phosphoinositol (PhoIns)-specific phospholipase C enzymes (PLCs) are central to the inositol lipid signaling pathways and contribute to intracellular Ca2+ release and protein kinase C activation. Five distinct classes of PhoIns-specific PLCs are known to exist in mammals, which are activated by membrane receptor-mediated events. Here we have identified a sixth class of PhoIns-specific PLC with a novel domain structure, which we have termed PLC-eta. Two putative PLC-eta enzymes were identified in humans and in mice. Sequence analysis revealed that residues implicated in substrate binding and catalysis from other PhoIns-specific PLCs are conserved in the novel enzymes. PLC-eta enzymes are most closely related to the PLC-delta class and share a close evolutionary relationship with other PLC isozymes. EST analysis and RT-PCR data suggest that PLC-eta enzymes are expressed in several cell types and, by analogy with other mammalian PhoIns-specific PLCs, are likely to be involved in signal transduction pathways.</summary>
    <dc:date>2005-01-01T00:00:00Z</dc:date>
    <dc:creator>Stewart, AJ</dc:creator>
    <dc:creator>Mukherjee, J</dc:creator>
    <dc:creator>Roberts, SJ</dc:creator>
    <dc:creator>Lester, D</dc:creator>
    <dc:creator>Farquharson, C</dc:creator>
    <dc:description>Phosphoinositol (PhoIns)-specific phospholipase C enzymes (PLCs) are central to the inositol lipid signaling pathways and contribute to intracellular Ca2+ release and protein kinase C activation. Five distinct classes of PhoIns-specific PLCs are known to exist in mammals, which are activated by membrane receptor-mediated events. Here we have identified a sixth class of PhoIns-specific PLC with a novel domain structure, which we have termed PLC-eta. Two putative PLC-eta enzymes were identified in humans and in mice. Sequence analysis revealed that residues implicated in substrate binding and catalysis from other PhoIns-specific PLCs are conserved in the novel enzymes. PLC-eta enzymes are most closely related to the PLC-delta class and share a close evolutionary relationship with other PLC isozymes. EST analysis and RT-PCR data suggest that PLC-eta enzymes are expressed in several cell types and, by analogy with other mammalian PhoIns-specific PLCs, are likely to be involved in signal transduction pathways.</dc:description>
  </entry>
</feed>

